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ABSTRACT
MECHANISTIC STUDY OF HEME PROTEIN-MEDIATED NITRIC OXIDE
DIOXYGENATION USING PHOTOLYTICALLY PRODUCED NITRIC OXIDE
by
Karl Koebke
The University of Wisconsin-Milwaukee, 2015
Under the Supervision of Professor A. Andy Pacheco

The previously reported NO precursor [Mn(PaPy2Q)(NO)]ClO4 (1), where
(PaPy2QH) is N,N-bis(2-pyridylmethyl)-amine-N-ethyl-2-quinoline-2-carboxamide, was
synthesized and proven capable of producing as much as 180 µM NO when irradiated by
a single 3 mJ 500nm laser pulse, in a 0.15 cm path cell, without the need for additional
sacrificial reductants or oxidants. Species 1 was first used to study the reaction of nitric
oxide with oxy-myoglobin (oxyMb) to form ferric myoglobin (metMb) and nitrate. This
reaction had long been assumed to proceed via the same iron-bound peroxynitrite
intermediate (metMb(OONO)) as the metMb-catalyzed isomerization of peroxynitrite to
nitrate. Recent research showed that the metMb-catalyzed isomerization of peroxynitrite
to nitrate produces detectable amounts of nitrogen dioxide and ferryl myoglobin
(ferrylMb). This suggested a “caged NO2” mechanism for peroxynitrite isomerization.
The presence of free NO2 and ferrylMb products revealed that small amounts of NO2
escape from myoglobin’s interior before recombination can occur, and these should also
be generated in the reaction of oxyMb with NO, if the common intermediate
metMb(OONO) is formed. However, in time resolved UV/Vis spectroscopy experiments
reported herein no ferrylMb was detected when oxyMb and NO reacted. The sensitivity
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of the methodology is such that as little as 10% of the ferrylMb predicted from the
experiments with metMb and peroxynitrite should have been detectable. These results lead
to the conclusion that the oxyMb + NO and metMb + ONOO− reactions do not proceed via
a common intermediate as previously thought. The conclusion has significant implications
for researchers that propose a possible role of oxyMb in intracellular NO regulation,
because toxic NO2 and ferrylMb are not generated during NO oxidation by this species.
Nitric oxide precursor 1 was then used for investigating the interaction between NO
and the protein truncated hemoglobin N (trHbN) from the pathogen Mycobacterium
tuberculosis. Oxy-trHbN is exceptionally efficient at converting NO to nitrate, with a
reported rate constant of 7.45108 M1 s1 compared to 4107 M1 s1 for oxyMb. This
work analyzed the NO dioxygenation kinetics of wild type trHbN and a set of variants, as
well as the nitrosylation kinetics for the reduced (red-trHbN) forms of these proteins. The
NO dioxygenation reaction was remarkably insensitive to mutations, even within the active
site, while nitrosylation was somewhat more sensitive. Curiously, the most profound
change to the rate constant for nitrosylation was effected by deletion of a 12 amino acid Nterminal sequence. The deletion mutant exhibited first-order kinetics with respect to NO,
but was zero-order with respect to protein concentration; by contrast all other variants
exhibited second-order rate constants greater than 108 M1s1. TrHbN boasts an extensive
tunnel system that connects the protein exterior with the active site, and is likely the main
contributor to the protein’s impressive NO dioxygenation efficiency. The results herein
suggest that N-terminal deletion abolishes a large-scale conformational motion, in the
absence of which NO can still readily enter the tunnel system, but is prevented from binding
to the heme for an extended period of time.
iii
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Chapter 1
Introduction
1.1. Overview of nitric oxide’s physiological roles
Nitric oxide is what most would call a “late bloomer”. It was discovered by Joseph
Priestley in 1772 under the name nitrous air, but it wasn't until 1988 that the small molecule
would finally enter the limelight.1,2 Research by Furchgott and Zawadzki into the effects
of various factors on vascular endothelial linings in isolated blood vessels led to the
discovery of a compound then called “endothelium-derived relaxing factor” (EDRF),
which was released by the vascular endothelial lining in response to acetylcholine (Fig.
1.1).3-5 Several clues hinted at the idea that EDRF might actually be nitric oxide or a similar
compound. Evidence included work that demonstrated the inactivation of EDRF by
superoxide,6 with which nitric oxide has known reactivity,7,8 and inhibition of EDRF's
effects in vitro by hemoglobin,9 a well-established target for nitric oxide ligation.10 A third
piece of evidence was the fact that EDRF's effects were mediated by cyclic GMP, whose
synthesis was in turn catalyzed by soluble guanylate cyclase,11 an enzyme known to be
activated by nitric oxide.12 Final proof for nitric oxide's role in physiology came in 1987
from the work of two independent groups.13,14 The first group confirmed the identity of
EDRF as nitric oxide by comparing the UV/Vis signature of hemoglobin interacting with
the EDRF with the known spectrum of nitrosylated hemoglobin.13 The second group
compared the chemiluminescences of EDRF and NO reacting with ozone, and
demonstrated that these were identical.14
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Figure 1.1. Illustration of the original experiment that led to the discovery of the
endothelium-derived relaxing factor (EDRF; illustration reproduced with permission from
the original creator, Prof. Michael Palmer of the University of Waterloo).
Since the original discoveries endogenous nitric oxide has been found in multiple
tissues,15 and over- or under-abundances of NO have been implicated in pathological
conditions in numbers that are sometimes difficult to believe. Indeed, with the modern
understanding of nitric oxide it is difficult to name a pathological condition that doesn't
involve this gaseous compound in some way. Examples include tumor angiogenisis,
neurological disorders such as Alzheimer's and autism, and cardiovascular pathologies
such as diabetes and septic shock. Whether the noted changes in nitric oxide concentration
are a cause or effect, however, has not always been clear.16-21 It's a testament to how much
research still lies ahead for the biomedical field that such a crucial and ubiquitous
mammalian signaling molecule evaded detection for as long as it did.
Nitric oxide’s physiological roles fall into two broad categories. In nanomolar
concentrations it is used for signaling; its function as the EDRF is one example of a
signaling role, but there are many others. At micromolar concentrations NO becomes toxic,
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but then it can be effectively used for fighting off bacterial infections.22 In vivo NO is
synthesized from L-Arginine in two consecutive reactions that are catalyzed by a class of
enzymes known as nitric oxide synthases (NOS, Fig. 1.2).23,24 Two isoforms of NOS,
eNOS (“endothelial”) and nNOS (“neuronal”) generate small quantities of NO for
signaling, whereas a third isoform called iNOS (“inducible”) is used by the immune system
to generate large quantities of NO for bactericidal purposes. As implied by the name, iNOS
is inducible and only synthesized at need.23,24

Figure 1.2. Outline of the key processes of endogenous nitric oxide biology, ranging from
initial synthesis, through its role in signaling, to its elimination when no longer needed.
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Given NO’s potency as a signaling molecule, and its potential toxicity at higher
concentrations, its in-vivo concentration must be strictly controlled. This is challenging
because for a reactive molecule NO has a comparatively long half-life (~0.5 s), an
impressive diffusion rate of 3.3105 cm2/sec, and the ability to pass through cell
membranes unimpeded. Based on these features one can estimate from computational
studies that a single source of nitric oxide could affect an area as great as 200 micrometers.
The central nervous system provides a particularly dramatic example of the challenges that
this number poses, since 200 μm would correspond to as many as 2 million synapses within
range of that one NO source! This property has led to the use of the term volume
transmitter for nitric oxide in the central nervous system.25-27 Several putative methods for
NO control have been identified to date. In most cases the primary control method may
well be to position the recipient of the NO signal, soluble guanylate cyclase (sGC, Fig.
1.2), near enough to the NOS source to ensure that it is the first target encountered.12 In
blood it has been hypothesized that serum proteins such as albumin can buffer NO
concentrations by forming S-nitroso adducts,28-31 while oxy-hemoglobin (oxy-Hb) can act
as a terminal NO sink by mediating its oxidation to nitrate. Oxy-myoglobin (oxyMb) may
play a similar role in muscle tissue (Fig. 1.2),32-35 which will be one major topic of this
dissertation.
1.2. Heme and NO: from the cradle to the grave
It seems rather fitting for nitric oxide's biological relevance to be discovered by
Ignarro and colleagues via hemoglobin, as nitric oxide has a long history and ever-growing
relationship to heme proteins. Nitric oxide has been known as a ligand of hemoglobin
since 1937,10 and since the initial EDRF studies heme proteins have been implicated in
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nitric oxide synthesis, signaling cascades, and as NO sinks when they mediate NO
oxidation: the three proteins shown in Fig. 1.2, NOS, sGC and oxyMb, are all heme
proteins.12,24,36-41
This work focuses on the interaction of NO with two heme proteins, myoglobin
(Mb) from horse heart, and truncated hemoglobin N (trHbN) from the pathogenic
bacterium Mycobacterium tuberculosis. Myoglobin was chosen for study because it is by
far the most researched protein capable of nitric oxide oxidation, and so can be used to
answer very specific mechanistic questions by combining careful experimental design with
judicious use of the prodigious amount of kinetic information already available on the
protein. A detailed review of the Mb properties relevant to NO oxidation is provided in
Section 1.3, while the experiments performed in this project are described in Chapter 3.
The remarkable feature of oxy-trHbN, on the other hand, is its phenomenal efficiency as
an NO oxidant. This is over an order of magnitude higher than that of Mb, and very near
the theoretical limit imposed by the maximum rate at which two molecules can diffuse
toward each other in solution. TrHbN is reviewed in Section 1.4, and the new experiments
with it are presented in Chapter 4.
The high value of the rate constant for the reaction of oxy-trHbN with nitric oxide
puts this reaction at the limit of those that can be studied by rapid mixing methods such as
stopped-flow, so most reactivity studies done prior to the investigations described here
involved steady-state experiments. Chapter 2 describes the development and testing of a
protocol for generating NO in situ by laser flash photolysis of a stable precursor. By using
a 5 ns pulsed laser to rapidly generate NO from the precursor, coupled with a rapidresponse UV/Vis spectrophotometer, the reactions of NO with oxy-trHbN could be directly
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monitored with relative ease (Chapter 4). The laser photo-generation of NO also proved
useful in the investigation of the reaction of NO with oxyMb (Chapter 3).
1.3. Myoglobin as a prospective NO sink
Myoglobin’s role as an oxygen storage protein in tissues is widely accepted,42,43
although studies demonstrate that myoglobin-deficient mice have apparently normal
muscle function.44 Many researchers have suggested that the protein may also serve a
variety of other physiological functions such as being a sink for NO.32-35 Oxy-myoglobin
(oxyMb) reacts with NO to release nitrate, leaving the myoglobin in an aquated ferric state
known as aquomet-myoglobin (metMb) (Scheme 1.1).32,33,45 As mentioned earlier NO
plays many important physiological roles as a signaling molecule,36,46 all of which take
advantage of its transient nature. Thus, the reaction of oxyMb with NO could serve to
spatially limit the range of a NO signal within tissues that contain high concentrations of
myoglobin, such as cardiac and skeletal muscles, and to keep the concentration of NO
within the cell below toxic levels.32
The commonly accepted first step in the reaction of oxyMb with NO is the
formation of a transient peroxynitrite-bound intermediate (metMb(OONO)), as shown in
Scheme 1.1,47,48 though such an intermediate has never been directly detected. At alkaline
pH an intermediate was detected by UV/Vis stopped-flow45 and rapid freeze-quench EPR49
studies that at first was believed to be the peroxynitrite species. However, an intermediate
species with identical kinetic behavior was later detected in the reaction of ferrylMb with
NO2, and identified as the metMb(ONO2) adduct (Scheme 1.1).50 This assignment was
confirmed using rapid freeze-quench resonance Raman
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Scheme 1.1. Proposed mechanisms for the reaction of NO with oxyMb, and of
peroxynitrite with metMb, highlighting the proposed common pathways for the two
processes.
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spectroscopic analysis.51

One indirect piece of evidence for the intermediacy of

metMb(OONO) is that metMb and related proteins can catalyze the isomerization of
peroxynitrite to nitrate, presumably through the same intermediate, as shown in Scheme
1.1.52-55 Model studies with synthetic porphyrins by Schopfer et al. provide additional
indirect evidence.56
While a peroxynitrite intermediate is generally agreed upon in the reaction of
oxyMb with NO, there has been ongoing debate on the mechanism by which this
intermediate rearranges to the nitrate adduct (metMb(ONO2)), with some researchers
favoring a concerted rearrangement (Scheme 1.1, path 1),54,57 and others an O-O bond
homolysis to generate a ferryl myoglobin (ferrylMb) intermediate and “caged” NO2,
followed by a recombination in which the nitrogen of NO2 binds to the ferryl oxo group
(Scheme 1.1, path 2).51,53,55,56 A series of experiments that followed the reaction of
peroxynitrite with metMb have provided persuasive evidence that the metMb(OONO)
adduct rearranges according to the path 2 homolysis model. The culmination came in a
recent paper where Su and Groves were able to directly detect the putative ferrylMb
intermediate.55 This and earlier papers also reported the nitration of a specific tyrosine
within Mb (Tyr103), presumably by NO2 generated from the peroxynitrite fragmentation,
and lost through the cage escape pathway (Scheme 1.1, lower-right).53,55

With the

chemistry of the metMb(OONO) species now fairly well established, the study described
in Chapter 3 revisits the question of whether this species in fact represents a common
intermediate when oxyMb reacts with NO, and when metMb reacts with peroxynitrite.

9
1.4. Truncated Hemoglobin N from Mycobacterium tuberculosis
1.4.1. Nitric oxide dioxygenation limited by diffusion alone. Mb’s activity as a
NO sink may or may not be one of its main physiological roles, but there’s other evidence
suggesting that NO dioxygenation is one of the hemoglobin family’s most ancient
functions along with dioxygen scavenging and/or sensing of concentration gradients.58-60
Flavohemoglobin is the poster child for the evolution of the hemoglobin family towards
this function. The flavohemoglobin-mediated oxidation of nitric oxide in Escherichia coli
occurs with an incredible efficiency that few enzyme systems can match (a rate constant of
~ 2.4  109 M1 s1) and, unlike Mb, flavoHbs can catalytically convert nitric oxide to
nitrate in the presence of oxygen and FAD without an outside reductase.61 In 1999 trHbN
was discovered in M. tuberculosis, and found to oxidize NO at rates similar to those
displayed by flavoHb, an impressive feat for a single domain globin.62 The question arises:
why does M. tuberculosis express trHbN, and how does such a simple protein achieve its
remarkable efficiency for nitric oxide oxidation?
M. Tuberculosis currently infects about a third of the global population, and
according to the WHO Global Tuberculosis report of 2014 was the causative agent for 9
million new cases of tuberculosis (TB) in 2013 alone, with 1.5 million deaths resulting.
Furthermore, there were 480,000 new cases of multidrug resistant TB reported in 2013,
with 210,000 deaths.63 Part of the difficulty of trying to eradicate TB is the large pool of
otherwise healthy individuals who harbor the disease, but have not yet presented any
symptoms. Upon infecting a healthy individual M. tuberculosis' spread is stopped after
initial infection and replication inside host macrophages. The infected macrophages are
surrounded by newly recruited healthy macrophages to create the “caseous granuloma”, an
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environment characterized by low pH and low dioxygen concentration that simultaneously
contains high concentrations of toxic reactive oxygen and nitrogen species such as nitric
oxide.64
M. tuberculosis' ability to survive in the harsh environment of the caseous
granuloma is in part thanks to trHbN, a 30 kDa homodimeric heme protein.62 This protein's
oxygenated form reacts with NO to form nitrate in a reaction analogous to that of oxyMb
with NO (Section 1.3 and Chapter 3), but the rate constant for the reaction is over an order
of magnitude higher (initially reported as 7.45108 M1 s1, which is near the diffusion
limit, compared to 4107 M1 s1 for oxyMb).65,66 Nitrate is released from trHbN after
oxygenation, and the nitric oxide is essentially detoxified.62,66 The overall reaction of nitric
oxide oxidation is shown in Scheme 1.2.

Scheme 1.2. Nitric oxide oxidation by oxy-trHbN; note that superficially the reaction is
identical to that of NO with oxyMb (Scheme 1.1).
1.4.2. Substrate tunnels, Phe62 gating, and active site amino acid effects.
TrHbN’s remarkable efficiency for oxygenating NO, in addition to its exceedingly high
affinity for oxygen (P50 ~ 0.015 mm Hg compared to 1 mm Hg for Mb62,67), has made the
protein a target of considerable interest over the past fifteen years, and resulted in a number
of publications that address these phenomena.68-82 A crystal structure of oxy-trHbN solved
by Milani et al. (Fig. 1.3)69 showed an extensive tunnel system through the protein that was
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Figure 1.3. Truncated Hemoglobin N structure illustrated using Pymol, with the tunnel
system shown in blue. (pdb 1idr) tunnel system calculated using the Caver 3.0.1 plugin85

Figure 1.4. Active site of Truncated Hemoglobin N illustrated using Pymol, with relevant
amino acids labeled. (pdb 1idr)
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suitable for ligand diffusion to the active site. This provides one obvious possible
explanation for the high rate constant for NO oxygenation by this protein; by contrast Mb
exhibits no obvious tunnels from the exterior to the active site. Later molecular dynamics
(MD) studies utilizing the “Caver” program to analyze transient tunnels found that two
more tunnels (BE and EH) could be added to those seen in crystal structures (short and
long).76 The oxy-trHbN crystal structure also exhibited an extended hydrogen bonding
network between residues Y33, Q58 and the bound dioxygen (Fig. 1.4), and mutagenesis
studies showed that this network is critical for the protein’s high dioxygen affinity.62,68,69
Finally, the crystal structure together with computational studies also revealed an apparent
gating residue into the active site in F62 (Fig. 1.4).73,81,83,84 The initial computational
studies suggested that dioxygen binding to reduced protein induces a conformational
change that opens the F62 gate and facilitates nitric oxide entry into the active site.73
Further theoretical analysis revealed that Y33 and Q58, in addition to their roles in binding
dioxygen, might also play a role in protein tunnel dynamics through their links with F62.74
Later computational studies using a method known as “adiabatic reactive molecular
dynamics” (ARMD) indicated that Y33 might play a more active role in the reaction
mechanism, and a Y33A mutation was calculated to have a large effect on the reaction
rate.78 In a fairly recent study the F62 gate residue was mutated to Ile, Trp, Ala, or Tyr, and
the nitric oxide oxidation rate was monitored using a polarographic method.81 For all of
the mutants the overall nitric oxide oxidation rate decreased by a factor of two to three,
which confirmed a role for F62 in the protein's function.
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1.4.3. The mysterious Pre-A region and its effect on nitric oxide dioxygenation.
Away from the heme active site crystal structures of trHbN showed a unique motif on its
N-terminus that serves no apparent structural purpose, as it protrudes out from the globin
fold into the outside solvent. Nevertheless, when Lama et al.77 tested the importance of
this N-terminal motif by deleting it from trHbN, they found that this decreased the rate of
nitric oxide oxidation in steady state and nitric oxide titration experiments by seven-fold.
Further proof of the motif's crucial role in this reaction came from adding it to the Nterminal end of a homologous HbN protein from Mycobacterium smegmatis where it was
previously lacking, and observing a two-fold increased rate of nitric oxide oxidation in the
new mutant HbN. Molecular Dynamics simulations suggested that the importance of the
N-terminal motif was linked to its effect on the long tunnel (Fig. 1.3), in particular a
conformational change which forces the F62 gate into a closed position.77 However, recent
NMR studies show that in solution this motif does not adopt an alpha helical structure as it
does in crystal structures, and that its presence had no measurable effects on F62
dynamics.79
1.4.4. Objectives of the trHbN investigations. The methodology that is described
in Chapter 2, for rapidly generating NO from an inert precursor using a laser pulse, is
ideally suited for studying the extremely fast reaction of trHbN with NO. Chapter 4 of this
dissertation presents kinetic investigations of the interactions between NO, trHbN, and
several variants of trHbN, that were made possible by using the laser-initiated
methodology. These studies were designed to directly monitor the roles of the putative F62
gate, active site amino acids Y33 and Q58, N-terminal motif, and other protein features
that prior studies had identified as important.
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Chapter 2.
Developing [Mn(PaPy2Q)NO]ClO4 (where PaPy2Q = N,N-bis(2pyridylmethyl)-amine-N-ethyl-2-quinoline-2-carboxamide) as a
tool for investigating rapid reactions of proteins with nitric
oxide
2.1. Overview
2.1.1. Background on metal-based NO photo-precursors. The study of nitric
oxide and its interaction with proteins has attracted great interest since the late 1980s due
to the realization that this small molecule has many important physiological functions. In
particular it acts as an intracellular messenger when present in nanomolar concentrations,
while acting as a highly cytotoxic host defense mechanism when produced in micromolar
concentrations, due to its reaction with superoxide to form peroxynitrite.1 Nitric oxide’s
high reactivity makes it difficult to handle, which has led to the creation of a large number
of stable precursor compounds that release nitric oxide only under conditions readily
controlled in the laboratory, such as the application of heat, a change in pH, or exposure to
light.2,3 The interest of the Pacheco lab in reactions with nitric oxide that occur on
relatively fast time-scales, reaching down to microseconds, has led to an exploration of
precursors that release nitric oxide upon irradiation with short (nanosecond) laser pulses.
This chapter will focus on the development of methodologies for using one such precursor
in enzymatic studies.
Photo-initiation of reactions has been a hallmark of studying fast timescale
reactions and transient intermediates ever since the pioneering studies by Norrish and
Porter.4-6 Caged nitric oxide compounds include organic compounds such as the CNO
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family,7 as well as a large number of inorganic compounds based mostly on iron,8 or
ruthenium.9,10 Many of these compounds were created as mimics of bioinorganic metal
centers found in proteins of particular interest, and a review of these proteins that served
as muses for particular classes of synthetic compounds makes for interesting and
illuminating reading. Design of the NO photo-precursor class that will be the subject of
this chapter was inspired by a rigorous study of the non-heme iron enzyme nitrile hydratase,
which showed some interesting and unique chemistry with nitric oxide. This study will
now be summarized.
Nitrile Hydratases (NHase) are a class of metalloenzymes containing either Co or
Fe which convert nitriles to carboximides. Since its discovery in Arthrobacter sp. J-1,11
NHase has been adapted successfully for the large-scale productions of acrylamide and
nicotinamide, and the treatment of agricultural and industrial wastewater by the production
of acrylonitrile.12-14 While Co(III) NHase dominates the industrial applications, the Fe(III)containing NHase from Rhodococcus sp. N-771 attracted particular interest because it is
inactivated by nitric oxide, but can be reactivated if the NO is removed by photolysis.15
This was the first experimental evidence for photo-reactivation utilizing nitric oxide in
biology.16,17
Crystallographic studies of the active form of NHase from Rhodococcus sp. R312,
and of the inactive nitrosylated form of NHase from Rhodococcus sp. N-771, showed that
in each case the Fe center was formed by two mainchain amide nitrogen atoms, two
cysteine ligands post-translationally modified to sulfenic and sulfinic acids, and one
unmodified cysteine.18-20 The sulfinic and sulfenic acid cysteine residues 112 and 114,
along with Serine 113, were hypothesized to form a “claw” setting for nitric oxide and to
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be important factors for nitric oxide binding to the metal center. Calculations showed that
light photolytically cleaved the Fe-NO bond by promoting an electron into an orbital with
σ*(Fe-NO) character.17,21
Bioinorganic chemists became interested in NHase due to its unique metal center,
which was the first example of a metalloenzyme that contained deprotonated carboxamido
nitrogens, along with sulfur from cysteine in complex with a metal center, as well as
sulfinic and sulfenic acid cysteine ligations.22 The exceptional photo-activation quantum
yield of 0.48 found by laser photolysis also led to speculation that photo-reactive
compounds could be modeled after this novel iron center of NHase.15,23 NHase synthetic
models from a number of different groups gave insights into how the metal environment
of NHase gives an Fe(III) that is more labile, and acts as a Lewis acid instead of
participating in redox reactions.24,25 The presence of deprotonated carboxamido nitrogens
ligated to the Fe(III) center of NHase garnered particular interest.26 Carboxamido N
linkages to low-spin non-heme Fe with N or S coordination proved to stabilize the Fe(III)
redox state over Fe(II), shifting the redox potential as much as 1 V to the negative and
protecting the Fe against hydrolytic decomposition to a degree.25
While studying the effects of ligating a single carboxamido nitrogen to Fe(III) in
2002, Mascharak and co-workers reported nitric oxide photolability in the nitrosyl species
[(PaPy3)Fe(NO)](ClO4)2 (Fig. 2.1, where PaPy3 is N,N-bis(2-pyridylmethyl)amine-Nethyl-2-pyridine-2-carboxamide: a pentadentate ligand with a built-in single carboxamide
group).27,28 This compound, in which the metal center has {Fe(NO)}6 configuration,29
correctly mimicked the photochemical characteristics of the nitrile hydratase active site.28
Iron nitrosyls of this kind, however, proved unstable under biological conditions due to
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Figure 2.1. Chemical Structure of the PaPy3M(NO)+ complexes (Species 1 when M =
Mn).

Figure 2.2. Chemical Structure of PaPy2QM(NO)+ (Species 2 when M = Mn).
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reactions with oxygen,30-32 and NOx disproportionation.33 This led to the creation of
ruthenium and manganese versions of the compound: [(PaPy3)Ru(NO)](BF4)2 and
[(PaPy3)Mn(NO)]ClO4 (Fig. 2.1).34,35 These complexes were shown to be potent NO
delivery systems, suitable for biological applications, when irradiated with UV (Ru
complex) or visible (Mn complex) light. Their physiological utility was demonstrated in
studies of light-dependent activation of soluble guanylate cyclase in rat thoracic aortic ring
models, while their applicability to the study of fast NO reactions was revealed in a study
of NO binding to cytochrome c oxidase with an apparent lifetime of 77 µsec.35-37
Attempts to increase the photo-activity of the ruthenium and manganese complexes
led to the synthesis of a new ligand, PaPy2QH, where the pyridine directly connected to
the carboxamido group in PaPy3H is replaced with a quinolone (Fig. 2.2). The hope was
that this would act as a light harvesting group directly ligated to the metal. In support of
this hypothesis, the ruthenium nitrosyl derived from PaPy2QH proved to have increased
photo-activity at several wavelengths of incident light.38 Even more interesting was the
related Mn derivative, which showed photo-activity upon illumination with near IR
radiation with wavelengths as long as 900nm.39 This was the first metal nitrosyl with both
biological stability and activation by light at such low energy wavelengths.40
Computational studies of MnPaPy3NO (1) and MnPaPy2QNO (2) were done to in
an attempt to discover how these complexes were able to release nitric oxide using much
lower energy light (500-800nm) than their Ruthenium-based counterparts.41,42 Early
studies suggested that the ruthenium(III) complexes' nitric oxide photo-lability arose from
symmetry-allowed charge transfer transitions from bonding to antibonding molecular
orbitals within the metal-NO -backbond; the authors refer to such transitions as “dπ_π*
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→ π*_dπ”.9,43 Merkle et al. subsequently explained why NO was photo-labilized by 400 –
450 nm light in the Mn compounds, instead of UV light as in the Ru compounds, by
invoking an admixing of metal(d) → L(Py_π*) charge transfer character into the dπ_π* →
π*_dπ charge transfer transitions for the Mn complexes.41,42 This explanation, however,
did not account for the ability of complexes 1 and 2 to be photo-labilized with wavelengths
as long as 800nm.

At such low energies only dxy → L(Py/Q_π*) transitions are

theoretically predicted, which disallows any direct excitation of

dπ_π* → π*_dπ

transitions. Furthermore, direct excitation of a dπ_π* → π*_dπ transition could not explain
why NO photorelease is so much greater for species 2 than species 1, given that the dπ_π*
→ π*_dπ transition is predicted to have very similar energies for both 1 and 2. Taken
together these facts suggest that nitric oxide release by 600 – 800 nm light must occur
through a different mechanism than the direct mechanism described for ruthenium (III)
complexes. Merkle et al. suggested an indirect pathway by which photo-excitation first
occurs via the dxy → L(Py/Q_π*) transition, which can then populate a low-lying dxy →
π*_dπ excited state; the latter transition has zero oscillator strength and so can’t be directly
induced by irradiation. Once formed though, the dxy → π*_dπ excited state can undergo
intersystem crossing into a dxy → π*_dπ triplet state, which has a weakened Mn-NO bond
that makes it suited for photo-release of nitric oxide.41,42 Ligand effects on the energy of
the dxy → L(Py/Q_π*) excited state, and the sizable extinction coefficients in the 600800nm range, make the manganese nitrosyl complexes highly tunable for NO photorelease.
2.1.2. The problem of uncontrolled NO release.

Controlling nitric oxide

concentration physiologically and in in vitro experiments means not only having a
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procedure to generate it where and when it's needed, but also being able to eliminate it
when necessary. Compounds that irreversibly react with nitric oxide are sometimes called
nitric oxide sinks, and physiologically these include proteins studied by the Pacheco lab
such as myoglobin (discussed in Chapter 3),44 or truncated Hemoglobin N from
Mycobacterium tuberculosis (discussed in Chapter 4).45 Ruthenium complexes have
attracted attention as potential synthetic NO sinks because of the high stability of the RuNO bond, which persists through a variety of redox and substitution reactions.46-48
[RuIII(EDTA)H2O] (RuEDTA, Fig. 2.3) has shown particular promise due to its incredibly
efficient and strong bonding to nitric oxide, displaying a 2nd order rate constant of 2.24107
M1 s1, and binding constant greater than 108 M1.49 Investigations into the use of
RuEDTA as a therapeutic agent gave hope for its utility in septic shock therapy,50 as well
as tumor treatment.51 On the downside RuEDTA in aerobic aqueous environments is
known to form μ-oxo RuIII-RuIV dimers,52 which may cause difficulties for physiolgical
applications, since the bioavailability of this dimer is unknown. Because of this researchers
interested in therapeutic applications of NO scavengers have also investigated
[RuIII(H3dtpa)Cl], which does not show a tendency to dimerize (most likely because of
the pKa of the H2O molecule of 8.3).53 This compound has been tested for applications in
treatment of inflammation 54, inflammatory cascade management during cardiopulmonary
bypass,55 and cardiac allograft rejection.56 For in-vitro applications, those of interest in the
Pacheco lab, the eventual dimerization of RuEDTA is of little consequence, so
[RuIII(H3dtpa)Cl] will not be discussed further herein.
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Crystallographic studies of RuEDTA show that the ruthenium is coordinated by two
nitrogen atoms and three carboxylate groups of the EDTA, with H2O taking up the sixth
position (Fig. 2.3).57 The fourth carboxylate group of EDTA is commonly referred to as
the “pendant group”, does not directly coordinate to the ruthenium, and appears to be the
cause of the high lability of water from this complex. It has been suggested that the pendant
group labilizes the water by interacting with it and creating a somewhat open area for an
incoming nucleophile,58,59 though this hypothesis has not gone unopposed. An alternative
hypothesis suggests that activation for attack by the incoming nucleophile is a result of
transient binding by the pendant group to the
ruthenium

itself.60

Whatever

the

specific

mechanism, substitution of the pendant group
significantly alters the rate at which RuEDTA binds
to nitric oxide, and therefore its utility as a nitric
oxide sink.61 In particular in RuMEDTA, where the
pendant group is substituted with a methyl (Fig.
2.3), the rate of nitric oxide binding is decreased by
four orders of magnitude from 2.24107 M1 s at
Figure 2.3. Chemical Structures
of RuEDTA and RuMEDTA:
RuMEDTA, R = CH3; RuEDTA,
R = CH2COO.

7.3 C for RuEDTA, to 3103 M1 s1 at 15 C for
RuMEDTA.61
This chapter covers the synthesis of the

photo-active nitric oxide donor [Mn(PaPy2Q)(NO)]ClO4 (2), as well as the NO scavengers
RuEDTA and RuMEDTA, with particular attention to several difficult steps that have been
under-described in the available literature. The chapter also introduces the reader to the
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photochemical properties of 2 that must be considered when designing experiments in
which 2 is used to study rapid reactions of nitric oxide with proteins. Two studies in which
species 2 was actually used will be described in Chapters 2 and 3. Finally, this chapter
shows how RuMEDTA in particular can be used to capture nitric oxide slowly released
from 2 prior to laser photo-initiation, which can interfere with particularly sensitive
experiments. Kinetic studies of RuMEDTA binding nitric oxide will also be presented.
2.2. Materials and Methods
2.2.1. General materials. All reagents were purchased from Sigma-Aldrich or
Fisher Scientific unless otherwise specified. Methanol and ethanol were distilled over
magnesium methoxide or magnesium ethoxide, respectively, under anaerobic conditions.
Nitrogen, and argon gas were purchased from Airgas, while nitric oxide gas was purchased
from Praxair and purified by bubbling through a 2M NaOH solution, and then drying over
NaOH pellets before use.

The pH-change activated NO precursor 1-(N,N-

diethylamino)diazen-1-ium-1,2-diolate (DEANO) was prepared by the method of Drago
and Paulik,62 and handled as described by Purwar et al.63
2.2.2. Instrumentation. Routine UV/Vis spectra were obtained using a Cary 50
spectrophotometer (Varian); an instrument installed in the glovebox was used for airsensitive measurements. Photochemical fragmentation of 2 (Fig. 2.2) was initiated with
10 ns, 500 nm pulses from an OPO tunable laser (Opotec Rainbow Vis). An Olis RSM1000 Spectrophotometer measured the absorbance changes induced in solution by the laser
pulse. The configuration of the laser and spectrophotometer equipment was as described
in general terms elsewhere 64,65, except that the laser pulse was transmitted by fiber optic
cable instead of by mirrors. Except where noted, in all experiments the solutions were held
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in 1.5 mm  1.5 mm fluorometer submicro cuvettes (Starna). The laser pulse was focused
as a spot of ~5 mm diameter, which irradiated the entire cuvette window. The laser pulse
energies were measured before each day of experiments using a Scientech AC2501
bolometer; typical pulse energies were 3 mJ/pulse.
Where needed the redox-active dyes indigo di-, tri- and tetrasulfonate were
electrochemically reduced in a bulk electrolysis vessel, using a BASi Epsilon EC
potentiostat to set the potential to 300mV, and a Ag/AgCl electrode (BASi, Model RE5B) as a reference. Once reduced the reactions of the mediator dye solutions with putative
oxidants could be monitored by UV/vis spectroscopy using one of the Cary 50
spectrophotometers. Cyclic voltammograms of methyl viologen were collected before
setting the potential of the bulk electrolysis solution, and the calculated midpoint potentials
were used to account for any drift in the reference electrode (the midpoint potential of
methyl viologen was taken to be 0.449 V vs SHE).66
NMR spectra were obtained on a Bruker DPX300 with a 5 mm broadband (BBO)
probe.
2.2.3. Synthesis of species 2. The NO photo-precursor 2 (Fig. 2.2) was synthesized
using the procedure described by Eroy-Reveles et al;39 important details are provided
below. At each stage in the synthesis of the ligand N,N-Bis(2-pyridylmethyl)amine-Nethyl-2-quinolinecarboxamide (PaPy2QH), the intermediate product purities were
confirmed by NMR.
The synthesis of ethylquinaldate from quinaldic acid was straightforward and
exactly as previously described,39 except that longer reflux times and addition of slightly



Indigo disulfonate is more commonly referred to as “indigo carmine”.
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more sulfuric acid slightly improved the yields (see Results and discussion). A mixture of
1.83 g (9.09 mmol) of ethylquinaldate, 2.73 g (45.47 mmol) of ethylenediamine, and 1.4
mL of pyridine was heated on a boiling water bath for 4 hours, after which the solvent was
removed at reduced pressure, and the remaining oil was acidified to pH 5 with concentrated
HCl. After diluting with 30 mL of H2O, the aqueous solution was washed with CH2Cl2 (2
 100 mL). Concentrated NaOH was then added to the aqueous layer until no more
precipitation occurred, or the pH of the solution was 11. The desired product was extracted
from the aqueous layer with CH2Cl2 (4  75 mL), after which the organic layer was dried
over anhydrous MgSO4 and filtered. Removal of the solvent afforded the product (N-(2aminoethyl)-quinolinecarboxamide) as a yellow oil. After storage at 20 C overnight this
oil solidified to a pale yellow solid that could be crushed to a powder, before further
removal of solvent under a vacuum.
A mixture of 1.47g (6.83 mmol) of N-(2-aminoethyl)-quinolinecarboxamide, 22.24
g (13.66 mmol) and 2-(chloromethyl)-pyridine hydrochloride (Picolyl Chloride), dissolved
in 3.6 mL of deionized H2O and 2.8 mL of 10 M NaOH, was stirred at 70 C for 4 h. At
this point 45 mL of saturated NaOH solution was added to the mixture, and the desired
product (PaPy2QH) was extracted into CH2Cl2 (4  75 mL); the first CH2Cl2 aliquots were
brown, while the final one was pale yellow. The pooled brown organic layer was washed
successively with H2O adjusted to pH 5 using HCl (7  130 mL), saturated brine solution
(3  100 mL), and 10 M NaOH solution (3  100mL). Finally, the CH2Cl2 solution was
dried over anhydrous MgSO4 and filtered. Removal of the solvent afforded the ligand as
a dark brown oil.
The synthesis of Mn(PaPy2Q)(OH)]ClO4 basically followed the procedure of Eroy-
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Reveles et al,39 but we found that it was critical to do the synthesis under rigorously dry
and anaerobic conditions, in order to ensure that the desired product crystallized. This in
turn was essential for obtaining pure 2 in the subsequent step.
Important note: the final synthesis of 2, and all subsequent manipulations of this
species, must be carried out in as near as practicable to total darkness. A batch of 100
mg (1.6 mmol) Mn(PaPy2Q)(OH)]ClO4 was dissolved in 20 mL of a MeCN/MeOH
mixture (2:18) and thoroughly degassed with argon. The reaction vessel was then wrapped
in aluminum foil to keep it dark, and nitric oxide gas was passed over the solution for 10
minutes. The maroon solution was stored under positive nitric oxide pressure overnight
while stirring at room temperature. The solution was then transferred to a 20 C freezer
for at least 24 hours until green crystals of species 2 formed. All manipulations of 2 in
solution after its synthesis were done in dark rooms equipped with red lights that were kept
as dim as possible.
The Kinetics of the final reductive nitrosylation of Mn(PaPy2Q)(OH)]ClO4 were
measured by running the reaction in a vessel that contained a port through which aliquots
of the solution could be extracted using a gastight syringe. Aliquots were taken from the
mixture every forty minutes, diluted 1:100 in H2O, and examined by UV-Vis spectroscopy
in the 200 – 800nm range. Additional nitric oxide gas was added after every two
measurements.
The concentration of nitric oxide produced by a laser flash was determined by timeresolved UV/Vis spectrophotometry using the OLIS rapid scanning instrumentation
described in Section 2.2.2. The concentration could be calculated directly using the known
extinction coefficient spectrum of 239 when 2 was present in high concentrations (200-800
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µM), or indirectly by coupling the nitric oxide release to production of nitrosylated catalase
when 2 was present at low concentrations (5-30 µM). In these cases approximately 8 µM
catalase were added to act as a reporter, and the spectral changes observed after photolysis
in the 380 – 602 nm range were fit using the known extinction coefficient spectra of
catalase and its nitrosylated derivative.63,67
2.2.4.

Synthesis

of

Methylethylenediaminetriacetate

RuMEDTA
(MEDTA),

and

RuEDTA.

[RuIII(EDTA)H2O]

[RuCl5H2O]K2,
(RuEDTA),

and

[RuIII(MEDTA)H2O] (RuMEDTA) were synthesized following literature procedures.59,6870

One point of note is that it proved essential to synthesize [RuCl5H2O]K2 fresh in the lab

using the method of Mercer et al;68 commercially available material did not produce the
desired results. Note that the UV/Vis extinction coefficients calculated for the synthesized
RuEDTA and RuMEDTA products were lower than the literature values, suggesting that
the products were contaminated by non-absorbing impurities. The crude products were
used for the preliminary studies described here.
2.3. Results
2.3.1. Synthesis of species 2. The first three steps in the synthesis of photo-active
species 2 required very few changes from the original published procedure of Eroy-Reveles
et al.39 During ethyl quinaldate synthesis it wasn't uncommon to allow the solution to
reflux for 48 hours instead of the prescribed 24 h, and add an extra 1 mL of sulfuric acid to
the reaction mixture. With such minor changes yields as high as 95% could be obtained.
Also, it is important that when neutralizing with sodium bicarbonate the reaction mixture
is poured into the sodium bicarbonate and not vice versa. Due to the above, it proved
convenient in this neutralization step to use 100 mL of saturated sodium bicarbonate
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instead of the literature prescribed 20 mL.
The only notable change during the synthesis of N-(2-Aminoethyl)-2quinolinecarboxamide was a step in which the literature instructions were to make the
reaction mixture basic by adding 30mL of pH 10 NaOH solution. This proved ineffective,
so in the current work the pH of the reaction mixture was adjusted to pH 11 with
concentrated NaOH (~10M), or until additional precipitate no longer formed. Using this
procedure high yields of the desired product were obtained.
After obtaining the PaPy2QH ligand the literature gives two possible reaction
pathways for the final two inorganic synthetic steps.39 A recent paper implies that species
2 is best obtained from the intermediate Mn(PaPy2Q)(H2O)]ClO4;41 however, the original
reference of Eroy-Reveles et al. cautions that this species is air-sensitive, and recommends
making 2 from the stable intermediate Mn(PaPy2Q)(OH)]ClO4.39 The latter procedure was
used in this work. Synthesis of Mn(PaPy2Q)(OH)]ClO4 followed the published procedure,
but care was needed to keep the reaction dry and anaerobic, or the product didn’t
crystallize. Most likely exclusion of water was the critical parameter, but this was most
readily accomplished by blanketing the reaction mixture with dry argon, which excluded
oxygen as well.
The published final step in the synthesis of 2 appears straightforward, but in
practice product purification after the fact proved difficult. At first no green crystals would
form, but an impure brown powder could be obtained by adding 30 mL of ether to the 20
mL reaction solution. Later studies showed that this impure product contained oxidizing
equivalents of uncharacterized Mn(III) compounds (see Section 2.3.4), which could
complicate its use for certain experiments. To obtain crystalline 2 it was essential to use
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crystalline Mn(PaPy2Q)(OH)]ClO4 as starting material.
2.3.2. A kinetic study of the formation of 2 from Mn(PaPy2Q)(OH)]ClO4. The
realization that Mn(III) species could be contaminating non-crystalline preparations of 2
immediately raised the possibility that one such species could be unreacted
Mn(PaPy2Q)(OH)]ClO4 starting material. To determine if enough time was being allowed
for the reductive nitrosylation of Mn(PaPy2Q)(OH)] a new reaction vessel was designed
that would allow aliquots of the reacting solution to be removed for analysis without
introducing air into the vessel.
Figure 2.4a shows the UV/Vis absorption spectra taken during the reductive
nitrosylation of Mn(PaPy2Q)(OH)]ClO4 for the synthesis of 2. Spectra of reaction mixture
aliquots diluted 1:100 with water were taken every 40 minutes.

Figure 2.4b is an

absorbance vs. time slice taken at 500 nm through the spectra of Fig. 2.4a. This plot shows
that the absorbance at 500 nm increases linearly for about 300 min (6 h), then plateaus.
The nitrosylation step was usually allowed to proceed for at least 8 h, which should be
enough under the reaction conditions of Fig. 2.4. Note however that Fig. 2.4b shows the
nitrosylation to be essentially zero-order in Mn(PaPy2Q)(OH)]ClO4. Therefore, if the
amount of starting material were to be doubled in future syntheses, the time allowed for
the reaction should also be doubled.
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Figure 2.4. (a) UV-Vis absorption spectra taken every 40 minutes for 8 hours during the
reductive nitrosylation of 100 mg (1.6 mmol) Mn(PaPy2Q)(OH)]ClO4 using reaction
mixture aliquots diluted 1:100 in H2O. (b) Absorbance vs time slice taken at 500 nm
through the spectra of (a).
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2.3.3. Nitrosative properties of NO photo-precursor 2. Figure 2.5 shows the
amount of NO that was generated after irradiating a pH 7 solution initially containing 20
M 2 and 8.7 M catalase in a 0.3 cm pathlength fluorescence cell, with a 500 nm laser
pulse. The amount of NO produced was calculated from the known extinction coefficient
difference spectrum catNO – cat.63,67 Under these conditions the initial pulse produced
about 2.5 M NO, after which the amount of NO present increased linearly at a rate of
about 24 nM/s. The linear increase is attributable to NO photolysis caused by the
spectrophotometer probe beam. This experiment was repeated with concentrations of 2
varying from 5 to 30 µM to determine how the concentration of NO released depended on
the concentration of 2 initially present. Similar experiments were also done with solutions
initially containing 200 – 800 µM 2. At the higher concentrations of photo-precursor the
amount of NO generated could be determined directly from the spectral change arising
from denitrosylation of 2, sample spectral changes associated with these experiments are
provided in Chapter 3.
In Fig. 2.6 the data obtained in the presence and absence of catalase are combined
to show how the amount of NO generated by the laser pulses varied as a function of [2].
This is seen to initially increase as [2] increases, but then to level off. The data were fit
using Equation 2.1, which is an empirical equation that seeks to take into account self-

[ NO]  a  [2]  eb[ 2]

Eq. 2.1

screening by the photo-precursor. Thus, at very low concentrations of 2 the amount of NO
generated is predicted to increase roughly linearly with a slope a as predicted by Beer’s



The experiments in the presence of catalase were carried out by Jennifer McGarry of the Pacheco group.
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Figure 2.5. Concentration of nitric oxide produced after a solution initially containing 20
µM of photo-precursor 2 and 8.7 µM catalase in a 0.3cm pathlength cell was irradiated by
a single ~3 mJ laser pulse of 500 nm light. Red line: linear fit to the data, which yielded a
y-intercept of 2.4920.002 µM and a slope of 24.23  0.07 nM/s. Reaction conditions: 50
mM HEPES buffer adjusted to pH 7; see text for details.

Figure 2.6. Amount of NO released in solutions containing varying amounts of photoprecursor 2, housed in 0.3cm  0.3cm pathlength fluorescence cells, by irradiation with
single 500 nm, ~3 mJ laser pulses. Red trace: least-squares best fit to Eq. 2.1.
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law. However, as the concentration of 2 increases solution near the cuvette window begins
to screen the laser pulse from the solution deeper inside the cuvette, which is the solution
sampled by the spectrophotometer probe beam. At this point the increase in NO photogenerated departs from linearity and levels off. Presumably the amount of NO released
would actually decrease at even higher concentrations of 2.
The experiments summarized in Fig. 2.6 were done using a 0.3 cm  0.3 cm
pathlength fluorescence cuvette, which in retrospect is not optimal when self-screening is
an issue. In later experiments the Pacheco group has switched to 0.15 cm  0.15 cm cells.
Though the decreased pathlength for the probe beam decreases sensitivity, decreasing the
depth that the laser pulse must penetrate roughly doubles the maximum concentration of
nitric oxide that can be produced per pulse; with the shorter pathlength NO concentrations
as high as 160 µM have been generated (see for example Chapter 3).
2.3.4. Oxidative properties of non-crystalline preparations of species 2. Crude
preparations of 2 were found to be oxidizing agents in experiments where they were added
to solutions of reduced redox-active dyes. In preparation for these experiments a solution
containing 150 µM each of the reduced dyes indigo di-, tri and tetrasulfonate, in 1 M NaCl,
50 mM HEPES buffer adjusted to pH 7, was prepared as described in Section 2.2.2. One
aliquot of this solution was then mixed with one equivalent of buffer to give a solution with
a concentration of 75 µM/mediator, and the subsequent spectral changes were monitored
by UV/Vis spectroscopy in a glovebox every 15 s for 30 min (Fig. 2.7). The slow
absorbance increase with time seen at 616 nm is due to re-oxidation of the dyes in the
absence of any added oxidizing agents. Presumably the small amount of oxidation
observed is due to residual oxygen in the glovebox, so this experiment serves as a control
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for the experiments below.

Figure 2.7. UV/Vis spectral changes observed after
mixing 300 µL of a solution containing 150 µM each of
reduced indigo tetra-, tri-, and disulfonate, and 1 M NaCl
in 50mM HEPES buffer adjusted to pH 7, with 300 µL of
NaCl-free HEPES buffer (final concentrations of 75 µM
fer each of the mediators, and 0.5M NaCl). After mixing
UV/Vis spectra were taken every 15 seconds for 30
minutes.
Figure 2.8a shows the spectral changes observed after mixing an aliquot of the
reduced dye solution 1:1 with a solution containing NO formed from the precursor
DEANO.63 The mixed solution contained roughly 150 µM NO in addition to 75 µM of
each of the dyes. Figure 2.8b shows an absorbance vs. time slice through the Fig. 2.8a
spectra taken at 616 nm. The peak with maximum absorbance at 616 nm now grows in
more rapidly than in Fig. 2.7, demonstrating that NO can oxidize the reduced dyes. The
red trace in Fig. 2.8b is an exponential least-squares best fit to the data, and it shows that
the dyes are being oxidized with a half-life of about 6.7 min (400 s).
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Figure 2.8. (a) UV/Vis spectral changes observed after mixing 300 µL of a solution
containing 150 µM each of reduced indigo tetra-, tri-, and disulfonate, and 1 M NaCl in
50mM HEPES buffer adjusted to pH 7, with 300 µL of a solution containing NO generated
from the precursor DEANO. The mixed solution contained roughly 150 µM NO in
addition to 75 M of each reduced dye. Spectra were taken every 15 seconds for 30
minutes. (b) Absorbance vs time slice taken from (a) at 616 nm; the red trace is the leastsquares best fit with an exponential function.
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Figure 2.9. UV/Vis spectral changes observed after mixing 300 µL of a
solution containing 150 µM each of reduced indigo tetra-, tri-, and
disulfonate, and 1 M NaCl in 50mM HEPES buffer adjusted to pH 7, with
300 µL of a solution containing Mn(PaPy2Q)(OH)]ClO4. The mixed
solution contained 143µM Mn(PaPy2Q)(OH)]ClO4 in addition to 75 M
of each reduced dye. Spectra were taken every 15 seconds for 30
minutes.
Figure 2.9 shows the spectral changes observed after mixing an aliquot of the
reduced dye solution 1:1 with a solution of Mn(PaPy2Q)(OH)]ClO4 to give a final
concentration of 143 µM of the complex. In this case there is an immediate oxidation of
the dyes within the deadtime of the experiment, presumably by the Mn(III). Note however
that, over time, the amplitude of the 616 nm signal in Fig. 2.8 surpasses that of Fig. 2.9,
indicating that eventually the presence of NO leads to a greater extent of dye oxidation. A
possible explanation of this would be if the midpoint potential of Mn(PaPy2Q)(OH)+ is
comparable to those of the mediators (30 mV, 80 mV and 125 mV for the tetra- tri- and
disulfonate, respectively), so that an equilibrium is established between oxidized and
reduced species.
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Figure 2.10. (a) UV/Vis spectral changes observed after mixing 300 µL of a solution
containing 150 µM each of reduced indigo tetra-, tri-, and disulfonate, and 1 M NaCl in
50mM HEPES buffer adjusted to pH 7, with 300 µL of a solution containing the NO
precursor species 2 from a crude preparation. The mixture nominally contained 900 µM
of 2 in addition to 75 M of each reduced dye. Spectra were taken every 15 seconds for 30
minutes. (b) Absorbance vs time slice taken from (a) at 616 nm; the red trace is the leastsquares best fit with a combined exponential and linear function (Eq. 2.2).
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Figure 2.10a shows the spectral changes observed after mixing an aliquot of the
reduced dye solution 1:1 with a solution containing NO precursor species 2 from a crude
preparation, so that the mixture nominally contained 900 µM of 2. Figure 2.10b shows an
absorbance vs. time slice through the Fig. 2.10a spectra taken at 616 nm. The spectra of
Fig. 2.10a look different from those of Figs 2.7 – 2.9 because species 2 absorbs in the 500
nm – 800 nm range, and contributes to them. Nevertheless one can still distinguish the
characteristic signal at 616 nm from the indigo dyes growing over the underlying signal
from species 2. The spectral changes can be modeled with a combined exponential and
linear function (Eq. 2.2; red trace Fig. 2.10b). The exponential phase has
0
A616  A616
 Amp  (1  e  kt )  b  t

Eq. 2.2

a half-life of about 90 s, which is about 4.5 shorter than that seen in Fig. 2.8b for dye
oxidation by large amounts of NO generated from DEANO. This suggests that the
exponential oxidation phase may be caused by the presence of other oxidants, such as
Mn(III) species, in addition to NO released during sample preparation but before mixing.
The amplitude of the exponential phase is 0.017 absorbance units, or about 4% of that
observed in Fig. 2.8b in the presence of 150 M NO. The linear oxidation phase seen in
Fig. 2.10b is most likely due to NO released from 2 by photolysis with the
spectrophotometer probe beam, as seen also in Fig. 2.5. Finally, note that the 616 nm signal
at t = 0 is non-zero in Fig. 2.10, even after correcting for the contribution from species 2.
This could be due to “instantaneous” oxidation comparable to that seen in the presence of
143 µM Mn(PaPy2Q)(OH)]ClO4; however, a non-zero absorbance at t0 is also observed in
Fig. 2.8, where NO was generated from DEANO, and even in Fig. 2.7 where no oxidant
was specifically added. Thus, some dye oxidation appears to occur within the stock upon
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standing, so the t0 absorbance in these experiments is not a meaningful parameter.
2.3.5. Estimate of latent nitric oxide release. The results shown in Fig. 2.10
suggest that even in highly pure solutions of 2, some NO release may be occurring ahead
of laser photo-initiation. Figure 2.11 shows the results of an experiment designed to
quantify the extent of such pre-release of NO. In this experiment 10.0 µM of metmyoglobin (metMb) was reduced using 100 µM indigo tetrasulfonate, in a solution that
also contained 600 M pure 2. The solution was then transferred to a cuvette and
illuminated with a 500 nm, ~3 mJ laser pulse. Fig. 2.11a shows the UV/Vis spectra taken
before and after the laser pulse, while Fig. 2.11b shows the difference between these
spectra. The red trace in Fig. 2.11b is the least-squares best fit of the difference spectrum
using the independently obtained extinction coefficient spectra of reduced myoglobin
(Mbred), nitrosylated myoglobin (MbNO), and 2. From the absorbance change attributed
to photolysis of 2 one can estimate that about 60 M NO were released by the laser pulse,
well in excess of the amount required to nitrosylate 10 M Mbred. However, the absorbance
change in Fig. 2.11b attributable to Mbred nitrosylation is only 5.4 M, which indicates that
4.6 M was already nitrosylated prior to the laser pulse. This can also be seen qualitatively
from inspection of the absolute spectra in Fig. 2.11a. Thus, it appears that species 2 is
sufficiently photo-active that over time it can release about 1% of its NO prior to laser
irradiation, even when handled only under very dim, dark-room-red illumination.
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Figure 2.11. (a) UV/Vis spectra of a solution initially containing10 µM Mbred, 100 µM
indigo tetrasulfonate, and 600 µM 2, before (black trace) and after (red trace) illumination
with a 500 nm laser pulse. (b) Black trace: difference spectrum obtained from the traces
from (a); red trace: least-squares best fit of the difference spectrum using the independently
obtained extinction coefficient spectra of Mbred, MbNO and 2.
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2.3.6. RuMEDTA as a nitric oxide sink. For the experiments reported in Chapters
3 and 4 of this dissertation the protein reacting with NO was always in large excess, so
small amounts of NO released prior to laser irradiation were not a problem. However, in
other studies it is sometimes necessary to photo-generate from 2 an amount of NO in excess
of the protein with which it is reacting. In such experiments even a small amount of NO
leakage prior to laser pulse irradiation can become a major problem. A possible solution
to this difficulty is to add an NO scavenger to the stock solution of 2; in this section the
suitability for this purpose of the complex RuMEDTA is explored. RuMEDTA reacts with
NO relatively slowly (the reported rate constant is 3000 M1s1), but binds it strongly.61
The expectation was that such a species would keep the solution NO concentration very
low in stock solutions prior to mixing in the protein of interest, but that after the pulse
RuMEDTA would react with newly photo-generated NO too slowly to compete with the
reaction between NO and the intended protein. This hypothesis was tested in two
experiments that used catalase as the test protein. Catalase (Cat) binds NO rapidly and
strongly with a binding constant of 8.7106, and the rate constants for both NO binding
(1107 M1s1) and dissociation (1.6 s1) are known,63 with the former being 4300 larger
than the reported rate constant for NO binding to RuMEDTA.61
Figure 2.12a tracks the amount of nitrosylated catalase (CatNO) present at various
times following laser pulse irradiation of a solution initially containing 23.5 µM Cat, 125
µM 2, and nominally 210 µM of RuMEDTA. The concentration of CatNO was calculated
from the independently obtained UV/Vis extinction coefficients at 434 nm of Cat and
CatNO. As expected the NO generated by the laser pulse initially reacts rapidly with Cat
to generate CatNO, in a reaction phase that is complete within a few milliseconds. Over
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Figure 2.12. (a) Concentration of nitrosylated catalase (CatNO) present at various times
following 500 nm laser pulse irradiation of a solution initially containing 23.5 µM Cat, 125
µM 2, and nominally 210 µM of RuMEDTA. The concentration of CatNO was calculated
from the independently obtained UV/Vis extinction coefficients at 434 nm of Cat and
CatNO. (b) Same (a), but the solution initially contained nominally 840 µM RuEDTA.
Buffer: 50mM HEPES, 0.5 mM EDTA adjusted to pH7. Red traces: least-squares best fits
using Eq. 2.3.
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the next 60 s or so the concentration of CatNO in solution decreases as NO is transferred
to RuMEDTA. However, [CatNO] does not decrease to zero, indicating that the NO
ultimately equilibrates between Ru- and Cat-bound species.

Scheme 2.1. Competition for NO between catalase
(Cat) and RuMEDTA

Scheme 2.1 shows the relevant reactions, from which one can derive the differential
equation 2.3. Conveniently, values are available in the literature for all of the parameters
d[CatNO] kon k2 [Cat][RuMEDTA(NO)] koff k2 [CatNO][RuMEDTA]


dt
kon [Cat]  k2 [RuMEDTA]
kon [Cat]  k2 [RuMEDTA]

Eq. 2.3

in Eq. 2.3 except k2,61,63 while all the concentrations are either obtained directly from the
spectral changes, or calculated from stoichiometric considerations. The red trace in Fig.
2.12a was obtained from a least-squares fit of the data to Eq. 2.3, using a k2 value of 0.034
s1 , and a k2 value of 30,000 M1s1; surprisingly the literature value of k2 = 3,000 M1s1
could not be made to give even modestly reasonable fits, while 30,000 M1s1 gave a robust
minimum in the sum of squares. This suggests the possibility of a typographical error in
the original reported value,61 but a more thorough investigation will be needed to validate
this possibility. From the values of k2 and k2 one can calculate the binding constant for
the interaction between NO and RuMEDTA to be 8.8105 M1.
Figure 2.12b shows the results of a second experiment in which all the reaction
conditions were kept the same as in the experiment of Fig. 2.12a, except that nominally
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840 M of RuMEDTA were used instead of 210 M. Qualitatively the results of Fig. 2.12b
are as expected: the concentration of CatNO after the laser pulse decreases more rapidly,
and the net equilibrium predicted by Scheme 2.1 lies further to the right, in the presence of
the higher RuMEDTA concentration.

However, attempts to fit the data using the

parameters obtained from the Fig. 2.12a fit were unsuccessful. The red trace in Fig. 2.12b
was obtained using a k2 value of 5103 s1 (~10 smaller than obtained from the Fig. 2.12a
fit) and by artificially inflating the RuMEDTA concentration to 1.01 mM from the nominal
840 M value. Such large deviations from the expected values show that a more extensive
study will be needed to quantitatively characterize the reactivity of RuMEDTA with NO.
2.4. Discussion
2.4.1. The challenge of obtaining crystalline species 2.

The experiments

described in Section 2.3.4 show that Mn(PaPy2Q)(OH)]ClO4 is a reasonably strong
oxidizing agent, and demonstrate the importance of ensuring that neither this starting
material or other Mn(III) species are left in the final preparations of 2, if this compound is
to be used in experiments that are sensitive to oxidation. The kinetic study described in
Section 2.3.2 shows that the conversion of Mn(PaPy2Q)(OH)]ClO4 to 2 is zero-order in
starting reagent (Fig. 2.4), so one must be careful to increase the reaction time in proportion
with the amount of 2 being prepared. One should also be careful to ensure that enough NO
is provided: 0.1 g (1.6 mmol) of Mn(PaPy2Q)(OH)]ClO4 will require at least 2 equiv (3.2
mmol) NO, which in a closed system at 1 Atm and 298 K, will require the reaction vessel
to have 80 mL or greater capacity.
The published procedure for obtaining crystalline 2 is to simply leave the reaction
mixture in a freezer overnight;39 however, in our hands this method gave low yields,
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typically 3-6 mg (3-6 %) of crystalline product, even when dry and anaerobic technique
was used in both this step and in the synthesis of the precursor Mn(PaPy2Q)(OH)]ClO4.
The low yield is more than enough for many applications given that very little product is
needed for photochemistry, but some future optimization is warranted if 2 is to be
extensively used. One alternative method that was tried was to add 15 mL of ether as
precipitant for every 10 mL of the reaction mixture in MeCN/MeOH, which basically
combined elements from the current procedure with a step from the synthesis of 2 from
Mn(PaPy2Q)(H2O)]ClO4.39 This method did afford crystals at a high yield (26mg or 28%)
for one trial, but the result proved difficult to repeat. The use of dry anaerobic ether and
rigorous Schlenk technique seemed to be essential, but even so later trials always yielded
an impure solid upon ether addition.
2.4.2. The use of RuMEDTA as a sink for prematurely released NO. The
experiments summarized in Fig. 2.12 confirm that RuMEDTA has the desired properties
for a NO scavenger that specifically targets NO prematurely released from 2. Such a
scavenger should bind NO tightly and reasonably fast, but much more slowly than the
proteins being investigated using the laser photo-initiation method. Our results suggest
that the rate constant k2 (Scheme 2.1) for the interaction between RuMEDTA and NO may
be 10 higher than previously reported (30,000 M1s1 instead of 3,000 M1s1),61 but is
still orders of magnitude smaller than the rate constants for NO binding to proteins such as
catalase, or other heme proteins of interest to the Pacheco group. Consequently, Fig. 2.12
shows that in the presence of as much as 800 M RuMEDTA, essentially all of the NO
generated by the laser pulse will react initially with the protein of interest. Competition
between the protein and the RuMEDTA can occur over longer time scales if NO
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dissociation from the protein under consideration is appreciable, but for many applications
this is not a complication; indeed, it may be used to obtain information, such as the
magnitude of the protein’s NO dissociation rate constant.
In contrast to RuMEDTA, the more extensively investigated RuEDTA has a rate
constant greater than 107 M1s1.71 This is in the same ballpark as the NO associative rate
constants of many heme proteins such as catalase (1.3107 M1s1),63 so RuEDTA would
directly compete for NO on the timescale of interest. One could still envision using
RuEDTA as a scavenger in low concentrations, in experiments where very large quantities
of NO were being photo-generated. Under such conditions a certain amount of the photogenerated NO would indeed react with the scavenger, but plenty more would still be
available for interacting with the protein of interest. Thus RuMEDTA could be used as an
NO sink in the stock concentration of 2, but a small amount of RuEDTA would be added
along with the protein of interest to ensure that no NO reacted with the protein of interest
until the laser pulse created more NO than there was RuEDTA, and the excess would then
react with the intended protein. This system would allow the researcher to completely
avoid NO reacting with the intended protein until the laser pulse occurred. RuEDTA has
been synthesized for this purpose, but requires further characterization before use.
NO doesn’t bind RuMEDTA as tightly as it does RuEDTA (Kb ~ 9105 M1
compared to > 107 M1 for RuEDTA),71 but this binding should be sufficiently tight for
many applications. Fortuitously the difference in binding constants seems to be about 10
smaller than the difference in associative rate constants. This is because the rate constant
governing dissociation of NO from RuMEDTA actually appears to be smaller than that
governing dissociation of NO from RuEDTA; thus we estimate the half-life for NO
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dissociation from RuMEDTA to be ~22 s, whereas it would be ~3 s for RuEDTA.71 It may
be that the pendant carboxylate in RuEDTA, which is believed to help open a binding site
for NO to occupy,61,71 also contributes to the labilization of NO once bound.

Scheme 2.2. An alternative NO photo-precursor used in earlier studies of NO – protein
interactions.
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2.4.3. Comparison of species 2 with an earlier NO photo-precursor. Prior to
using species 2 as a photo-active precursor for NO, the Pacheco group had used the organic
compound N,N′-bis(carboxymethyl)- N,N′-dinitroso-1,4-phenylenediamine (species 3,
Scheme 2.2) in a series of protein studies,64,72,73 and published three papers on the
properties of this species.64,65,74 It is thus worthwhile to consider the relative merits of the
two photo-precursors as NO delivery vehicles.
Photolysis of species 3 is initiated by a UV laser pulse (308 nm), which sets in
motion the reactions shown in Scheme 2.2. In the first step the laser pulse causes 3 to
fragment, yielding NO and the radical species 4. This radical can recombine with NO, or
it can dissociate a second NO to give the stable species 5 (step 2). When producing very
low concentrations of nitric oxide the rate of the back-reaction in step 1 is negligible
compared to step 2, and 2 equivalents of NO are obtained for every equivalent of 3
photolyzed. However, as more of species 3 is photolyzed the second-order back-reaction
between NO and 4 begins to dominate the first-order decomposition of 4 to 5, and the
amount of NO generated per laser pulse levels off. In practice this limits the amount of
NO that can be photo-generated to the low micromolar range.64,74 The amount of NO
generated can be increased significantly in the presence of a sacrificial electron donor that
reduces 4 to the stable species 6 (step 3, Scheme 2.2),65,74 but this strategy must be used
with caution as the resulting perturbation of the solution potential can complicate data
interpretation.
Species 2 has several advantages over the older photo-precursor 3 for our purposes.
First, it can be activated with visible light instead of UV. Second, in contrast to the first
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step in Scheme 2.2 the initial photolysis of 2 is effectively irreversible, and the Mn(II)
photoproduct has proved to be inert in studies performed so far (the net reaction is shown
in Scheme 3.1 of the next chapter). Third, though the yields from the initial photolysis of
both 2 and 3 are very high, the irreversibility of species 2 photolysis allows yields above
100 M to be obtained in optimized systems (see Chapter 3). By contrast the maximum
yields from photolysis of 3 are in the low micromolar range, unless a sacrificial electron
donor is added to the solution. One of the advantages of species 2 is also its principal
disadvantage: its extreme photosensitivity throughout the visible spectrum means that it
releases NO when exposed to even the very low-level red light used during sample
preparation.
2.4.4. Summary. [Mn(PaPy2Q)(NO)]ClO4 (2) was successfully synthesized and
tested for use as a photo-activated precursor of nitric oxide in fast timescale UV/Vis
absorption experiments with catalase or other proteins that react rapidly with NO. The
study represents the first instance of this compound being used for microsecond timescale
kinetic studies. The maximum amount of nitric oxide produced from 2 photolysis to date,
using a 3 mJ 500nm laser pulse, and irradiating solution contained in a 0.15 cm path cell,
was 180 µM. This vastly exceeds the amount of NO that could be generated from species
3 (Scheme 2.2). Premature nitric oxide release from 2 prior to the laser pulse was observed
using nitrosylation of Mb, and was quantified as ~1% of the caged nitric oxide available in
the solution. This led to the synthesis of RuEDTA and RuMEDTA, and the successful
testing of RuMEDTA as a potential nitric oxide sink, that would take prematurely released
NO out of solution when necessary.
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Chapter 3
Does the oxidation of nitric oxide by oxy-Myoglobin share an
intermediate with the met-Myoglobin-catalyzed isomerization
of peroxynitrite?
3.1. Overview
The reaction of nitric oxide with oxy-myoglobin (oxyMb) to form ferric myoglobin
(metMb) and nitrate, and the metMb-catalyzed isomerization of peroxynitrite to nitrate,
have long been assumed to proceed via the same iron-bound peroxynitrite intermediate
(metMb(OONO), Scheme 1.1, also shown as Scheme 3.1 in this chapter for easy
reference).1-5. More recent research showed that the metMb-catalyzed isomerization of
peroxynitrite to nitrate produces detectable amounts of nitrogen dioxide and ferryl
myoglobin (ferrylMb).6 This suggests a mechanism in which the peroxynitrite binds to the
metMb, ferrylMb is transiently generated by dissociation of NO2, and nitrate is formed
when the NO2 nitrogen attacks the ferrylMb oxo ligand. The presence of free NO2 and
ferrylMb products reveals that small amounts of NO2 escape from myoglobin’s interior
before recombination can occur. Free NO2 and ferrylMb should also be generated in the
reaction of oxyMb with NO, if the common intermediate metMb(OONO) is formed.
However, this chapter presents a series of time resolved UV/Vis spectroscopy experiments
in which no ferrylMb was detected when oxyMb and NO reacted. The mechanistic
implications of this observation will be discussed.
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Scheme 3.1. Proposed mechanisms for the reaction of NO with oxyMb, and of
peroxynitrite with metMb, highlighting the proposed common pathways for the two
processes (see also Scheme 1.1).
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3.2. Materials and Methods
All reagents were purchased from Sigma-Aldrich or Fisher Scientific unless
otherwise specified. The light-activated NO precursor [Mn(PaPy2Q)NO]ClO4 (Scheme
3.2, species 1, where PaPy2Q is the pentadentate ligand N,N-bis(2-pyridylmethyl)-amineN-ethyl-2-quinoline-2-carboxamide), and the pH-jump activated NO precursor 1-(N,Ndiethylamino)diazene-1-ium-1,2-diolate (DEANO),7 were prepared by the methods of
Eroy-Reveles et al.

8

and Drago and Paulik,9,10 respectively. Horse-heart myoglobin as

obtained from Sigma was in the metMb form. This was reduced in a glove box using an
excess of electrolytically-generated methyl viologen monocation radical11 to generate
ferromyoglobin (Mb), which could in turn be converted to oxyMb by exposure to ambient
air. FerrylMb was generated by exposing metMb to excess hydrogen peroxide, which was
then removed by adding ~10−8 M catalase, as previously described.6 Nitrosylated metMb
(metMbNO) and Mb (MbNO) were prepared by exposing metMb and Mb, respectively, to
NO gas generated in situ from DEANO.9,10 Extinction coefficient spectra were obtained
for all the above-mentioned forms of myoglobin.

Scheme 3.2. Photolytic cleavage of 1 to produce an aquo species and free NO.
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All experiments described herein were carried out in solutions buffered at pH 7.4
using 2-[4-(2-hydroxyethyl)-piperazin-1-yl]ethanesulfonic acid (HEPES) sodium salt, and
made using 18 M purified water. Stock solutions of most reagents were made up in 50
mM HEPES. In the case of ascorbate, a 1.25 M stock solution was made by dissolving 5.5
g of ascorbic acid and 7.45 g of HEPES sodium salt in 50 mL water, and then adjusting the
pH to 7.4 with NaOH or HCl, as appropriate. Reaction mixtures were made by combining
appropriate volumes of the stock solutions. Routine UV/Vis spectra were obtained using
CARY 50 spectrophotometers (Varian); an instrument installed in the glovebox was
available for air-sensitive measurements. Photochemical fragmentation of species 1 was
initiated with 10 ns, 500 nm, laser pulses generated using an OPO tunable laser (Opotec
Rainbow Vis).

An OLIS RSM-1000 spectrophotometer was used to monitor the

absorbance changes induced in the reaction mixture by the laser pulse. The configuration
of the laser and spectrophotometric equipment was as described in general terms
elsewhere,12,13 except that the laser pulse was transmitted via an optical fiber instead of by
using mirrors. Reactions with lifetimes of less than 2 ms were monitored with the OLIS
RSM-1000 in fixed wavelength mode. Data arrays that tracked the changes in the complete
spectra as a function of time were then constructed from multiple absorbance vs. time traces
collected for the same reaction at varying wavelengths. For reactions with lifetimes higher
than 2 ms data were collected with the OLIS RSM-1000 in rapid-scanning Average 1 mode,
which provides 62 scans/s (1 scan every 16 ms). After verifying that no significant changes
were occurring on the ms timescale, the raw spectra were further averaged to obtain spectra
spaced 160 ms apart. For all experiments the solutions were held in 1.5mm × 1.5mm

64
fluorometer sub-micro cuvettes (Starna). The laser pulse was focused as a spot of ~5mm
diameter which irradiated the entire cuvette window. The laser pulse energies were
measured before and after each day’s experiments using a Scientech AC2501 bolometer;
typical pulse energy intensities at the cuvette were ~ 15-18 mJ/cm2.
All data were analyzed using programs written within the commercially available
software packages Origin version 6.0 (Microcal Software) or Mathcad 13 (PTC Software).
The analysis strategies used in our laboratories have been previously described;7,13-16
details specific to this work are provided in Appendix 1.
3.3. Results
In this study NO was generated photochemically by irradiating the photoactive
manganese nitrosyl complex 1 (Scheme 3.2).8 When species 1 is irradiated with a 500 nm,
10 ns laser pulse it fragments in less than 1 μs to release free NO and an aqua-substituted
product of 1, as shown in Scheme 3.2. This is a very convenient way of generating NO in
an aerobic solution of oxyMb, because under the reaction conditions free NO is in contact
with free oxygen for less than 0.5 ms before it is all consumed in the reaction with oxyMb.2
Thus unwanted side-reactions, particularly the formation of NO2 from direct interaction
between NO and O2, are easily avoided. For the purposes of the present study species 1 is
superior to other known NO photo-precursors for two reasons. First, the NO can be
generated in large quantities (as high as 150 μM in the present study) using longwavelength light (500 nm or longer); other high-yield NO photo-precursors that were used
in the past by this research group require UV laser pulses.13

Second, the aquated

photoproduct of 1 is not very reactive on the timescales being investigated, as is verified
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in experiments described below. Many other NO photo-precursors fragment to yield
products that are either strong oxidants 13 or strong reductants,17,18 which can take part in
side-reactions on the timescales of interest, thus complicating their use in experiments.

Figure 3.1. Difference spectrum obtained immediately after
irradiating a solution of 316 μM oxyMb and 1.66 mM 1 with a 500 nm
laser pulse. Solid blue trace: experimentally obtained data. Dashed red
trace: calculated by least-squares fit using the extinction coefficient
spectra of oxyMb, metMb, ferrylMb, and 1. Dashed green trace: same as
red trace but using the Mb extinction coefficient spectrum instead of the
ferrylMb one. The fitted experimental spectrum was the average of the
first 20 raw spectra collected every 16 ms using the Olis
spectrophotometer (absorbance remained essentially constant throughout
this time period, which allowed for signal averaging).
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3.3.1. Experiments with no ascorbate added. Figure 3.1 shows the difference
spectrum obtained immediately after irradiating a solution of 316 μM oxyMb and 1.66 mM
1 with a 500 nm laser pulse. The Fig. 3.1 difference spectrum can be fitted reasonably well
using the independently known extinction coefficients of metMb, oxyMb, 1 and ferrylMb
(Fig. 3.1, red dashed trace). Based on this fit, the changes in concentrations of the various
species are calculated to be ΔCmetMb = 81 μM, ΔCoxyMb = ΔC1 = −86 μM, and ΔCferrylMb =
5 μM. Note however that this method is quite insensitive, and a similar fit can be obtained
using the extinction coefficients of metMb, oxyMb, 1 and Mb (Fig. 3.1, green dashed
trace). In this case the calculated concentrations of the species are ΔCmetMb = −ΔC1 = 82
μM, ΔCoxyMb= −86 μM, and ΔCMb = 4 μM. Neither fit is improved by adding in
contributions from the extinction coefficient spectrum of MbNO. The presence of either
ferrylMb or Mb is mechanistically plausible: if a peroxynitrite intermediate is formed from
the reaction of oxyMb with NO, then ferrylMb is an expected product.6 On the other hand,
the rapid reaction of oxyMb with NO also consumes O2, thus perturbing the equilibrium
between oxyMb, free Mb and dissolved O2.
If one accepts the hypothesis that the same metMb(OONO) intermediate is
generated in the reaction of oxyMb with NO and in the metMb-catalyzed isomerization of
peroxynitrite (Scheme 3.1), then it is possible to estimate the expected final product
distribution using only kinetic parameters available in the literature.2,6,19-22 The relevant
reactions, together with the associated kinetic parameters and the source references, are
shown in Scheme 3.3. Su and Groves estimated that the rate for in-cage recombination of
NO2 and ferrylMb to form metMb(ONO2) is ~10× that of cage escape by NO2 (kr/ke ~ 10
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in Scheme 3.1).6 For the reaction that gave rise to the Fig. 3.1 results, in which ~86 μM of
oxyMb reacted with an equivalent amount of photogenerated NO, this would mean that
initially about 8 μM ferrylMb, 8 μM free NO2 and 78 μM metMb should have been
generated. This estimate of ferrylMb generated is about twice that calculated in the red
trace analysis of Fig. 3.1, but doesn’t take into account the subsequent fate of the NO2,
which can itself react with oxyMb, ferrylMb and NO as shown in Scheme 3.3.19,20 Using
the literature values of the rate constants for the Scheme 3.3 reactions it is straightforward
to predict the expected product distributions as a function of time (see Appendix 1). Figure
3.2 shows the calculated time evolution of all the species in Scheme 3.3, assuming initial
concentrations [oxyMb] = 316 M and [NO] = 86 M, where the NO concentration is
taken as equal to the amount of 1 photolyzed, as calculated from the Fig. 3.1 fit. Notice
that the Fig. 3.2 calculations predict that, under the given experimental conditions, the
reactions of NO2 with the various Mb species will themselves result in a net increase in the
ferrylMb concentration, so that after 10 ms the ferrylMb will reach ~16 M. Thus, the 5
M ferrylMb calculated in the red trace analysis of Fig. 3.1 is less than a third that predicted
for the reaction of oxyMb with NO, if one assumes that the reaction goes via the same
intermediate as the metMb-catalyzed peroxynitrite isomerization.6
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Figure 3.2. Time evolution of reactant and product concentrations that is expected
following the reaction of 85.6 µM NO with 316 µM oxyMb (initial concentrations in the
Fig. 3.1 data), if one assumes a metMb(OONO) intermediate in common with the metMb
+ ONOO− reaction. Concentrations were calculated using numerical integration of the
corresponding rate equations, and the known rate constants given in Scheme 3.3, as
described in Appendix 1. Panel (a) shows major species, panel (b) minor ones.
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Scheme 3.3. Known reactivities of NOx species with various Mb
forms expected to be relevant on the timescale of milliseconds.
Rate constants for each reaction were either experimentally
determined in this work or available from literature. References
for the rate constants are as follows: (a) Ref 35; (b) Ref 19; (c) Ref.
21; (d) Ref 18; (e) Ref 17.

3.3.2. Experiments in the presence of ascorbate. The result presented above
places an upper bound on the amount of ferrylMb produced when NO is photogenerated
from 1 in the presence of a large excess of oxyMb, but leaves open the question of whether
any ferrylMb is in fact produced. This is because the Fig. 3.1 spectrum is equally well
fitted if one assumes that Mb is a minority species instead of ferrylMb. Furthermore, the
minor features in the residual trace of Fig. 3.1 allow for the possibility that minority species
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other than Mb or ferrylMb are also contributing to the Fig. 3.1 spectrum, and one can’t
assess the significance of such species from analysis of single spectral traces such as Fig.
3.1.
In order to more precisely quantify the amount of ferrylMb produced in the reaction
of photogenerated NO with excess oxyMb, the Fig. 3.1 experiment was repeated in the
presence of varying amounts of ascorbate, with continued monitoring of the reaction
solution over tens of seconds. FerrylMb reacts with ascorbate in a second-order process
governed by a rate constant of 2.7±0.8 M−1s−1,23 which should generate a readily
detectable, ascorbate concentration-dependent kinetic fingerprint with a many-second
lifetime. When a solution containing 272 M oxyMb, 1.66 mM 1 and 200 mM ascorbate
was irradiated with a 500 nm laser pulse, an analysis analogous to that of Fig. 3.1 above
showed initial product distributions of either ΔCmetMb = 96 μM, ΔCoxyMb = ΔC1 = −100 μM,
and ΔCferrylMb = 4 μM, or ΔCmetMb = −ΔC1 = 97 μM, ΔCoxyMb= −100 μM, and ΔCMb = 3 μM
(see Appendix 1). The experiment was then followed for an additional 45s after the initial
laser pulse, and double-difference spectra were generated by subtracting the first difference
spectrum from every subsequent one. Figure 3.3a shows a number of these doubledifference spectra, collected at selected times after the laser pulse, and refined using
singular value decomposition (see Appendix 1).24,25 Figure 3.3b shows corresponding ΔAλ
vs time traces at selected wavelengths. The complete set of double-difference spectra,
collected at varying times and wavelengths, can be fitted empirically using a model that
builds the spectra from the known extinction coefficients of Mb, metMb, oxyMb and
species 1, and accounts for the time dependence of ΔA at each wavelength using Eq. 3.1.
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Figure 3.3. Spectral changes that follow irradiation of a solution initially containing
272 μM oxyMb, 1.72 mM 1 and 200 mM ascorbate with a 500 nm laser pulse. (a) Doubledifference spectra obtained by subtracting the first difference spectrum (equivalent to the
Fig. 1 spectrum) from all subsequent difference spectra that followed the laser pulse. The
representative spectra shown here were collected 0, 2, 4, 6, 8, 10, 20, 30, and 45s after the
initial spectrum. Theoretical traces (dashed red lines) were calculated as described in
Appendix 1. Arrows indicate regions where spectral changes are monotonic, while stars
indicate regions in which ΔA first increases and then decreases. (b) ΔA vs t slices at
selected wavelengths, corresponding to the data shown in (a). The short orange trace shows
the absorbance change at 596 nm that would accompany the reduction of 4 μM ferrylMb
to metMb by 0.2 M ascorbate
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The detailed fitting procedure is described in Appendix 1. Equation 3.1 shows that at any
given wavelength two components contribute to the total absorbance change, one varying
linearly and the second exponentially with time. The parameter m represents the rate of
change of the linear component (in AU/s), while Ainf and k represent the final
amplitude and rate constant, respectively, for the exponential component. The calculated
spectra and time traces are overlaid on the experimental data of Figs. 2.3a and 2.3b. From
the fitting procedure the changes in concentration with time of Mb, metMb, oxyMb and
NO (indirectly obtained from the concentration change of 1) were calculated; these are
plotted in Fig. 3.4. In addition, the value of the rate constant governing the exponential
part of Eq. 3.1 was calculated to be k = 0.133±0.005 s−1.
Eq. 3.1
Given the 2.7 M−1s−1 rate constant for the reaction of ferrylMb with ascorbate,23 any
ferrylMb present immediately after the laser pulse should have subsequently been reduced
by the 200 mM ascorbate in a pseudo-first order process with kobs = 0.54 s−1, which
translates to a half-life of 1.3 s. The Fig. 3.3 kinetic data show no evidence for such a
kinetic process. If 4 M of ferrylMb had in fact been present immediately after irradiating
the reaction solution, as suggested by spectral analysis analogous to that which produced
the red trace of Fig. 3.1 (Appendix 1), it should then have reacted with ascorbate to generate
metMb, giving rise to a detectable spectral signature with maximum amplitude at 596 nm.
Figure 3.3b compares the absorbance change expected from the reduction of ferrylMb to
metMb with that actually observed at 596nm. Though the predicted change is small, it
should have been clearly resolvable given the low noise of the data obtained on this
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Figure 3.4. (a) Changes in concentration of the myoglobin species that gave rise to the
spectral changes of Fig. 3.2, calculated as described in Appendix 1. Also shown is the
increase in [NO] with time that was effected by photolysis of 1 in the spectrophotometer
probe beam. This was calculated from the absorbance change that accompanied the
denitrosylation of 1. (b) Similar to (a), this plot shows the total myoglobin reduced from
the Fe(III) to the Fe(II) state as a function of time.
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timescale (a conservative estimate suggests that 1-2 M ferrylMb should have been
detectable by the applied method. Furthermore, the theoretical analysis of Scheme 3.3 and
Fig. 3.2 predicts a spectral change that is ~3-4× larger. On the basis of the Fig. 3.3 analysis
one can therefore conclude that ferrylMb is not present in detectable quantities (> 1-2 M)
by the time the first post-laser flash spectra are collected, 16 – 160 ms after the laser pulse.
Other minor species, such as Mb (e.g.: green trace, Fig 3.1), may be present at this point.

Scheme 3.4. Expected reactions between various forms of Mb, dioxygen and ascorbate.
Here AH− is ascorbate, and A−● is the ascorbyl radical. Two equivalents of H2O are
generated in step 3, one of which binds to Fe(III) in the metMb.
The results presented in Figs. 3.3 and 3.4 can be qualitatively explained on the basis
of NO formed by photolysis of 1 in the spectrophotometer probe beam, and of the known
reactivity of ascorbate with oxyMb and metMb that is outlined in Scheme 3.4.6,23,26 The
linear increase in NO concentration shown in Fig. 3.4 (ΔCNO/Δt = 4.7×10−7 Ms−1) arises
from photolysis of 1 by the spectrophotometer probe beam, as can be verified by submitting
solutions of pure 1 to the same treatment (Appendix 1). The NO so generated will
immediately react with oxyMb to produce metMb, thus contributing to the concentration
changes of these two species. Step 3 of Scheme 3.4 is a second process that results in a net
oxidation of oxyMb to metMb.26 In this process one equiv. of ascorbate first reacts with
oxyMb to generate metMb and H2O2.26 The metMb and H2O2 then react to give ferrylMb
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cation radical (ferrylMb+, formally Mb with Fe(V)),26,27 which is rapidly reduced by two
equiv. of ascorbate back to metMb. The net process of step 3 Scheme 3.4 results in the 4electron reduction of O2 to give 2 equivs. of H2O (one of which binds to the Fe of oxidized
myoglobin), with 3 of the necessary electrons coming from ascorbate and 1 equivalent from
the myoglobin Fe(II).

The 3 equivs. of ascorbyl radicals generated in the process

subsequently disproportionate.23,26 Counteracting the net oxidation of oxyMb to metMb
by NO and by step 3 of Scheme 3.4 is the reduction of metMb by ascorbate (step 1, Scheme
3.4). From experiments with metMb and ascorbate under anaerobic conditions the secondorder rate constant for this reaction is calculated to be 0.053 ± 0.002 M−1s−1 at pH 7.4
(Appendix 1). This step initially generates Mb, but in the presence of O2 the Mb is in
equilibrium with oxyMb (step 2, Scheme 3.4).
Figure 3.4b shows that over the time period monitored there was a net reduction of
Fe(III) (metMb) to Fe(II) (oxyMb and Mb), but that the rate of reduction slowed over time.
Immediately after the laser pulse the reaction mixture contains roughly 97 M metMb, 3
M Mb and 172 M oxyMb (as determined by analysis analogous to that which produced
the green trace of Fig. 3.1; Appendix 1). Presumably, as metMb is subsequently consumed
and reduced myoglobin is generated, the rates of the net oxidizing and net reducing
processes move towards a dynamic equilibrium, beyond which no further changes in
concentration would be observed. The distribution of reduced species also changes with
time as seen in Fig. 3.4a. Step 3 of Scheme 3.4 consumes oxygen, as does the reaction of
oxyMb with NO, and in the small cuvette employed for the experiments the oxygen is not
rapidly replaced by diffusion from the surroundings. Thus, over time, the concentration of
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oxyMb decreases and that of Mb increases. Experiments with solutions containing only
oxyMb and ascorbate in the same type of cuvette showed the same general reactivity
(Appendix 1), though the exact reaction conditions couldn’t be reproduced in the absence
of the laser pulse that rapidly consumed an initial quantity of O2.
In addition to the experiment described above (Figs. 3.3-3.4) similar experiments
were also performed in the presence of 100 M and 300 M ascorbate (see Appendix 1).
In all of these experiments the time-resolved spectra lacked the kinetic fingerprint that
would be expected if ferrylMb had been generated in the reaction of oxyMb with NO, but
were otherwise consistent with the expected reactivity of the reaction mixtures, as outlined
in Scheme 3.4. Finally, to ensure that the reaction of ferrylMb with ascorbate is not altered
under the specific reaction conditions employed in this study, authentic ferrylMb was
reacted with ascorbate in the presence and absence of 1, oxyMb or Mb. In all cases the
same rate constant was obtained, which in turn agreed with the literature values (see
Appendix 1).6,23
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Figure 3.5. Spectral changes observed at 409 nm after mixing 4.2 μM
ferrylMb with 238 μM 1. Blue circles: experimental data. Red curve:
theoretical fit to an exponential function.
3.3.3. Stability of ferrylMb in the presence of species 1, with and without laser
irradiation. The experiments presented above demonstrate conclusively that no ferrylMb
is detectable 16 ms after irradiating solutions of oxyMb and 1 with a 500 nm laser pulse.
However, they do not preclude the possibility that detectable amounts of ferrylMb were
generated on the µs timescale, but consumed prior to 16 ms in reactions specific to the
conditions employed. In order to test for this possibility, several experiments were
performed with authentic ferrylMb and 1.
Figure 3.5 shows the spectral changes observed at 409 nm after mixing 4.2 M
ferrylMb with 238 M 1. The absorbance at 409 increases exponentially, indicating that
the ferrylMb is being reduced to metMb with an apparent rate constant of 1.7×10−3 s−1.
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When the experiment was repeated in the presence of half the concentration of 1 the
apparent rate constant also decreased by half, showing that the reduction is first order in
[1], and second order overall. The value of the true second-order rate constant for reduction
of ferrylMb in the presence of 1 is therefore ~ 7 M−1 s−1. In the experiments with oxyMb
and 1 described above the concentration of 1 was typically between 1.5 and 2 mM,
therefore one expects any ferrylMb generated under those conditions to be reduced with a
half-life of ~ 50 – 65 s. This reaction is too slow to eliminate ferrylMb before it could be
detected in the experiments of the previous sections; in particular it would not compete
with the reaction of ferrylMb with 200 mM ascorbate, which is predicted to occur with a
half-life of 1.3 s.
As shown in Scheme 3.3, NO reacts rapidly with ferrylMb. Thus, the spectral
changes seen in solutions containing ferrylMb and 1 (Fig. 3.5) could simply be due to the
reaction between ferrylMb and NO photogenerated from 1 in the spectrometer probe beam.
Alternatively, the Mn(PaPy2Q)H2O+ that is co-generated from photolysis of 1 could also
contribute to ferrylMb reduction.

These possibilities were addressed in kinetic and

stoichiometric studies. In the kinetic experiments species 1 was photolyzed in the presence
of varying amounts of ferrylMb, and the subsequent reactions were monitored on the s
timescale (Fig. 3.6).

These experiments were carried out under pseudo-first order

conditions, such that the concentration of ferrylMb greatly exceeded the amount of NO
photo-generated in every experiment. The change in absorbance at 409 nm with time was
exponential at all ferrylMb concentrations (Fig. 3.6a), and plots of kobs vs [ferrylMb] were
linear (Fig. 3.6b), showing that the reaction was first-order in [ferrylMb] and second-order
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Figure 3.6. (a) Spectral changes observed at 409 nm after irradiating a solution containing
50 μM ferrylMb and 40 μM 1 with a 500 nm laser pulse. Blue trace: experimental data.
Red trace: data fitted to a single exponential. (b) Dependence of the observed rate constant
on [ferrylMb] when the experiment of part (a) was repeated with varying initial ferrylMb
concentrations. In all cases, [NO]generated  [ferrylMb]0.
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overall.

The true second-order rate constant for the reaction was calculated to be

(1.4±0.1)×107 M−1s−1 from the slope of the Fig. 3.6b line, a value that is close to that
previously reported in the literature for the reaction between NO and ferrylMb (Scheme
3.3).21
The agreement between the rate constant calculated from Fig. 3.6b and that reported
earlier by Herold and Rehman 21 demonstrates that NO is the fastest reducing agent present
in photolyzed mixtures of ferrylMb and 1. If it weren’t, the rate constant calculated from
Fig. 3.6b would have been higher than Herold and Rehman’s. The close agreement does
not, however, exclude the possibility that Mn(PaPy2Q)H2O+ also reduces ferrylMb at rates
comparable to, or lower than NO. To address this possible alternative the amount of
ferrylMb reduced and the amount of NO generated by photolysis of a given amount of 1
were determined independently, in a set of experiments that are described in Appendix 1.
In these experiments only one equivalent of ferrylMb was reduced per equivalent of 1
photolyzed, which shows that NO is the sole reducing agent generated in the photolysis. If
Mn(PaPy2Q)H2O+ were also capable of reducing ferrylMb on the sub-second timescale,
two equivalents of ferrylMb would have been reduced per equivalent of 1 photolyzed in
these experiments. Therefore, in the experiments in which solutions of oxyMb and 1 were
irradiated to generate NO, free ferrylMb generated by homolytic fragmentation of a
metMb(OONO) intermediate should have still been present 16 ms after photolysis, and
thus detectable.
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3.3.4. Evaluation of the Scheme 3.3 model.

Given that ferrylMb was not

generated in detectable quantities in the present experiments, contrary to the predictions of
earlier reports as outlined in Scheme 3.3, it is now necessary to assess the sensitivity of the
Scheme 3.3 conclusions to possible errors in the published kinetic parameters. One
question that immediately arises is whether Su and Groves could have overestimated the
amount of cage escape (Scheme 3.1) that occurred in their experiments; the values of k11
and k12 in Scheme 3.3 are based directly on this estimate.6 When the numerical simulation
that they used to obtain the kr/ke estimate of 10 was repeated, this estimate was found to be
very insensitive to even large variations in the inputted initial concentrations of metMb and
peroxynitrite. Therefore, Su and Groves’ estimate for initial ferrylMb generation via cage
escape cannot be very far off.
Next to be examined were the possible effects that uncertainties in the Scheme 3.3
rate constants might have on the predicted time evolution of the ferrylMb concentration.
Of all the parameters in Scheme 3.3 the one with the greatest reported uncertainty is k6, for
which the literature value is given as a range (104 M−1s−1 – 107 M−1s−1).20 For the
calculations that yielded Fig. 3.2 the upper bound was arbitrarily chosen (Appendix 1), but
a smaller value of k6 is unlikely to change the conclusions; if ferrylMb+ reacts more slowly
with oxyMb, then it is almost certainly still converted to ferrylMb by other competing
processes, such as reduction by ascorbate.
The fact that (k11+k12) and k2 are within 20% of the reported values2,21 was
independently verified herein (Appendix 1 and Fig. 3.6). Of the remaining parameters, k3
and k7 prove to be too small to have any real impact on the outcome of the simulations,
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given the reaction conditions being modeled. This leaves k4, k5, k8, k−8 and k9 as parameters
that could significantly affect the predicted time evolution of [ferrylMb].
The parameters k4, k5, k8, k−8 and k9 all govern the fate of the NO2 that putatively
escapes the protein cage.

Any increase in the ratio k5/k4 will lead to greater net

recombination of ferrylMb with NO2, thus decreasing the final amounts of both species.
However, in practice it would take a huge error in the literature derived value of this ratio
(0.267 from Scheme 3.3) to have any significant effect on ferrylMb survival under the
reaction conditions being modeled, where at all times the oxyMb concentration far
exceeded any ferrylMb that might be generated. Thus, for example, if the value of k4 is
decreased to 5×106 M−1s−1 and that for k5 is increased to 108 M−1s−1 (both these numbers
are well outside the reported uncertainties for the respective parameters), a simulation still
predicts the presence of ~10 M ferrylMb 10 ms after the laser pulse. A k5 value of 108
M−1s−1 for ferrylMb reaction with NO2 would make it by far the largest known rate constant
for the reaction of NO2 with a biomolecule,20 while the k4 value of 5×106 M−1s−1 would be
at the low end of values reported for the interaction of small gas molecules with either
oxyMb or Mb.2,20,28,29 And yet, much greater changes in the input rate constants would be
needed to decrease the ferrylMb concentration below 1-2 M (the estimated detection limit
for these experiments).
The processes governed by k8, k−8 and k9 determine the rate at which NO2 is
consumed independently of ferrylMb. The value of k8 for reaction of NO with NO2 is at
the diffusion limit, and so is unlikely to be underestimated.

However, if k−8 is

overestimated and/or k9 is underestimated in Scheme 3.3, then all else being equal the Fig.

83
3.2 analysis would be overestimating the amount of ferrylMb that is eventually generated
by reaction of NO2 with oxyMb. Note however that even in the extreme case whereby
none of the NO2 resulted in additional ferrylMb formation, one would still see the 10%
ferrylMb generated by the initial NO2 cage escape, if this were occurring.
To summarize, even if one assumes much larger uncertainties in the kinetic
parameters of Scheme 3.3 than are provided with the literature values, ferrylMb is predicted
to accumulate to concentrations 5 – 10× above the detection limit in the experiments
presented herein, if the reactions of oxyMb with NO and metMb with peroxynitrite share
a common metMb(OONO) intermediate, as proposed in Scheme 3.1.
3.4. Discussion
3.4.1. No common intermediate between metMb peroxynitrite isomerization
and oxyMb reaction with NO. Investigations by the Groves group and others over the
past decade have shown fairly convincingly that, during metMb-catalyzed isomerization
of peroxynitrite, some nitration of Tyr103 from the metMb takes place, and ferrylMb builds
up as a transient but detectable intermediate.5,6,30 These results are consistent with the
mechanism of Scheme 3.1 path 2, whereby peroxynitrite first binds the Fe heme center to
produce a metMb(OONO) intermediate, which then rapidly cleaves homolytically to form
ferrylMb and caged NO2. The NO2 can then either recombine with the ferrylMb to release
nitrate, or escape the cage; the latter path gives rise to the ferrylMb that is transiently
detectable, and to the observed Tyr103 nitration. In an early report the extent of cage
escape was estimated to be as high as 20%,30 but this was later revised downward to ~10%.6
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It has been widely assumed until now that the reaction between oxyMb and NO
proceeds through the same metMb(OONO) intermediate as the reaction between metMb
and peroxynitrite (Scheme 3.1); however, if this assumption is correct, then under
appropriate conditions one should be able to detect the ferrylMb side product due to 10%
cage escape of NO2, as Groves’ group did when reacting peroxynitrite with metMb.6 The
fact that this intermediate was not detected in any of the experiments presented herein calls
the assumption into question. In this regard the key experiments are those performed in
the presence of ascorbate (Figs. 3.3, 3.4 and Appendix 1). Single spectrum analyses such
as that given in Fig. 3.1 are of limited use because all of the components contributing to
such a spectrum may not be known. However, the kinetic analyses of the ascorbate
experiments are substantially more sensitive to ferrylMb concentration, and relatively
insensitive to the effects of unknown parameters. No matter what species are contributing
to the overall spectra, any spectral changes due to conversion of ferrylMb to metMb should
have been readily detectable if ferrylMb concentrations greater than 1-2 M had been
produced from the reaction between oxyMb and photo-generated NO. This is clear from
inspection of the short orange trace in Fig. 3.3b, which shows the spectral change at one
representative wavelength that would be associated with the conversion of 4 M ferrylMb
to metMb in the presence of 200 mM ascorbate. However, 4 M is only the largest amount
of ferrylMb consistent with analysis of the t0 spectrum for the data set (the analogue of the
Fig. 3.1 spectrum; see Appendix 1). If the reaction of oxyMb with NO had produced 10%
ferrylMb, as predicted from the experiments with metMb and peroxynitrite, the amplitude
of the Fig. 3.3 short orange trace should have been at least twice as large, and according to
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the extended analysis based on Scheme 3.3 it could have been as much as 4× greater.
Furthermore, the short orange trace of Fig. 3.3 is only for one wavelength. The analysis
presented herein was a global one, and the expected kinetic signature for ferrylMb
reduction to metMb was absent from the entire monitored spectral region (480 nm – 620
nm). The same was true in experiments with 100 mM and 300 mM ascorbate (see
Appendix 1).
The experiments with ferrylMb and 1 (Figs. 3.5,3.6 and Appendix 1) show that
neither 1 nor its photoproduct Mn(PaPy2Q)H2O+ will react with ferrylMb in less than 1s,
so if this species had been generated from oxyMb and NO it should have persisted long
enough to react with ascorbate on the timescale of seconds. Furthermore, the experiments
with ferrylMb and ascorbate show that the kinetics of this crucial reaction were unaffected
by the specifics of the reaction conditions (see Appendix 1). Together, the experiments
with ferrylMb confirm that this transient species should have been detectable if it had been
generated in the quantities predicted from experiments with metMb and peroxynitrite,6,30
via path 2 of Scheme 3.1.
3.4.2. Possible mechanism for the reaction of NO with oxyMb without a
peroxynitrite intermediate. Scheme 3.5 proposes one reaction mechanism for oxyMb +
NO that would yield a product distribution different from that obtained in the reaction
between metMb and peroxynitrite. In this scenario NO directly inserts into the oxyMb OO bond, thus completely bypassing the metMb(OONO) intermediate. Some model studies
with synthetic iron porphyrin complexes support the hypothesis that different mechanisms
may operate in reactions of ferric porphyrins with peroxynitrite and in reactions of
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oxyferrous porphyrins with NO. For example, Kurtikyan and Ford recently reported
careful studies in which synthetic complexes with the formula Fe(Por)(NH3)(O2), sublimed
in vacuo onto liquid nitrogen-cooled CaF2 or KBr surfaces, were exposed to NO gas.31
Even in these low-temperature studies the first detectable intermediate as the surface
warmed up was invariably the metMb(ONO2) adduct. From these studies Kurtikyan and
Ford concluded that if peroxynitrite intermediates actually formed, subsequent barriers for
their isomerization to nitrate species were at most ~7 kcal/mol.31 By contrast Lee et al. had
shown earlier that some water soluble Fe(III)porphyrins react with peroxynitrite to generate
very long lived oxoFe(IV) species and NO2, that only slowly recombine.32 The Kurtikyan
and Lee experimental conditions are very different (hydrophobic porphyrins adsorbed on
surfaces vs. water-soluble porphyrins in aqueous solution), and this alone could explain the
different product distributions. Alternatively it is also possible that the Kurtikyan and Ford
reactions proceeded via a mechanism akin to Scheme 3.5, while those of Lee et al. followed
path 2 of Scheme 3.1. It should be noted that Kurtikyan and co-workers did, very recently,
detect the cobalt equivalent of a peroxynitrite-bound species, and later NO2, when they
reacted synthetic oxy-coboglobin models with NO, using the surface deposition
methodology summarized above.33 Also, Schopfer and coworkers have reported indirect
evidence that synthetic Fe(Por)(NH3)(O2) complexes can react with NO via a pathway akin
to that shown in Scheme 3.1, path 2. When tetrahydrofuran (THF) solutions containing
tyrosine mimic 2,4-di-tert-butylphenol, and oxyMb mimic (THF)(F8)FeIII(O2+) [where F8
= tetrakis(2,6-difluoro-phenyl)porphyrinate(2-)], were exposed to NO, the nitrated product
2,4-di-tert-butyl-6-nitrophenol was recovered, as would be expected if free NO2 was being

87
formed from fragmentation of a peroxynitrite intermediate.34 Schopfer et al. did not directly
observe such an intermediate, but their experiments show that the question is far from
settled.
3.4.3. Possible mechanism for the reaction of NO with oxyMb that still allows
for a peroxynitrite intermediate Scheme 3.6 suggests an alternative to Scheme 3.5 that
would also allow the reaction mechanism for oxyMb + NO to deviate from that of metMb
+ peroxynitrite, but wouldn’t preclude a metMb(OONO) transient species in either case.
In this scenario the metMb(OONO) moiety itself

is formed in both reactions, and

fragments homolytically to release NO2 into the immediate surroundings of the heme, but
the conformation of the protein surrounding the heme center is assumed to be significantly
different in the two cases. This is depicted in Scheme 3.6 by representing the Fe(II)-derived
protein conformation by a rectangle surrounding the heme moiety, and that for Fe(III) by
an ellipse. If the conformation of the protein derived from metMb were “leakier” than that
derived from oxyMb (ke2 >> ke1 in Scheme 3.6), this would explain why ferrylMb and NO2
are produced in the former case and not the latter. Using the most conservative estimate
of the detection limit in the ascorbate experiments (~2 M), this mechanism would predict
that ke2 in Scheme 3.6 is at least 10× greater than ke1.
The fact that the reaction of oxyMb with NO gives different product distributions
than that of metMb with peroxynitrite has important implications for researchers
investigating the possible physiological role of myoglobin and related molecules as NO
sinks. Path 2 of Scheme 3.1, which has now been identified as the likely mechanism for
metMb-catalyzed isomerization of peroxynitrite,6 allows a significant amount of free NO2
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to escape the protein, and concomitantly results in formation of ferrylMb.

If NO

dioxygenation by oxyMb were to follow exactly the same path, then removal of the reactive
NO would be accompanied by generation of NO2 and ferrylMb, which in many ways are
at least as reactive. In contrast, the results of this investigation show that oxyMb converts
NO to NO3− without generating any detectable ferrylMb side product. This makes a
physiological role for myoglobin’s NO dioxygenase activity that much more plausible.
3.5. Material provided in Appendix 1
Determination of the rate constant for the reaction of metMb with ascorbate; The
reaction of oxyMb with ascorbate; The reaction of ferrylMb with ascorbate; Laser photoinitiated fragmentation of species 1 in the absence of protein; Expected result of mixing
100 M NO with 272 M oxyMb, if the reaction of oxyMb with NO shared an intermediate
with the metMb-catalyzed isomerization of peroxynitrite: a numerical simulation of the
product distribution’s evolution during the first 3 ms; Laser photo-initiated reaction of NO
with excess oxyMb in the presence and absence of ascorbate: analysis of the data;
Monitoring the reaction of oxyMb with NO on the microsecond timescale; Stability of
ferrylMb in the presence of species 1 after laser irradiation: stoichiometric analysis.
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Chapter 4
Truncated Hemoglobin N from Mycobacterium tuberculosis: NO
dioxygenation at the diffusion limit
4.1. Overview
Mycobacterium tuberculosis, the causative agent for the disease tuberculosis, is
thought to infect a third of the world wide population.1 This is at least in part due to the
nitric oxide dioxygenation activity of a small dimeric heme protein known as Truncated
Hemoglobin N (trHbN) and its impressive efficiency (second-order rate constant of
7.45108 M1 s1 compared to 4107 M1 s1 for oxygenated myoglobin (oxyMb)).2,3 This
reactivity protects M. tuberculosis from the NO produced by the host’s immune system by
converting the toxic substance into benign nitrate.3,4 The simplest explanation for the
superior efficiency of trHbN relative to myoglobin is the existence of a tunnel system
connecting the active site to the surface of trHbN which is not seen in myoglobin (Fig 4.1
and Section 1.4.2); however, over the past 15 years a large number of theoretical and
experimental studies have expanded on this explanation and provided some possible
alternatives.5-19
The high value of the rate constant for the reaction of oxy-trHbN with nitric oxide
puts this reaction at the limit of those that can be studied by rapid mixing methods such as
stopped-flow or flash photolysis, so most reactivity studies done to date have involved
steady-state experiments. The laser photo-initiation method of generating nitric oxide in
situ that was presented in Chapter 2, and used to study the interaction of oxyMb with nitric
oxide (Chapter 3 and ref. 20), is ideally suited for investigating fast reactions of nitric oxide.
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Figure 4.1. Crystal structure of trHbN showing the positions of the
heme, the two major tunnel systems that presumably allow small
molecules access to the active site, the putative gating amino acid
Phe62, and the short -helical N-terminal domain referred to as the
“pre-A region” (see text for details).
This chapter presents kinetic investigations of the conversion of nitric oxide to nitrate by
oxy-trHbN (Scheme 4.1), as well as the binding of nitric oxide to reduced trHbN (redtrHbN, Scheme 4.2), for the wild type protein and a series of mutants. In particular these
studies were designed to directly monitor the roles of the putative F62 gate, active site
amino acids Y33 and Q58, N-terminal motif, and the sensitivity of the dioxygenase activity
to the heme's midpoint potential (see overview in Section 1.4). Kinetics for the reaction of
wild type red-trHbN with NO are also compared to those previously measured for redtrHbN reaction with dioxygen (kon = 2.5107 M1 s1)4 to gain insight into the proposed
ligand discriminatory functions of the tunnel system in trHbN.
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Scheme 4.1. Nitric oxide oxidation by oxy-trHbN.

Scheme 4.2. Nitric oxide binding to red-trHbN
4.2. Materials and Methods
4.2.1. General materials. All reagents were purchased from Sigma-Aldrich or
Fisher Scientific unless otherwise specified.

The light-activated NO precursor

[Mn(PaPy2Q)NO]ClO4 (species 1, where PaPy2Q is the pentadentate ligand N,N-bis(2pyridylmethyl)-amine-N-ethyl-2-quinoline-2-carboxamide) was prepared by the method
of Eroy-Reveles et al.21 with slight alterations detailed in Chapter 2
4.2.2. Protein expression, purification and handling. The gene for Truncated
Hemoglobin N (trHbN) from M. tuberculosis was synthesized for optimal codon usage by
Genscript before cloning into a pET19 vector and transforming into BL21(DE3)
Escherichia coli for expression. Mutants were either produced in the lab by phusion sitedirected mutagensis PCR (Thermo Scientific Phusion Site-Directed Mutagenesis Kit) or
purchased from Integrated DNA technologies as a gBlock gene fragment, before restriction
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and ligation into pET19. Bacterial cultures were grown overnight at 37 C in LB media,
after which the cells were concentrated and lysed using a sonic dismembrator (model CL334) to release the cell contents, and the resulting suspension clarified by addition of
streptomycin sulfate to a final concentration of 1% and centrifugation.
Protein was purified using a two-step purification procedure. In the first step the
clarified cell lysate was loaded onto a 50 mL anion exchange Q-Sepharose column (GE
Healthcare) using a loading buffer consisting of 10 mM 2-[4-(2-hydroxyethyl)-piperazin1-yl]ethanesulfonic acid (HEPES) sodium salt, 5104 M ethylenediaminetetraacetic acid
disodium salt (EDTA), pH 7 (Buffer A). The protein mixture was then eluted using 500
mL of a linear gradient starting with Buffer A and ending with Buffer B, which contained
0.2 M NaCl in Buffer A. In the second purification step the trHbN-containing fraction
from step 1 was concentrated to ~1-2 mL and passed through a 500 mL Sephacryl S-100
Size Exclusion Column (GE Healthcare) using a buffer consisting of 50 mM
tris(hydroxymethyl)aminomethane hydrochloride salt (Tris/HCl), 5104 M EDTA, and 0.1
M NaCl adjusted to pH 8. At each stage of the purification protein purity was assessed by
monitoring the ratio of A416/A280 in the UV/Vis spectrum, the ultimate goal being to get
ratios of 3 or higher. The final purity of the trHbN was assessed by SDS-PAGE gel
electrophoresis. The concentration of each purified protein stock solution was determined
by use of the pyridine hemochrome assay.22 All reported concentrations are for trHbN
monomer, which is equivalent to the concentration of heme found by the above pyridine
hemochrome assay.
TrHbN stock was reduced in an anaerobic glovebox using a slight excess of
electrolytically produced methyl viologen monocation radical, with Catalase (~1108M)
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added to avoid the accumulation of hydrogen peroxide from reduction of oxygen in the
solution. The reduced solution was then either brought into air to make the oxygen bound
variant (oxy-trHbN), or used directly from the glovebox without contacting air for
experiments on the reduced form itself (red-trHbN). The Q58V Y33F double mutant of
trHbN required a preliminary step involving oxidation with excess potassium ferricyanide
trihydrate to clear a bound carbon monoxide from its heme, and clearing out the potassium
ferricyanide trihydrate from the buffer using 10 kDa MWCO centrifugal filters (centricon);
after this initial step the protein was treated as above.
Solutions for the kinetics experiments contained either oxy-trHbN or red-trHbN,
and the NO photo-precursor 1, in mole ratios ranging from 2:1 to 1:2. Unless otherwise
stated the buffer was 50 mM Tris/Cl, 5104M EDTA, pH 8.

Based on previous

experiments the laser pulse used for these experiments typically released ~10% of the
possible nitric oxide from a given solution of 1. Thus, the stated experimental conditions
were chosen so that the solution NO concentration after the laser pulse would be about
10% of protein concentration, in order to maintain pseudo-first-order conditions.
4.2.3. Equilibrium and time-resolved spectroscopic analysis. Routine UV/Vis
spectra were obtained using a Cary 50 spectrophotometer (Varian); an instrument installed
in the glovebox was used for air-sensitive measurements. Photochemical fragmentation of
photoactive species 1 was initiated with 10 ns, 500 nm pulses from an OPO tunable laser
(Opotec Rainbow Vis). An Olis RSM-1000 spectrophotometer was used to measure the
absorbance changes induced in solution by the laser pulse. The configuration of the laser
and spectrophotometer equipment was as described in general terms elsewhere 23,24, except
that the laser pulse was transmitted by fiber optic cable instead of by mirrors.

For all
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experiments the solutions were held in 1.5 mm  1.5 mm fluorometer submicro cuvettes
(Starna). The laser pulse was focused as a spot of ~5 mm diameter which irradiated the
entire cuvette window. The laser pulse energies were measured before each day of
experiments using a Scientech AC2501 bolometer; typical pulse energies were 3 mJ/pulse.
Reactions with lifetimes of less than 10 ms were monitored with the Olis RSM-1000 in
fixed wavelength mode.

Single wavelength experiments were fit using Origin 6.0

(Microcal Software) with one- or two-exponential equations. The apparent rate constants
obtained from four or more separate experiments, in which protein concentrations were
varied while keeping the amounts of NO generated sufficiently low to ensure pseudo-first
order conditions, were then re-plotted against protein concentrations, and the true first- or
second-order rate constants were obtained from the resulting linear fits. Complete timeresolved spectra for reactions with short lifetimes were constructed by combining
individual time traces collected at specific wavelengths as described above. The time traces
were collected in random order relative to the collection wavelength. The reconstructed
time-resolved spectra were subjected to Singular Value Decomposition (SVD) to determine
the number of spectral components and smooth out noise, after which the processed spectra
were fit to appropriate exponential models using programs custom-built in Mathcad 15
(PTC Software). The analysis strategies used in our laboratories have been previously
described.24-28
UV/Vis spectro-potentiometric titrations of trHbN were performed using a BASi
Epsilon EC potentiostat to set the potential, and a CARY Bio 50 UV/Vis spectrophotometer
to obtain the spectra at each applied potential. The complete apparatus was housed in an
anaerobic glove box. Controlled potentiometric electrolysis of the solution was performed
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in an optically transparent thin-layer electrode (OTTLE) cell similar to one used in earlier
experiments by this group28 and others.29,30 In preparation for experiments a solution
containing oxy-trHbN (106 µM wild-type or 144 µM V80A mutant) and 100 µM each of
Indigo Tetrasulfonate, Indigo Carmine, and Gallocyanin as mediators, was prepared in a
buffer containing 50 mM HEPES and 200 mM NaCl, adjusted to pH 7.0. The oxy-trHbN
so prepared was then reduced to red-trHbN by controlled-potential electrolysis at 200 mV
applied potential, using a bulk electrolysis cell rather than the OTTLE cell. Spectropotentiometric titrations were then performed in one of two ways. In the first method the
red-trHbN generated by bulk electrolysis was transferred to the OTTLE cell, where UV/Vis
spectra in the range from 250 – 800 nm were collected at applied potentials ranging from
200 mV to +100 mV (vs. SHE) in 10 – 20 mV intervals. The second method was similar
except that the red-trHbN was fully oxidized to the met-trHbN form in the bulk electrolysis
cell at +100 mV applied potential, and then subjected to potentials from +100 mV to 200
mV (vs. SHE) in the OTTLE cell. The midpoint potentials obtained by the two methods
were then averaged to account for any biases arising from the OTTLE cell design. An
Ag/AgCl electrode (BASi, Model RE-5B) was used as a reference. Cyclic voltammograms
of methyl viologen were collected before assembling the spectropotentiometric datasets,
and the calculated midpoint potentials were used to account for any drift in the reference
electrode (the midpoint potential of methyl viologen was taken to be 0.449 V vs SHE31).
Datasets were also collected with identical mediator solutions in the absence of trHbN, and
these were subtracted from the corresponding trHbN data sets to account for any spectral
changes during the titration that arose from mediators. The corrected datasets were
analyzed using programs written within the commercially available software package

99
Mathcad 15 (PTC Software). Data analysis broadly followed the methodology used
previously by this group;28 details specific to this work are provided in the Results.
4.3. Results
4.3.1. Single wavelength UV/Vis time-resolved studies. Figure 4.2a shows the
spectral changes observed at 422 nm after exposing a 50 mM tris pH 8 solution initially
containing 28.1 M oxy-trHbNY33F+Q58A mutant and 15 µM of the photoactive NO species
1 to a 500 nm, 10 s laser pulse. After an initial ~30 µsec artifact caused by the laser pulse
over-saturating the voltage output of the photomultiplier tubes, an absorbance decrease due
to the reaction of the protein with NO (Scheme 4.1)4 is clearly visible; this was fit using an
exponential decay equation (red trace, Fig. 4.2) to obtain an apparent first-order rate
constant, kobs. The experiment was repeated using concentrations of oxy-trHbNY33F+Q58A
varying from 9.4 to 56.4 µM, each time adjusting the amount of 1 so that the amount of
NO generated by the laser pulse was ~0.1 the protein concentration (to maintain pseudofirst-order conditions).

A re-plot of kobs as a function of the oxy-trHbNY33F+Q58A

concentration was linear (Fig. 4.2b), and yielded a second-order rate constant for the
reaction of protein with NO of k = (7.50.7)108 M1s1.
Experiments comparable to those shown in Fig. 4.2 were performed using redtrHbNY33F+Q58V in place of the oxygenated protein. Once again individual experiments
using protein concentrations in 5-10 excess of the [NO] generated could be fit using
exponential functions, and a plot of the apparent first-order rate constants so obtained as a
function of the red-trHbNY33F+Q58V concentrations was linear (Fig. 4.3). From these results
the second-order rate constant for the reaction of red-trHbNY33F+Q58V with NO (Scheme
4.3) was determined to be (92)108 M1s1. Note that the experiments with
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Figure 4.2. (a) Spectral changes at 422nm that accompany 500 nm laser pulse irradiation
of a solution initially containing 28.1 µM oxy-trHbNY33F+Q58A mutant and 15 µM NO
photo-precursor 1 in a 50 mM Tris, 0.5 mM EDTA buffer adjusted to pH 8. Red trace:
single exponential fit of the data. Under these conditions the apparent rate constant kobs for
the spectral change was 25,7001,300 s1. From the total change in absorbance amplitude
one could also estimate that the laser pulse generated ~1.5 µM nitric oxide. (b)
Dependence of kobs on the concentration of oxy-trHbNY33F+Q58V mutant; concentrations of
photo-precursor 1 were varied from experiment to experiment so that the amount of NO
generated was always ~0.1 that of oxy-trHbNY33F+Q58V. From the linear fit to the data the
second-order rate constant for reaction of NO with oxy-trHbNY33F+Q58V was determined to
be (7.50.7)108 M1s1.
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red-trHbNY33F+Q58V were more technically challenging than those with the oxygenated
protein because the full sample preparation had to be done in the glovebox and in the dark.
As a result less protein concentrations were used for these experiments.

Scheme 4.3. Reaction sequence that could explain the lack of
dependence on protein concentration of the interaction between redtrHbNdelN and NO. In species B NO is within the protein tunnel
system, but not bound to the heme.
In addition to the experiments shown in Figs. 4.2 and 4.3, similar experiments were
performed to determine the reactivities with NO of oxygenated and fully reduced wild type
trHbN, and of a series of variants. The results are summarized in Fig. 4.4. As was the case
for the oxy-trHbNY33F+Q58V double mutant, the reactions of the other oxygenated variants
with NO were first-order with respect to NO and protein concentrations, and second-order
overall. The red bars in Fig. 4.4 show the calculated second-order rate constants for each
of the variants. Error estimates range from less than 10% to about 20% of the calculated
rate constants, which are reasonable given that some of the faster reactions monitored
approached the time resolution limit of our instrumentation (see for example Fig. 4.2a).
The reactions of the red-trHbN variants with NO were also first order with respect to NO
and protein concentrations, with the exception of a variant in which the N-terminal pre-A
motif (Fig. 4.1) was deleted (hereafter referred to as trHbNdelN). For this variant the
reaction with NO was first-order in NO concentration but zero-order in protein
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Figure 4.3. Dependence of kobs on the concentration of red-trHbNY33F+Q58V mutant;
concentrations of photo-precursor 1 were varied from experiment to experiment so that the
amount of NO generated was always ~0.1 that of red-trHbNY33F+Q58V. From the linear fit
to the data the second-order rate constant for reaction of NO with red-trHbNY33F+Q58V was
determined to be (92)108 M1s1.

Figure 4.4. A graphical summary of the second order rate constants for the reactions with
NO of the oxygenated and fully-reduced forms of the trHbN variants presented herein.
WT: wild type trHbN; DM: Y33F+Q58V double mutant; delN: deletion mutant lacking
the pre-A motif (Fig. 4.1). A tabular form of this data is provided in Appendix 2.
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Figure 4.5. Dependence of kobs on protein concentration for the reaction with
NO of the mutant lacking the short pre-A helix (red-trHbNdelN, Fig. 4.1). Notice
that in this case kobs appears to be a true first-order rate constant that is invariant
with changes in protein concentration. The solid red line shows the average
value of kobs, while the dashed lines are placed at one standard deviation to
either side.

concentration (Fig. 4.5). Thus, Fig. 4.5 shows that the apparent rate constant in fact
remained invariant at 33001200 s-1 as the red-trHbNdelN concentration was increased from
~5 M to 35 M.
So far this section has focused on the fastest UV/Vis spectral changes observed
after exposing wild type trHbN and several variants to laser photo-generated NO.
However, further inspection also revealed spectral changes on longer timescales following
the reactions of both oxy-trHbN and red-trHbN with NO. Figure 4.6 shows an example in
which a solution initially containing 21.2 μM red-trHbNWT and 40 μM photo-precursor 1
was irradiated with a laser pulse. Figure 4.6a shows the initial absorbance change
occurring on the s timescale, but Fig. 4.6b shows an additional change that occurred over
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tens of ms. As with the rapid absorbance change this slower change could be fit with a one
exponential decay function. However, whereas the kobs for the fast phase exhibits linear
dependence on protein concentration as discussed earlier, the kobs for the slower phase
shows no dependence on protein concentration (Fig. 4.6c). Taking the average of the kobs
values from Fig. 4.6c yields 130  25 s1 as the value of a true first-order rate constant.
Slower time scale UV/Vis absorption changes were also seen when oxy-trHbN was
reacted with photo-generated NO (Scheme 4.1). Figure 4.7 shows an example in which a
solution containing 10.7 μM oxy-trHbNWT and 20 μM photo-precursor 1 was irradiated
with a 500nm laser pulse to produce ~2 μM NO. The time trace of Fig. 4.7a (plotted on a
logarithmic scale) was fitted to two exponentials. When the experiment was repeated with
varying concentrations of oxy-trHbN the apparent rate constant for the second (slow)
kinetic event was found to be roughly invariant with protein concentration (Fig. 4.7b);
however, the 2-exponential fits were not as good at higher protein concentrations because
the faster absorbance changes came progressively closer to the deadtime of the
instrumentation as the concentration increased past ~30 μM. Furthermore, the average first
order rate constant obtained for the slow phase (250  92 s1) displayed a large degree of
scatter (Fig. 4.7b).
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Figure 4.6. Spectral changes observed after a solution initially containing 21.2 μM redtrHbNWT and 40 μM photo-precursor 1 was irradiated with a 500 nm laser pulse to produce
~4 μM NO. (a) Changes observed on the s timescale; (b) changes observed on the ms
timescale. (c) Dependence of the apparent rate constant for the slower process shown in
(b) on protein concentration.
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Figure 4.6. Spectral changes observed after a solution initially containing 21.2
μM red-trHbNWT and 40 μM photo-precursor 1 was irradiated with a 500 nm
laser pulse to produce ~4 μM NO. (a) Changes observed on the s timescale;
(b) changes observed on the ms timescale. (c) Dependence of the apparent rate
constant for the slower process shown in (b) on protein concentration.

The single wavelength experiments described thus far provide no insight into the
possible origins of the slow exponential phases observed upon exposure of red-trHbN and
oxy-trHbN to NO. Indeed, in attributing the fast exponential phases to the processes of
Schemes 4.1 and 4.2, one is implicitly relying on previous studies where these processes
were observed, since single-wavelength studies provide no spectral cues that can be
assigned to specific chemical changes. In order to gain more insight into the nature of the
slow processes the reactions of red-trHbN and oxy-trHbN with NO were investigated in
two global UV/Vis time-resolved experiments, in which the spectral changes were
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Figure 4.7. (a) Spectral changes at 430 nm that follow laser pulse irradiation of a solution
initially containing 10.7 µM oxy-trHbN and 20 µM photo-precursor 1 (which produced ~2
µM NO). Red trace: best non-linear least-squares fit to a 2-exponential model. (b)
Dependence of kobs for the slow phase of (a) on concentration of oxy-trHbN.
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monitored as a function of probe wavelength as well as time. These experiments are
described in the next section.
4.3.2 Global UV/Vis time-resolved studies. Complete time-resolved spectra for
selected reactions of oxy-trHbN or red-trHbN with NO were constructed by combining
multiple individual time traces, collected at different wavelengths, but under identical
conditions. The reconstructed time-resolved spectra were subjected to Singular Value
Decomposition (SVD) to determine the number of spectral components and smooth out
noise, after which the processed spectra were fit to appropriate exponential models.
In one experiment the spectral changes observed after irradiating samples
containing 19.3 μM red-trHbN and 20.4 μM of photo-precursor 1 were monitored in the
range from 400 – 450 nm. SVD analysis revealed two spectral components above the noise
level, though one of these showed systematic time dependence but not wavelength
dependence (See Appendix 2). The SVD-processed data were fit to the 2-exponential
equation 4.1, where At is the absorbance change at wavelength  and time t; 1 and 2
are the amplitudes of components 1 and 2, respectively at wavelengths ; and k1obs

A ,t  1 (1  e k1obst )   2  (1  e k2 obst )

Eq. 4.1

and k2obs are the apparent first-order rate constants for the respective exponential processes.
Figure 4.8a shows spectra collected at selected times after the laser pulse, and the
corresponding calculated least-squares fits, while Fig. 4.8b shows the A vs time trace
obtained at 420 nm, one of the wavelengths at which the magnitude of A was largest. The
associated values of kobs were determined to be 6800 s1 and 97 s1, respectively; the
spectral components 1 and 2 are provided in Appendix 2. It is important to note that
although 1 and 2 were allowed to vary independently in the fit, they have very nearly
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Figure 4.8. (a) UV/Vis spectral changes observed at selected times after irradiating a
solution of 19.3 μM red-trHbN and 20.4 μM photo-precursor 1 with a 500 nm laser pulse.
The blue traces were obtained at 120 s intervals starting at 80 s, while the green ones
were obtained at 10 ms intervals starting at 1 ms. The red dashed traces are least-squares
best fits to Eq. 4.1. (b) Blue trace: A vs time slice through the spectra from (a) obtained
at 420 nm; Red trace: least-squares best fit at this wavelength. The values obtained for kobs
were 6800 s1 and 97 s1 for the fast and slow phases, respectively.
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identical shapes, with maximal positive deflections around 420 nm and maximal negative
deflections near 440 nm. That this must be so is evident from the fact that all of the
representative spectra in Fig. 4.8a have similar shapes. The result is consistent with the
observation that only one of the SVD components shows systematic wavelength
dependence (Appendix 2), and suggests that any apparent differences between the two
components are simply a result of differing admixtures of noise. The spectral changes
shown in Fig. 4.8a, both on the s and ms timescales, are those expected for nitrosylation
of red-trHbN. Thus it appears that heme nitrosylation occurs in two phases: the first rapid
phase has first-order dependence on [red-trHbN] while the second is independent of protein
concentration; both phases have first-order dependence on [NO].
Figure 4.9 shows the spectral changes that were observed when solutions
containing 30.6 μM oxy-trHbN and 73.8 μM photoprecursor 1 were irradiated with laser
pulses, and the resulting A vs time traces obtained at varying wavelengths were combined
to produce complete time-resolved spectra. In this case SVD analysis revealed three
spectral components that showed systematic time dependence, but only one that showed
clear wavelength dependence (Appendix 2). In contrast to the results shown in Fig. 4.8 for
the reaction of red-trHbN with NO, the difference spectra in Fig 4.9 first increase in
amplitude but then decrease (this is clearly seen in the A404 vs t slice of Fig. 4.9b). To
account for this the SVD-processed data were fit to the 3-exponential equation 4.2, where
At is the absorbance change at wavelength  and time t; 1 – 3 are the amplitudes of
components 1 – 3, respectively, at wavelengths ; and k1obs – k3obs are the apparent firstorder rate constants for the respective exponential processes. The negative signs in front

A ,t  1 (1  e k1obst )   2 (1  e k2 obst )  3 (1  e k3obst )

Eq. 4.2
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Figure 4.9. (a) UV/Vis spectral changes observed at selected times after irradiating a
solution of 30.6 μM oxy-TrHbN and 73.8 μM photo-precursor 1 with a 500 nm laser pulse.
The blue traces were obtained at 40 s intervals starting at 60 s, while the green ones were
obtained at 5 ms intervals starting at 1 ms. The red dashed traces are least-squares best fits
to Eq. 4.2. Note from the associated arrows that the spectral amplitude increases for the
early blue traces, but decreases for the later green traces (b) Blue trace: A vs time slice
through the spectra from (a) obtained at 404 nm; Red trace: least-squares best fit at this
wavelength. The values obtained for kobs were 3.33104 s1, 910 s1 and 55 s1 for the three
kinetic phases, respectively.
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of 2and 3 make these into spectral components that are subtracted from the difference
spectra at longer timescales (Appendix 2). The rate constants calculated from the fitting
procedure were 3.3104 s1, 900 s1, and 55 s1 for k1obs – k3obs, respectively.
As was the case for the red-trHbN experiment, the Fig. 4.9 time-resolved difference
spectra share very similar shapes, which in this case are characteristic of the difference
between the oxy-trHbN and met-trHbN spectra. Thus we surmise that 1 – 3are really
all the same spectral component, but that they contain differing admixtures of noise. This
interpretation suggests that, after NO oxidizes oxy-trHbN to met-trHbN, a fraction of the
aquomet species is converted back to oxy-trHbN by an as-yet unknown process. It is not
clear why three exponential functions are required to fit the time-resolved spectra of Fig.
4.9, whereas two exponentials suffice to fit absorbance vs. time traces obtained at a singlewavelength (Fig. 4.7a). The magnitude of the 2component is rather small (Appendix 2),
and it is possible that this feature is an artifact of reconstructing the Fig. 4.9 spectrum from
multiple individual absorbance vs. time traces. Further studies will be needed to address
these questions.
4.3.3. Spectropotentiometric studies.

Figures 4.10 and 4.11 compare the

electrochemical properties of trHbNWT with those of the trHbNV80A mutant. Figure 4.10a
shows the spectral changes at 435 nm observed for a solution initially containing redtrHbNWT (106 µM), as an applied potential was increased stepwise in 10 mV increments
from 200 mV to 100 mV. Figure 4.10b shows the comparable data obtained when a
solution initially containing met-trHbNWT (106 µM) was exposed to applied potentials that
decreased in 10 mV decrements from 100 mV to 200 mV. The red traces in Fig. 4.10 are
least-squares fits to the exponential form of the Nernst Equation 28, which yielded midpoint
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potentials of 11mV and 30mV, respectively from (a) and (b). The calculated average
midpoint potential for reduction of met-trHbNWT is therefore 2011 mV. When the
experiments of Fig. 4.10 were repeated using the trHbNV80A mutant (144 µM, Fig. 4.11),
an analogous analysis (red traces) showed that the average midpoint potential for the
mutant was 3510 mV, or 15 mV more negative than the wild type.

Given the

uncertainties of the measurements, this difference was not deemed very significant.
4.4. Discussion
4.4.1. Effects of active site mutations on trHbN’s reactivity with NO. Mutations
to active site amino acids had relatively small effects (Fig. 4.4) on the reactions of oxytrHbN and red-trHbN (Schemes 4.1 and 4.2, respectively) with NO. Oxy-trHbNWT has an
impressive 1.4109 M1 s1 second-order rate constant for reaction with NO according to
our measurements. Active site amino acid mutations Q58A and Y33F+Q58V decreased
this rate constant by about half (to 5.8108 M1 s1 and 7.1x108 M1 s1, respectively), while
the Y33A mutation had essentially no effect. This shows that Q58 plays a more meaningful
role in tuning the enzyme’s dioxygenase activity than does Y33; however, halving a rate
constant so near the diffusion limit is a relatively small effect. Tyrosine 33 is critical to
trHbN’s exceptionally high oxygen affinity,4 but previous studies have left its effect on NO
dioxygenation less certain. Mutation of a comparable Tyr group in the closely related
flavohemoglobin from E. coli leads to an 80-fold decrease in the protein’s NO dioxygenase
activity,32 and a similar outcome was predicted for trHbN on the basis of this result; early
whole-cell assays appeared to support the prediction.3 More recently Mishra and Meuwly
presented a theoretical study using a method called adiabatic reactive molecular dynamics
(ARMD) that predicted significant retardation of NO dioxygenation in Y33A mutants, and
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Figure 4.10. Spectral changes at selected wavelengths of a solution initially containing 106
μM trHbN in 50 mM buffer containing Tris/Cl adjusted to pH 8, and a mixture of
electrochemical mediators containing 100 μM Indigo Tetrasulfonate, Indigo Carmine, and
Gallocyanine. (a) Applied potential initially set at 200 mV, then increased in 10 or 20
mV steps until reaching 100 mV; (b) Reverse of (a): applied potential initially set at 100
mV, then decreased in 10 or 20 mV steps until reaching 200 mV. Black squares:
experimental data; red lines: least-squares fits to the exponential form of the Nernst
Equation,28 which yielded midpoint potentials of 11mV and 30mV, respectively from
(a) and (b). The calculated average midpoint potential for reduction of met-trHbN is
2011 mV.
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Figure 4.11. Spectral changes at selected wavelengths of a solution initially containing
~144 μM trHbNV80A mutant in 50 mM buffer containing Tris/Cl adjusted to pH 8, and a
mixture of electrochemical mediators containing 100 μM Indigo Tetrasulfonate, Indigo
Carmine, and Gallocyanine. (a) Applied potential initially set at 200 mV, then increased
in 10 or 20 mV steps until reaching 100 mV; (b) Reverse of (a): applied potential initially
set at 100 mV, then decreased in 10 or 20 mV steps until reaching 200 mV. Black squares:
experimental data; red lines: least-squares fits to the exponential form of the Nernst
Equation,28 which yielded midpoint potentials of 25mV and 45mV, respectively from
(a) and (b). The calculated average midpoint potential for reduction of met-trHbN is
3510 mV.
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a somewhat smaller retardation for mutations in Gln 58.15 In contrast to these reports, a
2005 QM-MM theoretical study by Crespo et al. predicted exactly what we observed here:
little or no direct effect on NO dioxygenase activity upon mutation of Tyr 33, and a modest
decrease in activity accompanying mutation of Gln 58.10 The report by Crespo et al. did
also suggest a greater indirect role for Tyr 33 and Gln 58 in modulating the NO dioxygenase
rate constant, which involved triggering a conformational switch in Phe 62, an amino acid
that appears to control ligand passage via the long diffusion tunnel that connects the active
site to the protein exterior (Fig. 4.1).10 This hypothesis was further elaborated in two later
articles,33,34 and is discussed more extensively in the next section.
The rate constant for reaction of red-trHbNWT with NO was calculated to be 2.2108
M1 s1, but increased to 9.3108 M1 s1 for the red-trHbNY33F+Q58V double mutant, and
4.6108 M1 s1 for red-trHbNY33A mutant. The rate constant for the red-trHbNQ58A mutant
was essentially unchanged (2.6108 M1 s1). These results parallel those seen by Ouellet
et al. for the reactions of O2 and CO with red-trHbNWT and comparable active site variants:
for both gases the Tyr 33 variant rate constants were substantially higher than those of the
wild type, and approached the diffusion limit.35 A series of laser flash photolysis studies
with the NO adducts of the met-trHbN variants, together with molecular dynamics
simulations of the red-trHbN variants, provided persuasive evidence that displacement of
a non-coordinated distal site water molecule, held in place by tight interaction with Tyr 33,
provides the main barrier to ligand binding.35 Notably, the rate constant for NO binding to
red-trHbNWT (2.2108 M1 s1) was 4 – 10 times higher than that for O2 binding to the wild
type protein, which was determined to be between (2.5 – 5.6) 107 M1 s1 in stopped-flow
and flash photolysis studies.3,35 This difference is levelled in the Tyr 33 mutants, which
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display near-diffusion limit rate constants for all three gases, NO, O2 and CO.
4.4.2. The role of Phenylalanine 62. Crystal structures of trHbN showed that Phe
62, which is situated at the junction between the active site and the long tunnel that connects
the active site with the protein exterior (Fig. 4.1), can adopt two possible conformations:
one of these blocks the tunnel, and the other leaves the tunnel open.6-8 Later theoretical
studies showed that this “gate” in the long tunnel was controlled to a great extent by Tyr
33 and Gln 58.10,33,34 For example, molecular dynamics simulations showed that the Phe
62 gate spends most of its time closed in red-trHbN, but most of its time open in oxytrHbN, due to conformational changes triggered in Tyr 33 and Gln 58 after dioxygen
binding. 33,34 Furthermore, the simulations also predicted that in Y33F or Q58A mutants
the Phe 62 gate would stay closed regardless of the presence or absence of dioxygen at the
active site.34 These results led to the hypothesis of a “dual-path mechanism” for trHbN
whereby dioxygen migration into red-trHbN proceeds exclusively via the short tunnel
(since the long tunnel is blocked in the deoxy form of the protein), but that NO transport
proceeds via the long tunnel once dioxygen binding opens this pathway up.33
The results discussed in the previous section showed that the reaction of NO with
oxy-trHbN was only marginally affected by mutation of Q58, and completely unaffected
by changes to Y33. Assuming that the theoretical studies are correct, and that the long
tunnel of Q58 or Y33 variants is stuck in a closed position, these findings demonstrate that
there is no barrier to NO entering the active site of oxy-trHbN through the short tunnel. In
apparent contradiction with this conclusion a very recent article noted that in four F62
mutants of trHbN the steady-state NO dioxygenase activity of the protein decreased from
30% – 50%, whereas the association rate constant for CO with the red-trHbN mutants was
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unaffected; the protein’s oxygen affinity was likewise unaffected.18 From these results the
authors concluded that F62 plays a key role in controlling NO’s access to oxy-trHbN, but
does not affect gas binding to red-trHbN, in agreement with the dual path mechanism. In
this present study two gate mutants, oxy-trHbNF62A and oxy-trHbNF62W, were both found
to have rate constants for NO dioxygenation that were lower than the wild type (Fig. 4.4):
4.7108 M1 s1 (34% WT) for oxy-trHbNF62A, and 6.8108 M1 s1 (52% WT) for oxytrHbNF62W. These results are in rough agreement with the steady-state results of Oliveira
et al, though in the latter trHbNF62W was found to have lower activity than trHbNF62A (30%
vs 50% of WT, respectively).18 However, what seems most remarkable about the combined
results of the two studies is not the absolute magnitudes of the changes in reactivity. Rather
it is the fact that a reactivity decrease was observed for both trHbNF62W, in which
phenylalanine was replaced with a bulkier side chain, and trHbNF62A, in which the
replacement side chain should have been small enough to leave the long tunnel
permanently open.33 This suggests that the mutations to F62 disturb gas access to the active
site in a complex way that can’t be readily correlated with a simple gate which affects
passage through the long tunnel. A more likely explanation for the observed reactivity
decrease in the mutants, also suggested by Oliveira et al, is that F62 plays an important role
in preventing collapse of the B and E helices that control ligand accessibility to the active
site.18 Finally note that, whereas the rate constant for CO binding to red-trHbN mutants
was the same as for the wild type,18 our results show (Fig. 4.4) that the rate constants for
mutant nitrosylation are lower than for the wild type: 1.2108 M1 s1 (52% WT) for oxytrHbNF62A, and 1.6108 M1 s1 (70% WT) for oxy-trHbNF62W. Again this result can’t be
neatly incorporated into a simple dual path mechanism in which access to oxy-trHbN and
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red-trHbN are distinct.
4.4.3. The role of the pre-A motif on the reactivity of trHbN. As mentioned in
Section 1.4.3, in a recent paper Lama et al. showed that when the first 12 amino acids (the
“pre-A sequence”) were deleted from the N-terminus of trHbN, the resulting trHbNdelN
mutant exhibited a drastic decrease in its NO dioxygenase activity.14 An equally intriguing
result was that when a pre-A sequence was added to a trHbN orthologue from
Mycobacterium smegmatis, which lacks its own pre-A sequence and shows minimal NO
dioxygenase activity, the augmented mutant now displayed increased activity.14 Taken
together these results clearly demonstrate that the pre-A sequence plays a key role in
providing trHbN with NO dioxygenase activity, despite its remoteness from the active site.
On the basis of molecular dynamics simulations Lama et al. proposed that thermal
fluctuations in the highly flexible pre-A region influence backbone motion of the protein,
which in turn influences the conformational state of the Phe 62 gate residue (see previous
section); in trHbNdelN the simulations showed that the gate was stuck in a closed position.14
Recent NMR studies disagreed with the concept of the pre-A motif having an effect on the
dynamics of Phe 62; however, the question of what caused the dramatic loss of NO
dioxyganese activity observed by Lama et al. upon deletion of this motif remained.16
The results of the present work are inconsistent with the explanation of Lama et al,
given that the rate constant for reaction of NO with oxy-trHbN is not significantly affected
by the removal of the pre-A sequence (Fig. 4.4; the value of the rate constant for trHbNdelN
was (1.00.1)109 M1 s1, compared with (1.40.1)109 M1 s1 for the wild type).
Instead our results show that it is ligand association with red-trHbN that is most profoundly
affected by deletion of the pre-A region. The reaction of red-trHbNdelN with NO is no
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longer second-order overall, now being independent of protein concentration, and
governed by a rate constant of 3300  1200 s1 (Fig. 4.5). Presumably the reactions of
dioxygen and carbon monoxide with red-trHbNdelN would be affected similarly to NO,
though this will have to be confirmed in future experiments. In that case it is the change
in the oxygenation rate of red-trHbNdelN that is responsible for the profound difference in
NO dioxygenase activity between trHbNdelN and trHbNWT in steady state assays, not the
oxygenated proteins’ relative ability to oxidize NO. This hypothesis does not explain the
dramatically decreased rate for the reaction of NO with trHbNdelN compared to trHbNWT
reported by Lama et al. for NO titration experiments;14 however, this rate difference
disappeared when we tested for it using our more rigorous photo-initiated NO delivery
system (see Appendix 2).
The overall first-order kinetics observed for the reaction of red-trHbNdelN with nitric
oxide can be understood in terms of Scheme 4.3, where red-trHbNdelNNO represents an
NO adduct in which the gas has entered the protein through the substrate tunnels but has
not bound to the iron, while red-trHbNdelN(NO) represents the iron-nitrosylated protein.
Thus, according to this model nitric oxide is able to enter the tunnel system without notable
impedance, but once ensnared in the tunnels it is in some way prevented from immediately
binding the active site as it normally would in red-trHbNWT.
As mentioned in Section 1.4.2, in addition to the long and short tunnels seen in the crystal
structure,6 a theoretical study by Daigle et al. recently identified two additional tunnels that
open only transiently (the “BE” and “EH” tunnels).13 The authors proposed that these
tunnels could temporarily store NO or dioxygen within the protein. These two tunnels, in
addition to the permanent “long” tunnel visible in the crystal structure that appears to open
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or close according to circumstances (Fig. 4.1),10,33,34 are promising candidates for locations
within trHbN where NO could be temporarily trapped in the trHbNdelN variant. Presumably
the decreased backbone mobility in key regions of trHbN that accompanies the pre-A
deletion, as found in the calculations of Lama et al,14 disturbs some kind of unlocking
mechanism present in the wild type (this is discussed further below). It should be noted
however that this decreased backbone mobility was not observed in NMR studies of the
cyanide bound trHbNdelN variant.16
Under pseudo-first-order conditions with red-trHbNdelN in excess, Scheme 4.3 leads
to a single-exponential rate law in which the apparent rate constant kobs has hyperbolic
dependence on total protein concentration (Eq. 4.3; see Appendix 2). Such a rate law is
only consistent with the results of Fig. 4.5 (where kobs is independent of protein
concentration) if [HbNtotal] (~ [red-HbNdelN]) >> K11 for all the protein concentrations
sampled. These ranged from 5 M to 35 M (Fig. 4.5), from which one can estimate that
K11 can be at most 5107 M, or K1 must be at least 2106 M1 according to the mechanism
k obs 

k 2 [HbN total ]
K11  [HbN total ]

Eq. 4.3

of Scheme 4.3. Such a value is entirely reasonable given what is known about trHbN. One
can assume that entry to the tunnel system (k1 in Scheme 4.3) will be diffusion limited
(~109 M1s1), so if K1 ~ 2106 M1 then k1 would have to be ~500 s1, which corresponds
to a half-life of ~1.4 ms for tunnel residence.
Two molecular-level explanations that could give rise to Scheme 4.3 build directly
on the known chemistry of trHbN that has been discussed here. The first is that the closed
putative Phe 62 gate residue traps NO in the long or EH tunnels of the delN mutant, and
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only slowly allows access to the reduced heme center. The second is that motions in the
N-terminus play a crucial role in displacing the non-coordinated distal site water molecule
that is held in place by tight interaction with Tyr 33, and which has been proposed to
provide the main barrier to ligand binding to red-trHbNWT as discussed earlier.35 Given the
results above that reveal no barrier to NO oxidation by oxy-trHbNdelN despite
computational evidence that its long tunnel is also blocked by Phe 62, we tentatively favor
the second mechanism. However, some involvement of Phe 62 is also possible, and other
molecular-level mechanisms could be proposed. An obvious and important follow-up
experiment will be to test the nitrosylation kinetics of a red-trHbNdelN+ Y33F+Q58V mutant: if
the only role of the pre-A region is to help mobilize the non-coordinated distal site water
molecule, then eliminating the Tyr 33 that holds the water in place should boost the rate
constant for heme nitrosylation to the diffusion limit, as it does for red-trHbNY33F+Q58V.
This experiment is planned for the near future.

Scheme 4.4. Resonance forms used to describe oxy-hemes.
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4.4.4. V80A: a mutant designed to affect the trHbN midpoint potential. The
final mutant synthesized and tested in this project was V80A. Valine 80 is a surface amino
acid that helps make up a wall near the proximal side of the trHbN heme. The mutation
V80A was meant to decrease the steric bulk at that point, thus increasing the accessibility
of solvent to the heme, which in turn was expected to decrease its midpoint potential.36,37
Oxy-hemes can be understood in terms of three resonance forms (Scheme 4.4), whereby
the dominant resonance form is expected to vary with changes to the protein
environment.38,39 Recent studies indicate that the character of the bound oxygen may affect
its proclivity for the nitric oxide dioxygenation reaction to occur.40 The ultimate goal of
this experiment was to determine the effect of a midpoint potential shift, and corresponding
change in the nature of the coordinated heme, on its reactivity with NO.
Spectroelectrochemical experiments to determine the heme midpoint potentials of
trHbNWT and trHbNV80A were performed going from oxidized protein to reduced, as well
as going from reduced protein to oxidized (see Results Section 4.3). This was required
since the design of the spectroelectrochemical cell can introduce different biases in the
measured potentials depending on which direction the applied potential is changed in. The
results show that the differences in calculated midpoint potentials were consistently around
20 mV, which is an acceptable uncertainty for the current needs. The reported midpoint
potentials, 2011 mV for trHbNWT and 3510 mV for the trHbNV80A mutant, were
obtained as the averages of the midpoint potentials obtained when changing the applied
potentials in opposing directions.
Kinetic experiments using the 15 mV downshifted V80A mutant showed that the
rate constants for the reaction of nitric oxide with oxygenated protein (1.99109 M1 s1)
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and the binding of nitric oxide to reduced protein (4.74108 M1 s1) were increased relative
to the wild-type values by similar degrees (Fig. 4.4). Since both reduced and oxygenated
protein kinetics are affected to roughly the same extent, it seems more likely that the effect
of the V80A mutation is to somehow increase the accessibility of nitric oxide to the active
site, rather than to tune the bound oxygen’s reactivity.
The effect of the V80A mutation on the heme midpoint potential proved to be fairly
minor (a shift of 15 mV), and it’s possible that in mutants showing greater changes to the
midpoint potential the reactivity of oxy-trHbN would be more profoundly affected. To date
no other electrochemical mutations have been prepared, but this is a promising avenue for
further research. Future investigators will have to be cautious though, because a too drastic
change in the heme midpoint potential would lead to a heme incapable of binding dioxygen.
4.4.5. The slow phase in red-trHbN nitrosylation.

Figures 4.6 and 4.8

demonstrate that nitrosylation of red-trHbN occurs in two phases: a fast phase that depends
on both NO and protein concentrations, and a slow phase that depends only on NO
concentration. Scheme 4.5 suggests one possible mechanistic explanation for this

red-trHbN  NO 
 red-trHbN(NO) [red-trHbN  NO]
k1
B
C
A
[red-trHbN  NO] 
 red-trHbN(NO)
k2
C
B
Scheme 4.5. Reaction sequence that could explain the presence of two
exponential phases during nitrosylation of red-trHbN. The rate constant
k1 is second order and governs the encounter between free NO and protein,
but produces two species B and C. In species C NO is within the protein
tunnel system, but not bound to the heme. It then slowly finds its way to
the active site in a process governed by the first-order rate constant k2.
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behavior. According to this mechanism after NO enters red-trHbN it can either take a direct
path to the heme center (Scheme 4.5, species B), or it can become momentarily trapped in
a remote site within the protein (Scheme 4.5, species C), and only slowly make its way to
the active site. The conversion of species C to species B would be governed by the firstorder rate constant k2, and would depend only on the concentration of C. Under pseudofirst-order conditions with protein in excess this process would appear to depend only on
the concentration of NO generated by the laser flash, as is observed experimentally. This
mechanism is reminiscent of that proposed in Scheme 4.3 for the red-trHbNdelN mutant,
and once again several structure-based explanations for it can be proposed on the basis of
the known trHbN structure. For example, one could propose that the fast phase arises from
NO that enters the trHbN short tunnel, whereas the slow phase is due to NO that enters the
long tunnel and is momentarily trapped behind the Phe 62 gate.10,33,34 A more general
explanation is that the NO can be trapped in any one, or all of the transient BE and EH
tunnels recently identified by Daigle et al,13 as well as in the long tunnel (see Section 4.4.4
above).

Scheme 4.6. Alternate explanation for the presence of two exponential
phases during nitrosylation of red-trHbN, which was ruled out by the
experimental evidence (see text for details).
Initially an alternative mechanism shown in Scheme 4.6 was considered as an
explanation of the kinetics for the reaction of NO with red-trHbN, but this was
subsequently ruled out as will now be described. In the Scheme 4.6 mechanism red-trHbN
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exists in two conformational states, one of which provides direct access to the active site
([red-trHbN]open in Scheme 4.6), and the other which can bind NO, but in which direct
access to the heme is blocked ([red-trHbN]closed in Scheme 4.6). According to this
mechanism exchange between the isomers is slow compared to the rate of NO binding to
either isomer, and NO trapped in the closed isomer has no way of reaching the active site.
Under pseudo-first-order conditions with protein in excess all of the photogenerated NO
would rapidly bind to the protein, but only that which bound to any available “open”
conformer would immediately give rise to red-trHbN(NO). Then, after the initial rapid
nitrosylation phase, further nitrosylation would be governed by the slow isomerization of
[red-trHbN]closed to [red-trHbN]open. The Scheme 4.6 mechanism predicts that in a series
of experiments where the protein concentration is kept constant but the amount of
photogenerated NO is increased, the ratio of amplitudes for the fast and slow phases should
stay roughly constant as NO is increased up to the initial concentration of [red-trHbN]open,
but thereafter should decrease because additional NO will only be able to bind to the [redtrHbN]closed. This experiment was done using the F62A mutant for which the fast phase
was slow enough that both phases could be monitored in a single experiment (Fig. 4.12a).
As seen in Figs. 4.12b and 4.12c, the ratios of amplitudes for the fast and slow phases
remained constant at 42 as the amount of photogenerated NO was increased, which is
consistent with the Scheme 4.5 but not the Scheme 4.6 mechanism. Finally, note that in
Scheme 4.5 NO binding to red-trHbN is shown as irreversible. If NO can escape into the
solvent from the red-trHbNNO blind tunnels more rapidly than it can reach the active site,
then the Scheme 4.5 kinetics would become indistinguishable from those of Scheme 4.6.
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4.4.6. The slow phases in the reaction of NO with oxy-trHbN. As is the case
for the reaction of red-trHbN with NO, Figures 4.7 and 4.9 reveal multiple phases for the
reaction of oxy-trHbN with NO, this time a total of three kinetic phases (Fig. 4.9). Once
again the slow phases show no dependence on protein concentration, and first-order
dependence on [NO]. However, in the reaction of oxy-trHbN with NO the slow phases
reverse the initial protein reaction: the spectra of Fig. 4.9 reveal that met-trHbN is being

slowly converted back to oxy-trHbN. At present we have no explanation for this
observation, though it is entirely reproducible and was observed for all of the trHbN
variants investigated in this study. One likely possibility is that the phenomenon is an
artifact of the experimental procedure. As described in the Materials and Methods
section, prior to kinetic studies stock trHbN was first reduced to the red-trHbN form with
methyl viologen monocation radical to eliminate any met-trHbN that might have formed;
this was especially important for variants that held oxygen more weakly than the wild
type. For the experiments with oxy-trHbN the methyl viologen-reduced red-trHbN was
then brought out of the glovebox and exposed to air to generate the oxygenated form. It
is possible that excess methyl viologen monocation radical generated an as-yet
uncharacterized reductant capable of reducing the met-trHbN generated in the reaction of
oxy-trHbN with NO. Such a reductant would have to survive the initial exposure to
oxygen (which the monocation radical would not), but be capable of reducing met-trHbN
on the observed timescales. To test this hypothesis, future studies should carefully
control the amount of methyl viologen monocation radical used to prepare the oxy-trHbN
for the experiments.
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Figure 4.12. (a) Spectral changes at 440 nm following irradiation by a 500 nm laser pulse
of a solution initially containing 21.7 µM red-trHbNF62A mutant and ~80 M NO photoprecursor 1 (enough to produce ~8 µM nitric oxide). Red trace: least-squares fit using a
two exponential model. (b) Effect of varying the NO concentration on the amplitudes of
the two exponential phases shown in (a) above; (c) Ratios of the calculated amplitudes for
the two exponential phases plotted in (b) above. Red solid line: average value; dashed lines
are one standard deviation from the average.
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Figure 4.12. (a) Spectral changes at 440 nm following irradiation by a 500 nm
laser pulse of a solution initially containing 21.7 µM red-trHbNF62A mutant and
~80 M NO photo-precursor 1 (enough to produce ~8 µM nitric oxide). Red
trace: least-squares fit using a two exponential model. (b) Effect of varying the
NO concentration on the amplitudes of the two exponential phases shown in (a)
above; (c) Ratios of the calculated amplitudes for the two exponential phases
plotted in (b) above. Red solid line: average value; dashed lines are one standard
deviation from the average.
Though for now the results of Figs. 4.7 and 4.9 stand as empirical observations
without obvious mechanistic explanations, the results of Fig. 4.9 in particular do serve to
rule out one possible complicating reaction that might have been expected upon exposing
oxy-trHbN to a laser pulse. In the past ligand dissociation from both oxy-trHbN and the
red-trHbN(CO) has been effected with 530 nm laser pulses,35 and one might have expected
similar chemistry in the present studies. However, Fig. 4.9 shows no evidence of oxygen
dissociation, so either the process does not occur upon irradiation with 500 nm laser pulses,
or it occurs to an extent too small to be detected by our methods. A possible reason for this
is that 500 nm is near an absorbance minimum for oxy-trHbN, whereas 530 nm (the laser
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irradiation wavelength used in previous studies) sits on the shoulder of the protein’s 545
nm absorbance maximum.
4.4.7. Summary.

Perhaps the most striking feature about the rate constant

governing the reaction of oxy-trHbN with NO is how little it is affected by mutations to
the protein (Fig. 4.4). For all of the mutants investigated the observed rate constant lay
near the theoretical diffusion limit, and the difference between the largest and smallest rate
constants was at most a factor of four. The results demonstrate that NO access to the active
site heme is only minimally affected by any of the mutations, and are consistent with the
2005 computational studies of Marti et al. that predicted only modest effects on NO
oxidation rates by mutations to active site amino acids such as Tyr 33 and Gln 58.10 Later
studies noted how Phe 62 can block the long and EH tunnels that connect the heme to the
protein surface,33-35 but clearly NO can access the active site via the short or BE tunnels
which remain open.6,35
Changes in the reactivity of red-trHbN with NO were for the most part also modest,
spanning the range from (0.2 – 1.0)109 M1s1. The fastest nitrosylation rates were
observed for the trHbNY33A+Q58A double mutant, which supports the hypothesis of Ouellet
et al. that these residues hold in place a non-coordinating water, the displacement of which
provides the main barrier to ligand binding to the reduced protein.35 The red-trHbNdelN
variant provides a dramatic exception to the otherwise modest effects of trHbN mutations.
For red-trHbNdelN the rate constant for nitrosylation is much lower than that of other
variants, and is first-order rather than second-order. This shows that the pre-A N-terminal
sequence plays a critical role in opening the heme iron to NO binding, and suggests that
dioxygen binding to red-trHbNdelN would be similarly affected. Future studies are planned
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for testing this important conjecture. The work of Lama et al. first demonstrated that NO
dioxygenase activity of trHbNdelN is greatly decreased relative to the wild type,14 but our
results (Fig. 4.4) show that the reaction of oxy-trHbNdelN with NO is not affected by the
mutation. If dioxygen binding to red-trHbNdelN is affected to the same extent as NO binding
is, that would explain the decreased activity observed under steady-state conditions.
A final observation from this study that is worth noting is the fact that the rate
constant for reaction of red-trHbNWT with NO (2.2108 M1 s1) is 5 – 10 greater than
previously reported for the reaction of dioxygen with red-trHbNWT (2.5107 M1 s1 from
stopped flow, or 5.6107 M1 s1 from laser flash photolysis).4,35 This seems surprising
since one would expect trHbN to have evolved to bind dioxygen more rapidly in order to
maximize formation of the active oxy-trHbN form in a mixture of both NO and dioxygen.
The observation does however lend some credence to a recent conjecture made by Cazade
and Meuwly, who proposed that the native state of trHbN is red-trHbN(NO), and that the
bound NO must be replaced by oxygen before reaction can occur.17 Future studies on this
interesting protein should further explore this possibility.
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Chapter 5
Conclusions and suggestions for further study
5.1 Concluding Remarks
The three primary accomplishments of this dissertation were to develop a method
for generating over 100 M of nitric oxide in situ on the sub-microsecond timescale, and
then using this method to obtain important new insights on the interaction of NO with the
heme-containing proteins myoglobin (Mb) and truncated hemoglobin N (trHbN). The
complex Mn(PaPy2Q)(NO)]ClO4 (species 1), where (PaPy2QH) is N,N-bis(2pyridylmethyl)-amine-N-ethyl-2-quinoline-2-carboxamide was synthesized with only
slight modifications from a published protocol,1 as detailed in Chapter 2. When photolyzed
with a 500 nm, ~3 mJ, 5 ns laser pulse, in a 0.15 cm  0.15 cm fluorescence cell, species 1
yielded as much as 180 µM NO.
One potential limitation of species 1 (which ironically is also one of its strengths)
is that, being so sensitive to visible light of all wavelengths out into the near-infrared, it is
almost impossible to prevent it from releasing small amounts of NO prematurely. This was
not a problem for the studies presented herein, in which protein concentrations were always
in large excess of NO concentrations, but could pose problems in other studies. The
complexes

[RuIII(EDTA)H2O]

and

[RuIII(MEDTA)H2O],

where

EDTA

is

Ethylenediaminetetraacetate and MEDTA is methylethylenediaminetriacetate,2-5 were
synthesized for possible future use as scavengers of prematurely released NO, and crude
samples were shown to bind nitric oxide at around the expected kinetic values.6
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Once its photochemical properties were established, species 1 was first used in a
study of the dioxygenation of NO by horse heart oxyMb. This reaction has been proposed
to be important for NO detoxification in muscle tissue;7 however, recent stopped-flow
UV/Vis studies by Su and Groves of the metMb-catalyzed isomerization of peroxynitrite
to nitrate called this hypothesis into question.

These studies indicated that the

isomerization proceeded through a caged NO2 – ferrylMb intermediate, but with about 10%
NO2 cage escape.8 A heme-bound peroxynitrite was long a presumed intermediate on the
pathway of NO’s conversion to nitrate, but escape of 10% NO2 from the intermediate’s
fragmentation would lead to a build-up of ferrylMb and NO2, which are arguably more
deleterious to cell health than the NO that the reaction was originally meant to detoxify.
The authors pointed to this as evidence that nitric oxide dioxygenation by Mb was likely
not a physiologically relevant means of nitric oxide detoxification in vivo.
The exceptionally high concentrations of NO produced per laser pulse by photolysis
of 1 allowed the rapid reaction between NO and oxyMb to be initiated in quantities high
enough that the buildup of 10% ferrylMb predicted by Su and Groves should have been
readily detectable.8 Furthermore, numerical simulation using kinetic parameters available
in the literature indicated that, under the reaction conditions employed in our experiments,
10% ferrylMb represented a lower boundary of a range that could go as high as 16%.
Contrary to prediction though, fitting of the UV/Vis spectrum obtained immediately after
the laser pulse with the known extinction coefficient spectra of the expected products
indicated that at most ~4% ferrylMb was being produced. Further reactions in the presence
of ascorbate, which should have reacted with any available ferrylMb over several seconds
and generated a characteristic spectral signature, proved that no more than 1 µM ferrylMb
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was produced during these experiments.

This result has important implications for

bioinorganic chemists and physiologists alike. Peroxynitrite rearrangement to nitrate
catalyzed by metMb cannot go through the same intermediate as NO dioxygenation by
oxyMb, which calls into question the long-held assumption that NO dioxygenation begins
with the formation of a bound peroxynitrite intermediate.

Not including such an

intermediate would require a complete rethinking of the mechanism by which NO
dioxygenation occurs.

Physiologists should likewise take note that the decreased

production of ferrylMb (1% at most instead of 10%), and consequently also of NO2, means
that NO dioxygenation by oxy-Mb may be an important pathway for in vivo NO
detoxification after all. Both of these implications will require further study.
TrHbN is capable of the same NO dioxygenation reaction as Mb, but is over an
order of magnitude more efficient (the rate constant calculated herein for the reaction of
oxy-trHbNWT with NO was 1.4109 M1 s1, compared to 4107 M1s1 for oxyMb).9
Crystal structures of trHbN had previously revealed a tunnel system connecting the protein
surface to the active site, which provides the simplest explanation for trHbN’s superior
efficiency compared to Mb. However, over the years theoretical and experimental studies
had brought up a number of other possibilities.10-20 The methodology for generating NO
from photoprecursor 1 allowed these possibilities to be investigated in unprecedented
detail.
Kinetic results on trHbN variants showed an incredible robustness of the NO
dioxygenase activity in the face of mutations. Two active site variants showed either no
(trHbNY33A) or minimal (trHbNQ58A) decreases in NO dioxygenation rates, consistent with
theoretical predictions by Crespo et al.13 On the other hand these changes, and the very
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slight changes in nitrosylation rates of trHbNF62A and trHbNF62W mutants, were inconsistent
with predictions that NO preferentially accesses the active site via the long tunnel during
dioxygenation.12,14,16,21 The mutations of Phe 62 in particular should have had profound
effects on the topology of the long tunnel, and these should have affected the observed
reaction rates accordingly. Instead, the results of our experiments suggest that during
dioxygenation NO can readily access the heme via the short tunnel, which remains open at
all times.
Perhaps the most interesting trHbN mutant studied in this work was trHbNdelN, in
which the so-called “Pre-A” N-terminal sequence of 12 amino acids17 was deleted.17 This
mutant exhibited a remarkable change in nitrosylation kinetics, becoming zero order with
respect to protein concentration. By contrast its NO dioxygenation kinetics remained
unchanged. The pre-A sequence is remote from the trHbN active site, so this finding
indicates that the mutation is affecting the general dynamics of the protein in such a way
that NO can still enter the protein, but is now blocked from binding to the heme for an
extended period of time. A high priority area of future study should be to determine the
mechanism for this blocking phenomenon. One promising hypothesis, founded on a prior
theoretical study,21 is that a water tightly bound in the active site (but not directly to the
heme) can no longer be dislodged as efficiently without the pre-A initiated dynamics. This
hypothesis could be tested by mutating the amino acids that hold the water in place (see
below).
Finally, the comparison between the second-order rate constant governing
nitrosylation in wild type trHbN (2.2108 M1 s1) and the literature values governing
dioxygen binding (2.5107 M1 s1 5.6107 M1 s1)10,21 deserves special mention. It
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seems surprising that NO binding is an order of magnitude more efficient than O2 binding,
in a protein that should benefit from preferential dioxygen binding when faced with a
choice between the two gases.
Several further studies with trHbN are currently in the works at the Pacheco lab. A
photo-activated dioxygen donor is being developed for use in laser photolysis studies, and
this should greatly simplify testing of the hypothesis that the delN mutant of red-trHbN
affects not only the pathway through which NO travels, but also that of dioxygen.
Theoretical analysis suggested that the amino acids Tyr33 and Gln58 hold in place the
water that blocks access to the heme in red-trHbN (see above),21 so a new triple mutant
Y33F+Q58V+delN will be used to test if the decreased nitrosylation rate that we observed
for the delN mutant is due to dynamic changes that affect this water’s exit. A final line of
investigation planned for the near future is to test the effects of mutations near the heme’s
proximal ligand. For example, Met77 is hydrogen bonded to the proximal His81, and
computational studies have suggested that it should have a significant effect on the
character of the bound oxygen,13 which in turn could affect NO dioxygenation. This
avenue of investigation was only briefly touched on in this work, but could prove very
interesting.
We hope that the insights presented herein will help inform further theoretical
studies of the fascinating trHbN protein that operates at rates on the cusp of what is possible
in solution. It is even possible that future studies of trHbN could lead to new treatments
for the causative agent of tuberculosis, and some forays in this direction were recently
reported by Ascenzi et al.22 In this regard, the profound sensitivity of the rates for gas
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binding to heme on the mobility of the pre-A region may be a particularly attractive
candidate for future study.
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Appendix 1 Supplementary Material to Chapter 3
A1.1. Determination of the rate constant for the reaction of metMb with ascorbate

Figure A1.1. A plot showing the dependence of V0/[metMb] on total
ascorbate concentration, where V0 is the initial rate at which metMb is reduced
to oxyMb. OxyMb was shown to be the only reaction product by fitting the
changes in the complete difference spectra as a function of time using the
extinction coefficient spectra of metMb and oxyMb. The red trace is a linear
fit to the data, whose slope (0.053 ± 0.002 M1s1) is the second-order rate
constant for the reaction of ascorbate with metMb.

A1.2. The reaction of oxyMb with ascorbate.
The reaction of approximately 280 µM oxyMb with 0.2 M ascorbate was followed
by UV/vis spectroscopy. Spectra were collected every 12s for 1h in the spectral range from
450 - 800 nm, in the same 1.5 mm × 1.5 mm micro-cuvette that were used in the laser
photo-initiation experiments.

In addition a spectrum of the mixture was obtained

approximately 8h after the reaction was initiated. SVD analysis of the data revealed 4
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Figure A1.2. (a) UV/Vis spectral changes observed at
582 nm after 0.2 M ascorbate were mixed with ~280
µM oxyMb. (b) product distribution as a function of
time after reaction initiation, as determined by fitting
the spectra at the given time points with the extinction
coefficient spectra of oxyMb, metMb, Mb, an
extinction coefficient spectrum determined for a
putative reaction product present after 8h (Fig. A1.3a),
and an adjustable baseline.

distinct spectral components. Figure A1.2a shows
the time trace obtained at 582 nm, which is one of
the absorbance maxima for oxyMb. The trace

Figure A1.3. (a) An extinction coefficient
spectrum calculated for the product(s) of
the reaction between 0.2 M ascorbate and
280 µM oxyMb, that were still present 8h
after reaction initiation. The spectrum was
obtained by dividing the absorbance at
each wavelength by pathlength and the
total Mb concentration (i.e. 280 µM, the
concentration of oxyMb at t0). (b) UV/Vis
spectra observed at selected times after
mixing 0.2 M ascorbate with 280 µM
oxyMb, and the best fits to the spectra that
were obtained using the extinction
coefficient spectra of oxyMb, metMb, Mb,
the spectrum of part (a) and an adjustable
flat baseline.

gives an idea of the complexity of the spectral changes: after a brief lag A582 decreases over
a 590s time period, then briefly increases before decreasing again. Despite the complexity,
individual spectra can be well fitted using the known extinction coefficient spectra of
oxyMb, metMb and Mb, plus contributions from a rising baseline and from an artificial
extinction coefficient spectrum constructed from the UV/Vis spectrum obtained after 8h.
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Figure A1.2b shows how the concentration of each species changes with time, while Fig.
A1.3b shows the spectral fits at selected times. Figure A1.3a shows the synthetic extinction
coefficient spectrum used to correct the data for appearance of the unidentified final
product. The need to adjust the baseline and contribution from the “final product”
independently introduced an extra degree of freedom that is not warranted from SVD
analysis, and thus precluded an automated least-squares fit to the data. Nonetheless
individual spectra could be readily simulated if the concentration parameters were adjusted
by hand. The contributions from the final species and the baseline constitute nothing more
than an empirical correction; however, the contributions by oxyMb, metMb and Mb all
show very narrow least-squares tolerances, and are thus deemed reliable.
The results of this experiment confirm that in the cuvette used for the laser photoinitiated experiments described in the main text and below, both Mb and metMb can be
generated when oxyMb reacts with ascorbate, as proposed in Scheme 3.4. In particular
Equilibrium (2) of Scheme 3.4 can shift to form Mb from oxyMb, because molecular
oxygen is consumed sufficiently rapidly that it can’t be replenished from the surrounding
atmosphere by diffusion. In the experiments presented here Mb begins to appear only after
a lag time of about 100s, because at time zero the solution concentration of O2 is very
nearly that predicted by Henry’s law for equilibrium of a solution with air. By contrast,
immediately after the laser pulse in the laser photo-initiated experiments, ~100 µM of
oxyMb had already been converted to metMb, with concomitant consumption of ~100 µM
Mb-bound O2 (e.g. Fig. 3.1). As a consequence Mb would begin to appear much sooner,
within less than 10s after the laser pulse.
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A1.3. The reaction of ferrylMb with ascorbate.
Given the importance of the reaction between ferrylMb and ascorbate to the
interpretation of our results, we deemed it imperative to ensure that this reaction is not
affected by our specific reaction conditions. Accordingly the reaction was carried out in
the presence of species 1, in the presence of 1 and oxyMb, and in a solution containing no
other species. The precise reaction conditions are listed in Table A1.1. In each case
ferrylMb was reduced to metMb in an apparent first-order process, as judged by monitoring
spectral changes in the 560-580 nm region, and fitting these with the known spectral
components from ferrylMb and metMb. The apparent rate constants are listed in Table
A1.1 as kobs. Using the derivations of Kroger-Ohlsen and Skibsted3 we calculated the
theoretical values of the pseudo-first order rate constants that govern the reaction of
ferrylMb with ascorbate, given the reaction conditions listed in Table A1.1; these are listed
in the table under the heading kasc. Now recall that we showed, in the main part of the
paper, that the NO photo-precursor 1 can also effect ferrylMb reduction, in a process
Table A1.1. Reduction by ascorbate of ferrylMb to metMb at pH 7.35 and 25° C; comparison of
observed vs theoretical apparent rate constants.
Reaction conditions

kobs (s−1)

kasc (s−1)a

k1 (s−1)b

ktheor = (kasc+k1)

ktheor/kobs

130 µM ferrylMb, 1 mM
ascorbate

0.006

0.015

0

0.015

2.5

65 µM ferrylMb, 500 µM
ascorbate, 500 µM 1

0.005

0.0081

0.0035

0.012

2.4

65 µM ferrylMb, 500 µM
ascorbate, 250 µM 1, 250 µM
oxyMb

0.004

0.0081

0.0018

0.0099

2.5

a.

Calculated from Eq. 2 of ref. 3.
main manuscript.

b.

Based on the second-order rate constant of 7 M−1s−1, obtained in the
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governed by a second-order rate constant with a value of ~7 M−1s−1. Using this value we
calculated k1, the pseudo first-order constant that would be observed for this process given
the reaction conditions listed in Table A1.1. Finally, the expected rate constant ktheor
governing reduction of ferrylMb to metMb for each set of reaction conditions was
calculated as the sum of kasc and k1. From Table A1.1 it is clear that the theoretical value
ktheor consistently over-estimates the calculated value kobs of the rate constant governing
reduction of ferrylMb by ascorbate. However, the ratio ktheor/kobs is completely unaffected
by the presence or absence of 1 and/or oxyMb, showing that these species do not affect the
reaction.
In their paper Kroger-Ohlsen and Skibsted showed that at low pH the dependence
of the apparent rate constant for reduction of ferrylMb by ascorbate is quite non-linear, but
that it becomes linear with a limiting value of 2.7 M−1s−1 at high pH and 25° C.3 At pH
7.35 the non-linear contributions are estimated to be minor, but still significant when using
low ascorbate concentrations such as those listed in Table A1.1 (see Fig. A1.4a).
Accordingly, for the experiments of Table A1.1 the value of kasc was calculated using Eq.
2 from Kroger-Ohlsen and Skibsted’s paper. As mentioned earlier the kasc values so
obtained lead to over-estimates of the experimentally derived constants (kobs); indeed, the
kobs values all lie about mid-way between those that would have been predicted by the
Kroger-Ohlsen/Skibsted equation and those predicted from the high pH limiting value of
2.7 M−1s−1.

However, the ratios ktheor/kobs that are calculated from the formula are

significantly more invariant than those calculated by deriving ktheor from the limiting value.
From this we conclude that, while overestimated by the Kroger-Ohlsen/Skibsted equation,
some non-linear contributions to kasc are still present at pH 7.35. At higher ascorbate
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concentration the non-linear contributions to kasc become progressively less significant by
comparison with the limiting value of 2.7 M−1s−1, as seen in Fig. A1.4b. Therefore, in order
to simplify the discussion, the limiting value was used to calculate the theoretical trace of
Fig. 3.3a in the main text, and in the other experiments described below, in which mixtures
of oxyMb, 1 and various ascorbate concentrations were exposed to laser pulses. This
approach is especially justified given that the Kroger-Ohlsen/Skibsted equation appears to
overestimate the non-linear contributions at this pH. Note that our conclusions would in
no way be affected by changing the value of kasc by 2×, or even 3× in either direction. In
all cases the presence of ferrylMb would have left a readily detectable kinetic fingerprint,
which was absent in our experiments.

Figure A1.4. Dependence on [ascorbate] of the pseudo-first order rate constant of the reaction between
ascorbate and ferrylMb, as calculated from equation 2 of ref. 3 (blue traces), or from the second-order rate
constant 2.7 M−1s−1 that becomes dominant as pH increases (red traces): (a) at low ascorbate
concentrations, and (b) at the ascorbate concentration ranges used in the experiments with oxyMb,
ascorbate and 1.
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A1.4. Laser photo-initiated fragmentation of species 1 in the absence of protein

Figure A1.5. Results of irradiating a 1.8 mM solution of 1, in pH 7.4 Hepes buffer, with a 500 nm laser
pulse. (a) Changes in absorbance immediately following the pulse (t160 ms) and after 10s, 20s, 30s, 40s,
50s and 60s; the arrow indicates the direction of the absorbance displacement. The blue traces were
experimentally determined, the red ones were calculated by least-squares using a matrix form of Beer’s
law and the independently determined extinction coefficient spectrum of 1. No other components were
required to obtain a good fit. (b) The amount of 1 consumed as a function of time, which also
corresponds to the amount of NO generated. The red trace is a linear least-squares fit. The laser pulse
generated 132±1 µM NO from 1. Photolysis by the probe beam subsequently generated more NO at a
constant rate of (0.846±0.003) µM/s. The amount of NO generated could be controlled by varying the
initial [1] or by changing the intensity of the laser pulse.

A1.5. Expected result of mixing 100 µM NO with 272 µM oxyMb, if the reaction of
oxyMb with NO shared a common intermediate with the metMb-catalyzed
isomerization of peroxynitrite: a numerical simulation of the product distribution’s
evolution during the first 3 ms.
Scheme 3.3 of the main text summarized the reactions that would be expected if
the reaction between NO and oxyMb resulted in formation of a peroxynitrite intermediate,
that then further reacted as shown in Scheme 3.1 Path 2, recently proposed by Su and
Groves.4 The differential equations used to model this process and arrive at the plots of
Fig. 3.2 are given below and on the following pages. The variable names used to represent
the reactant species in these equations are provided in Scheme A1.1, which is otherwise
identical to Scheme 3.3.
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Scheme A1.1. oxyMb + NO reaction summary

Eq. A1.1

Eq. A1.2

Eq. A1.3

Eq. A1.4
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Eq. A1.5
Eq. A1.6
Eq. A1.7
Eq. A1.8

The differential equations were modeled using Mathcad 13's “RKadapt” algorithm,
which performs a numerical integration using the procedure of Runge-Kutta with adaptive
stepsize. The graphs of Fig. 3.2 were obtained using 1000 steps in an interval from 0 to
0.02s, but identical results were obtained when 10000 steps were used. All of the rate
constants are exactly those provided in literature references (see main text, Scheme 3.3)
except for k6 which is not known with certainty. Goldstein et al. provide a range of (104
M−1s−1 < k6 < 107 M−1s−1) for this parameter,5 and we arbitrarily chose the upper bound. A
smaller value of k6 is unlikely to change the conclusions; if ferrylMb+∙ reacts more slowly
with oxyMb, then it’s probably still converted to ferrylMb by another competing process,
such as reduction by ascorbate.
A1.6. Laser photo-initiated reaction of NO with excess oxyMb in the presence and
absence of ascorbate: analysis of the data.
A1.6.1. 0.200 M ascorbate. This is the reaction presented in Figs. 3.3 and 3.4 of
the main text. Figure A1.6 shows the difference spectrum obtained immediately after
irradiating a solution of 272 μM oxyMb, 1.72 mM 1 and 200 mM ascorbate with a 500 nm
laser pulse, and was used to obtain the rough upper bounds on possible ferrylMb and/or
Mb concentrations present immediately following the laser pulse, as described for Fig. 3.1
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of the main text. The double-difference spectra obtained by subtracting the Fig. A1.6
spectrum from spectra obtained during the subsequent 45s were initially processed using
SVD analysis, which unambiguously
revealed two components above the
noise (Fig. A1.6). Visual inspection of
absorbance vs time traces at various
wavelengths showed that at some
wavelengths the absorbance varied
virtually linearly with time, whereas at
Figure A1.6.
Difference spectrum obtained
immediately after irradiating a solution of 272 μM
oxyMb, 1.72 mM 1 and 200 mM ascorbate with a 500
nm laser pulse. Solid blue trace: experimentally
obtained data; dashed red trace: calculated by leastsquares fit using the extinction coefficient spectra of
oxyMb, metMb, ferrylMb and 1; dashed green trace:
same as red trace but using the Mb extinction coefficient
spectrum instead of the ferrylMb one. The fitted
experimental spectrum was the average of the first 20
raw spectra collected every 16 ms using the Olis
spectrophotometer.

others it varied non-linearly (see for
example Fig, 3.3b).

We therefore

constructed a Mathcad program to fit
the SVD-processed data with a 2component system, in which one
component varied exponentially with

time, while the other varied linearly The time-dependence was incorporated into a matrix
T, defined in Eq. A1.9, in which i represents the number of time points,

Eq. A1.9

and k1 is a parameter that can be adjusted within the program. The corresponding
wavelength dependence of the two components was incorporated into a second matrix Λ,
which is defined in Eq. A1.10. In this equation ΔA is the SVD-processed matrix of
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absorbances. Finally, a matrix of theoretical absorbance values (ΔAcalc) was calculated
using Eq. A1.11, and the sum of squares for ΔA−ΔAcalc was computed.
Eq. A1.10
Eq. A1.11
This sum of squares was minimized by varying the adjustable parameter k1, which yielded
the excellent fits shown in Fig. 3.3 of the main text.
Up to this point the fitting procedure provides no indication of the actual chemical
species contributing to the spectra; this information was obtained by analyzing the
components of Λ. In this matrix the values of the first row (Λ1,j) represent the absorbance
amplitudes of the exponentially varying component at wavelengths λj as t →∞ (i.e., they
represent the maximum spectral amplitude reached by this component). By contrast, the
values of the second row (Λ2,j) represent the absorbance changes per second at λj of the
linearly varying component. The two components are plotted against wavelength in Fig.
A1.6, together with theoretical overlays obtained by fitting each component using the
known extinction coefficient spectra of oxyMb, metMb, Mb, 1, a flat baseline, and the
matrix form of Beer’s law.6-9 In the case of the first component the fitting procedure
provides the concentration of each myoglobin species that is produced by the exponential
process as it goes to completion. For the second component the fitting procedure provides
the concentration of each species that is generated every second by the linear process. In
both cases we applied the constraint that ΔCoxyMb=

−(ΔCmetMb + ΔCMb).

The net

concentration change of each species as a function of time is thus given by Eqs. A1.12 –
A1.15, which combine the contributions by the linear and exponential processes. These
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equations were used to construct the Fig. 3.4 graphs.
Eq. A1.12
Eq. A1.13
Eq. A1.14
Eq. A1.15
A1.6.2.

No ascorbate added.

The double-difference spectra obtained by

subtracting the Fig. 3.1 spectrum from spectra obtained during the subsequent 45s were
initially processed using SVD analysis, which unambiguously revealed a single component
above the noise. The SVD-processed data could be fitted in a way similar to that described
for the 0.2 M ascorbate data (Section A1.6.1), this time revealing that the one component
varies virtually linearly with time (Fig. A1.9a). The fitting procedure yielded a matrix Λ,
as described by Eqs. A1.9 and A1.10, with a single row that represents the changes in
absorbance per second of the linearly varying component. The component Λ1, plotted
against wavelength, is shown in Fig. A1.9b (blue trace), together with a least-squares fit of
the data using Beer’s law, the known extinction coefficient spectra of Mb, metMb, oxyMb,
1, and a flat baseline(red trace of Fig. A1.9b). The analysis shows that the major change
observed on the timescale of tens of seconds is oxidation of oxyMb to metMb, presumably
by NO photogenerated from 1 by the probe beam (the fit was constrained such that the
amount of 1 consumed each second matched the amount of metMb generated). In all, our
calculations show that about 35 μM metMb were generated during the 45s that the reaction
was monitored, compared to the ~90 μM generated in less than a ms by the initial laser
pulse. The best fit suggests that a very small amount of Mb is also consumed every second:
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~5% compared to the amount of oxyMb consumed. This may represent some of the Mb
generated during the initial laser photo-initiated process.
A1.6.3.
Figure

A1.10

0.100 M ascorbate.
shows

the

spectrum

obtained immediately after 280 μM
oxyMb and 1.79 mM 1 were irradiated
with a laser pulse in the presence of 0.100
M ascorbate. The results are comparable
to those obtained either in the absence of
ascorbate (Fig. 1) or in the presence of 0.2
M ascorbate (Fig. A1.6): about 105 µM
oxyMb have been oxidized by photogenerated NO to yield primarily metMb
(100 µM), though small amounts (~4-5
µM) of either ferrylMb or Mb are also

Figure A1.7. SVD-analysis of the double-difference spectra obtained after irradiating a solution of 272
µM oxyMb, 1.72 mM 1, and 200 mM ascorbate with a 500 nm laser pulse.1,2 (a) The three U components
corresponding to the highest ranked singular values, and their associated autocorrelation values Cu.2 (b)
The corresponding V components and associated autocorrelation values Cv, and (c) the singular values
of the first 6 components. Note the very low autocorrelation value U3, and the fact that the values of S3
onwards vary linearly and are much smaller than S1 and S2. Based on these factors we conclude that two
spectral components give rise to the observed changes in ΔA.
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generated. This experiment confirms
that addition of any amount of
ascorbate has no effect on the initial
photo-initiated

reaction

between

oxyMb and NO.

The

double-

difference

obtained

spectra

by

subtracting the Fig. A1.10 spectrum
from spectra obtained during the
subsequent
processed

45s

were

initially

using

SVD

analysis,

which unambiguously revealed a
single component above the noise.
The SVD-processed data could be
fitted in a way similar to that
described for the 0.2 M ascorbate data
(Section A1.6.1). This time the single
component

could

be

fitted

satisfactorily using an exponential
function (Fig. A1.11a); however, the
reaction was followed for less than

Figure A1.8. (a) The first row of Λ, representing the final
absorbance spectrum of the exponentially varying component as
t→∞, plotted against wavelength. (b) The second row of Λ,
representing the changes in absorbance per second of the linearly
varying component, plotted against wavelength. The red traces
are the least-squares fits of the data using Beer’s law, the known
extinction coefficient spectra of Mb, metMb, oxyMb and 1, and
a flat baseline. The concentrations and concentration changes of
each species were obtained from the fitting procedure. The
shifting baselines in the components are most likely due to the
same reactions that give rise to the nearly featureless spectrum
of Fig. A1.3a when mixtures of oxyMb and ascorbate are
allowed to interact for extended periods of time.

two half-lives (kcalc = 0.0258 s−1, t0.5 =
27 s), so the exponential fit should be viewed as purely empirical. The fitting procedure
yielded a matrix Λ, as described by Eqs. A1.9 and A1.10, with a single row that represents
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the changes in absorbance that
would be expected after infinite time
if the reaction were to continue to
evolve

exponentially.

component

Λ1,

plotted

The
against

wavelength, is shown in Fig. A1.11b
(blue trace), together with a leastsquares fit of the data using Beer’s
law, and the known extinction
coefficient spectra of Mb, metMb,
oxyMb and 1 (red trace of Fig.
A1.11b). One sees that the major
change observed on the timescale of
tens of seconds is net reduction of
Figure A1.9. (a) ΔA vs t slice at 580nm for the doubledifference spectra obtained by subtracting the Fig. 3.1
spectrum from subsequent spectra that followed the laser
pulse. The calculated trace was obtained by fitting all of
the data to a linear function in a manner analogous to that
described in Section A1.6.1. (b) Row of the matrix Λ
obtained as described by Eqs. A1.9 and A1.10, which
represents the changes in absorbance per second of the
linearly varying component, plotted against wavelength.
The red traces are the least-squares fits of the data using
Beer’s law, the known extinction coefficient spectra of
Mb, metMb, oxyMb, 1, and a flat baseline. The
concentration changes of each species were obtained from
the fitting procedure. The shifting baseline, as calculated,
would lead to a total absorbance change of less than 0.002
AU during the 45s that the reaction was monitored.

metMb back to oxyMb (and possibly
a very small amount of Mb), as
expected in the presence of ascorbate
(Scheme 3.4). The predicted final
concentration of metMb is not zero,
presumably because oxyMb is also
being re-oxidized to metMb by the
NO generated via photolysis of 1 in

the probe beam, so that the two processes eventually balance out. Note that for this
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experiment the contributions to Λ1 by 1 and a shifting baseline could not be deconvoluted
from each other. For convenience contributions of ΔC1 = 10 μM and zero baseline were
used to fit the trace in Fig. A1.11b, but multiple combinations of [1] and baseline gave
comparable fits. In contrast, when fitting the results obtained in the absence of ascorbate,
or in the presence of 0.200 M ascorbate Fig. 3.9b and Fig. A1.8), the sums of squares were
quite sensitive to the choices made for these parameters.
Figure A1.11a shows fitted absorbance changes at both 580nm and 596nm.
Notably,

a

very

small

absorbance increase is seen at
the latter wavelength, whereas
a

much

more

substantial

absorbance decrease (short
solid green trace in Fig.
A1.11a) should have been seen
if 5 μM ferrylMb had been
Figure A1.10. Difference spectrum obtained immediately after
irradiating a solution of 280 μM oxyMb and 1.79 mM 1 with a
500 nm laser pulse, in the presence of 0.100 M ascorbate .
Solid blue trace: experimentally obtained data; dashed red
trace: calculated by least-squares fit using the extinction
coefficient spectra of oxyMb, metMb, ferrylMb and 1; dashed
green trace: same as red trace but using the Mb extinction
coefficient spectrum instead of the ferrylMb one. The fitted
experimental spectrum was the average of the first 20 raw
spectra collected every 16 ms using the Olis
spectrophotometer.

present, as predicted by one
analysis

of

Fig.

A1.10.

Furthermore, the results from
the Groves group predict that
even more ferrylMb (> 15 μM)
should

have

accompanied
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Figure A1.11. (a) ΔA vs t slices at 580 and 596 nm for the double-difference spectra obtained by
subtracting the Fig. A1.10 spectrum from subsequent spectra that followed the laser pulse. The
calculated traces were obtained by fitting all of the data to an exponential function in a manner analogous
to that described in Section A1.6.1. The short green trace shows the absorbance change at 596 nm that
would accompany the reduction of 5 μM ferrylMb to metMb by 0.1 M ascorbate. (b) Row of the matrix
Λ obtained using Eqs. A1.9 and A1.10, which represents the difference spectrum that would arise after
infinite time if the reaction were to continue to evolve exponentially. The red traces are the least-squares
fits of the data using Beer’s law and the known extinction coefficient spectra of Mb, metMb, oxyMb and
1. The concentration changes of each species were obtained from the fitting procedure.

formation of 100 μM metMb from oxyMb and NO, if the reaction had proceeded via the
intermediate formed when metMb isomerizes peroxynitrite.4
A1.6.4.

Other ascorbate concentrations.

In addition to the experiments

described in the main text and in sections A1.5.1-A1.5.3 above, we also carried out similar
experiments in the presence of 0.3M and 0.6M ascorbate. The results were similar to those
reported, except that with the higher ascorbate concentrations a significant amount of Mb
was generated by reduction of oxyMb, even before the sample was irradiated with a laser
pulse. This Mb reacted with the photo-generated NO to yield nitrosomyoglobin (MbNO),
which further complicated the analysis. The data are not included here as they shed no
new light on the problem of interest in this report, but they were analyzed and are available
from the Pacheco lab upon request.
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It should be noted that in no other cases did we see evidence for MbNO
accumulation. Indeed, when fitting the spectra of Figs. 3.1, A1.6 or A1.10 the sum of
squares invariably increased if even small contributions from this species were added in
the fits. Given the low precision of the single-spectrum analyses this is not conclusive
evidence for the complete absence of MbNO, but it does show that any contributions from
this species must be minimal.
A1.7. Monitoring the reaction of oxyMb with NO on the microsecond timescale
A1.7.1. Using 1 to generate NO. In addition to the experiments presented above,
the reaction of oxyMb with NO was also monitored on the microsecond timescale. A series
of absorbance vs. time traces were collected 5 nm apart in the wavelength range from 480
- 630 nm, and combined to generate a set of time-resolved spectra. This set of timeresolved spectra were subjected to SVD analysis as described in Section A1.6.1, which
revealed 5 components with featured time traces but only three with spectral
Eq. A1.16

Figure A1.12. (a) Selected spectral changes observed on the µs timescale after a solution containing
250 µM oxyMb and 1.75 mM 1 is irradiated with a 500 nm, 5 ns laser pulse. (b) time trace at 584
nm. In both cases the experimental data are shown in blue, while the best fits using Eq. A1.16 are
shown in red.
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features. Figure A1.12a shows the spectral
changes observed at some representative
times in the SVD-processed data set, while
Fig. A1.12b shows the time trace obtained
at 584 nm in the same set. The complete
data set was fitted to Eq. A1.16, which is
the analogue of Eq. 3.1 in the main text,
using the same methodology as described
in Eqs. A1.9 and A1.10. This equation has
two

exponential

terms

with

initial

amplitudes Λ1λ and Λ2λ that decrease to
zero over time, and which arise from a
transient response by the photomultipliers
to the laser flash (they are featureless in the
wavelength domain). More interestingly it
also has two components that increase
exponentially from zero with amplitudes
Λ3λ and Λ4λ, and a constant background
component Λ0λ. These three components
are presented in Fig. A1.13. Component
Λ3λ, which increases with apparent rate
Figure A1.13. Three spectral components obtained
by fitting the time-resolved spectra of Fig. A1.12 to
Eq. A1.16. Λ1 and Λ2 were featureless as they
reflected the photomultiplier response to the laser
flash.

constant 1.15×104 s−1, is fitted very well
with the known extinction coefficient
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spectra of oxyMb and metMb (Fig. A1.13a), and shows that in this phase about 50 µM
oxyMb is converted to metMb. If we assume that the apparent rate constant k3obs depends
linearly on [oxyMb]0, then the value of the true second-order rate constant k3 is 4.6×107
M−1s−1, which almost exactly matches the expected value of k11+k12 (Schemes 3.3 and
A1.1) reported by Herold et al.10 To some extent such a good match must be coincidental,
since the experimental conditions were not strictly pseudo-first order (hence we should
have underestimated k3). However, the closeness of the match does suggest that we are
observing the same reaction as Herold et al (OxyMb + NO), despite the fact that NO was
generated in an unusual way. Interestingly, the component Λ4λ, which increases with
apparent rate constant 4.2×103 s−1, is also well fitted with the same known extinction
coefficient spectra of oxyMb and metMb (Fig. A1.13b), this time showing that ~16 µM of
oxyMb are being converted to metMb. Finally, the time-independent component Λ0λ (Fig.
A1.13c) is very well fitted with the known extinction coefficient spectrum of species 1,
and reflects the fact that ~65 μM of 1 were photolyzed to produce NO within the dead time
of the experiment. Reassuringly, this value for NO generated matches the total amount of
oxyMb subsequently converted to metMb.
It is unclear why two components Λ3λ and Λ4λ are observed here. Even if the
oxidation of oxyMb to metMb by NO is biphasic, a single reaction type should only give
rise to a single spectral component. And yet, if only one spectral component is used to
multiply both exponentials in the analysis, the fit is substantially worse. Most of the
differences in the fast and slow components can probably be attributed to differential
admixing of noise (the smaller amplitude component A4λ is substantially noisier than the
higher amplitude A3λ). However, it may be that distinct processes are in fact being
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observed in the two kinetic phases, but that the spectral changes are subtle enough to allow
both to be fitted adequately with the same two extinction coefficient spectra. In this regard
a promising hypothesis is that the fast exponential phase actually reflects conversion of
oxyMb to metMb(ONO2) (Scheme 1), while the second phase reflects substitution of NO3−
by H2O at the heme center. Such a biphasic process is indeed observed at high pH,5,10-12
but is too fast to be observed by rapid-mixing at lower pHs. Ours is the first analysis of
the oxyMb + NO reaction on the µs timescale, and thus presents the first opportunity to see
evidence of the process at pH 7.4.
A1.7.2. Using an alternative NO photo-precursor. During the review process
for chapter 3 as an article the point was made that because oxyMb is photo-labile, the laser
pulse might be leading to O2 dissociation. The reviewers asked what effect this might have
on the article’s conclusions. The results shown in Section A1.7.1 exhibit no evidence of
oxyMb photolysis. Such photolysis would have at first generated Mb from oxyMb, which
would have been revealed during analysis of the Fig. A1.13 spectral components. Even if
free Mb had formed though, it would have either re-combined rapidly with O2, or it would
have reacted with free NO to generate the kinetically inert MbNO.† As an example we
now present an early experiment in which oxyMb photolysis was observed. In this
experiment N,N’-bis(carboxymethyl)-N,N’-dinitroso-p-phenylenediamine8 was used as the
NO photo-precursor.

†

This photo-precursor is activated by 308 nm light, which is

The inertness of MbNO is well known, and discussed in Eich, R. F., Ph.D Thesis,
Rice University, Houston, TX, 1997, and references therein.
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Figure A1.14. (a) Selected spectral changes observed on the s timescale after a solution containing 45
M oxyMb and 40 M N,N’-bis(carboxymethyl)-N,N’-dinitroso-p-phenylenediamine was irradiated with
a 308 nm laser pulse. (b) Time traces at 408 nm and 418 nm. In both panels the best fits using Eqs A1.17,
A1.18 are in red, while the experimental data are in either blue or green.

substantially more energetic than the 500 nm light used to activate 1.
Figure A1.14a shows the spectral changes observed at representative times after
irradiating a solution of 40 μM oxyMb and 40 μM N,N’-bis(carboxymethyl)-N,N’dinitroso-p-phenylenediamine with a 308 nm laser pulse, while Fig. A1.14b shows
representative time traces at 408 nm and 418 nm, respectively.

The spectra were

reconstructed from individual absorbance vs time traces, and subjected to SVD, as
described in Section A1.7.1. The SVD analysis revealed 3 components. The data were
fitted to a model in which a species X0 present immediately after the laser pulse decays
first to species X1 and then to species X2, via successive first-order processes. The 2-step

Eq. A1.17
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Figure A1.15. Three spectral components obtained by fitting
the time-resolved spectra of Fig. A1.14 to Eqs. A1.17 and
A1.10.
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extinction

coefficient
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spectra of oxyMb, metMb and Mb to obtain a good fit, and shows that during the first
exponential phase the Mb generated from oxyMb photolysis recombines with O2. MetMb
generated by the reaction of oxyMb with NO during the first exponential phase also
contributes to this component. Finally, the third component (Fig. A1.15c) can be well fitted
using only the spectra of oxyMb and metMb, and reflects purely oxidation of NO by
oxyMb.
The results of the experiment with N,N’-bis(carboxymethyl)-N,N’-dinitroso-pphenylenediamine are consistent with the known reactivity of Mb with O2 and NO. The
literature rate constant for the reaction between O2 and Mb is (1.4×107 M−1s−1),13
comparable to that for reaction of NO with Mb (1.7×107 M−1s−1).14 In this experiment [O2]
>> [NO] (~300 μM for O2 in an air-saturated solution, compared to ~2.1 μM for NO), so
given the comparable second-order rate constants O2 will vastly out-compete NO for the
free Mb. In the other experiments presented in the article, including that shown in Section
A1.7.1, the amount of NO generated by the laser pulse was substantially greater (80-100
μM), so NO would compete more effectively for free Mb if this were generated. However,
as mentioned above, MbNO is kinetically inert and would play no active role in the
chemistry of interest in the main text. This was observed in the experiments with high
ascorbate concentration (>300 mM) mentioned in Section A1.6.4.
A1.8. Stability of ferrylMb in the presence of species 1 after laser irradiation:
stoichiometric analysis.
The experiments described in this section were designed to test whether the
Mn(PaPy2Q)H2O+ generated by laser photolysis of 1 is capable of reducing ferrylMb on
the s timescale. To address this possibility the amount of ferrylMb reduced and the
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amount of NO generated by photolysis
of a given amount of 1 were
determined independently, in a set of
experiments outlined in Fig. A1.16.
The blue circles in Fig. A1.16 show
how much ferrylMb was reduced 1s
after solutions containing 150 M 1
Figure A1.16. Blue circles: amount of ferryl reduced
1s after irradiating solutions containing 150 µM 1 and
varying amounts of ferrylMb (given in parentheses)
with a 500 nm laser pulse. The abscissa represents the
fraction of photons absorbed by 1 in each case, as
determined using Eq. A1.18. Red squares: amount of
Mb nitrosylated 1s after irradiating solutions containing
150 µM 1 and 100 µM Mb with a 500 nm laser pulse.
Here, fraction of photons absorbed by 1 is given by Eq.
A1.19. Experiments with Mb were done before and
after those with ferrylMb, and serve to quantify the
amount of NO generated from 150 µM 1, given the
laser energy on the given day.

and

varying

concentrations

of

ferrylMb were irradiated with a 500 nm
laser pulse.

The concentrations of

ferrylMb in each case are given in
parentheses, while the abscissa reports
the fraction of photons absorbed by 1
relative to the total absorbed by the

solution at a given concentration (as defined by f1 in Eq. A1.18). The value of f1 decreases
smoothly as [ferrylMb] increases, which leads to a decrease in the amount of ferrylMb
reduced at fixed [1] (the 150 M point is an outlier, probably resulting from a laser missfire). Self-screening is a common phenomenon in photochemical experiments, and must
always be accounted for.
Eq. A1. 18

To accurately determine the amount of NO being generated from a solution
containing 100 M of 1, solutions containing this amount of 1 and 100 M Mb were
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photolyzed to generate MbNO, whose spectral signature is substantially stronger, and thus
more accurately quantified, than that from the simple disappearance of 1. This experiment
was repeated before and after the experiments with ferrylMb, and the amounts of MbNO
generated in each case are shown as red squares in Fig. A1.16. Once again the total
concentration of Mb in solution is reported in parentheses in Fig. A1.16, while the abscissa
in this case is the fraction f2 of light absorbed by 1 relative to the total absorbed by the
solution of Mb and 1 (Eq. A1.19).
Eq. A1.19

Figure A1.16 shows that, provided the values of f1 and f2 are comparable,
the amount of ferrylMb reduced 1s after irradiation of a solution of ferrylMb and 1 matches
the amount of Mb nitrosylated in a solution initially containing the same amount of 1 and
Mb. From this one can conclude that the only species capable of reducing ferrylMb on the
s timescale after photolysis of 1 is NO itself; Mn(PaPy2Q)H2O+ will not reduce ferrylMb
on this timescale. A separate set of experiments that used higher concentrations of 1 and
ferrylMb provided the same results (data not shown). Therefore, in the experiments in
which solutions of oxyMb and 1 were irradiated to generate NO, any free ferrylMb
generated by homolytic fragmentation of a metMb(OONO) intermediate should have still
been present 16 ms after photolysis, and thus detectable.
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Appendix 2 Supplementary Material to Chapter 4
A2.1. trHbN variant NO dioxygenation and nitrosylation kinetics table
Variant
Wild type
Q58A
Y33A
DM (Y33F+Q58V)
F62A
F62W
Pre-A Deletion
V80A

NO dioxygenation 2nd order rate Nitrosylation 2nd order rate
constant
constant
9
1 1
(2.2  0.3)108 M1s1
(1.37  0.07)10 M s
(5.8  0.5)108 M1s1
(2.6  0.4)108 M1s1
9
(1.44  0.07)10 M1s1
(4.6  0.9)108 M1s1
(9  2)108 M1s1
(7.5  0.7)108 M1s1
(4.7  0.7)108 M1s1
(1.2  0.1)108 M1s1
(6.8  0.3)108 M1s1
(1.6  0.3)108 M1s1
N/A
(1.03  0.09)109 M1s1
9
(2.0  0.3)10 M1s1
(4.7  0.6)108 M1s1

Table A2.1 Tabular form of kinetic results presented in bar graph form in Fig. 4.4

A2.2. Effect of a laser-induced artifact on laser-initiated time-resolved UV/Vis
spectroscopy experiments
Laser-induced artifacts are often a problem when working at faster timescales, and our
system is no different. Figure A2.1 shows the layout for the photolysis and spectroscopic
experiments done in Chapter 4 of the main text. Light from the laser pulse randomly
scattered into the sample photomultiplier tube causes an artifact which can last 50-100 s,
as the photomultiplier tube is “blinded” by the incredible laser intensity.

Further

experiments suggest that the sample itself may also add to this effect, perhaps due to
fluorescence (figures not included). Figure A2.2 shows an example of the artifact from an
experiment containing 38.9 M oxy-trHbN. Pump-probe experiments that do not take this
into account can often show exponential fits with non-zero A0, which is not included in
analysis. For example, prior to correcting for the artifact, Fig. 4.6a from the main text
exhibited a significant non-zero A0. Figures A2.3a and A2.3b show the exponential fits of
this experiment with and without subtracting the artifact as an exponential equation
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calculated from the fit of Fig. A2.2. Fortunately, while the difference in the rate constants
calculated before and after artifact subtraction (5900 s1 vs. 7050 s1) is significant in this
experiment, most of the experiments exhibited much smaller artifact effects.
Consequently, when corrected and uncorrected data are used to calculate the second-order
rate constant (Figs. A2.4a and A2.4b) the differences are minimal: (2.30 ± 0.17)108
M1s1 compared to (2.16 ± 0.17)108 M1s1. Given this result, while the rate constant for
red-trHbN + NO in Fig. 4.4 and the experimental trace in Fig. 4.6a have been adjusted in
this way, none of the other kinetic analyses in this work have been similarly edited.

Fig A2.1. Schematic of the system
used in the Pacheco lab for
photolytic creation of NO and
UV/Vis measurements within a
solution

Fig A2.2. Spectral changes at 412nm that
accompany 500 nm laser pulse irradiation
of a solution initially containing 38.9 µM
oxy-trHbNWT in a 50 mM Tris, 0.5 mM
EDTA buffer adjusted to pH 8. Red trace:
single exponential fit of the data. Under
these conditions the apparent rate constant
kobs for the spectral change was
10,5001,000 s1.

171

Fig A2.3. Spectral changes observed after a solution initially containing 21.2 μM redtrHbNWT and 40 μM photo-precursor 1 was irradiated with a 500 nm laser pulse to
produce ~4 μM NO. (a) With exponential equation of artifact subtracted, and a fitted
kobs of 7050s; (b) original data with a fitted kobs of 5900s1
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Fig A2.4. Dependence of kobs on the concentration of red-trHbNWT; concentrations of
photo-precursor 1 were varied from experiment to experiment so that the amount of
NO generated was always ~0.1 that of red-trHbNWT. (a) Original data: from the linear
fit to the data the second-order rate constant for reaction of NO with red-trHbNWT was
determined to be (2.30.2)108 M1s1. (b) data with artifact subtracted from each
individual experiment: from the linear fit to the data the second-order rate constant for
reaction of NO with red-trHbNWT was determined to be (2.20.2)108 M1s1.
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A2.3. Derivation of rate law for trHbNdelN nitrosylation (Equation 4.3)

Scheme A2.1. Reaction sequence that could explain the lack
of dependence on protein concentration of the interaction
between red-trHbNdelN and NO. In species B NO is within
the protein tunnel system, but not bound to the heme. (also
see Scheme 4.3)
NO Pseudo – 1st order, protein in excess

at time t

Let:
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Then:

If HbNT  K11 then kobs  k2 as observed experimentally for trHbNdelN at all
concentrations investigated (5 M)

A2.4. NO titration experiments with oxy-trHbNdelN
In reference 1 the authors describe a series of experiments in which oxy-trHbNwt and
oxy-trHbNdelN are both titrated with equivalents of NO. In the case of oxy-trHbNwt the
oxidized met-trHbNwt was generated instantaneously as expected. However, the authors
reported that after addition of NO to oxy-trHbNdelN, conversion to the met form took as
long as 30 – 40 minutes. We found this finding surprising given the results presented in
Fig. 4.4, which showed that the second-order rate constant governing the interaction of
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Figure A2.5. Difference spectra of 47.5 M oxy-trHbNdelN and 176.7 M 1 photolysed
with 500nm (a) 1 (b) 2 or (c) 3 laser pulses. Experimental absorbance differences are
fit with (a) 24 M (b) 39 M or (c) 47.5 M oxy-trHbNWT converting to an equimolar
amount of met-trHbNWT.
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oxy-trHbNdelN with NO was comparable to that of the wild type. One possible
explanation for the discrepancy could arise from our use of large excesses of protein
relative to NO, necessary to maintain pseudo-first order conditions. Under such
conditions we could not rule out the possibility that we were monitoring a small fraction
of active protein in equilibrium with a much larger fraction of protein present in an
inactive conformation.
This hypothesis was tested in a series of experiments in which a solution initially
containing 47.5 M oxy-trHbNdelN and 170 M of photoprecursor 1 was irradiated with
laser pulses in quick succession. The results are shown in Figs. A2.5, and A2.6, and
summarized in Fig. A2.7. Under these conditions a single laser pulse led to immediate
oxidation of over half (24 M) of the
oxy-trHbNdelN (Figs. A2.5a and A2.7),
and within three pulses all of the oxytrHbNdelN was fully oxidized; we found
no evidence of a slowed NO
dioxygenation.
The amount of oxy-trHbNdelN converted
to met-trHbNdelN after each laser pulse
was calculated using the independently
obtained extinction coefficient spectra
for the wild type versions of the two
species, and did not incorporate the
contributions from photolysis of 1.

Figure A2.6. Difference spectrum of 47.5
M oxy-trHbNdelN and 176.7 M 1
photolysed with four 500 nm laser pulses.
The experimental difference is fit using the
extinction coefficient spectrum of 47.5 M
oxy-trHbNWT converting to an equimolar
amount of met-trHbNWT, but an obvious
deviation occurs at ~422nm, which is likely
caused by excess NO nitrosylating mettrHbNdelN.
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Nevertheless the fit after the first laser
pulse is reasonably good. The fits get
progressively worse after more laser
pulses, and is very poor after the fourth
pulse (Fig. A2.6).

This is because

excess NO is now present, and can
nitrosylate the met-trHbNdelN after it has
been generated.
To summarize, our experiments in which
large amounts of NO are added to oxytrHbNdelN

are

consistent

with

our

Figure A2.7. Summary of the [met-trHbN]
produced when 47.5 M oxy-trHbN and
176.7 M 1 were photolysed with 500nm
laser pulses, as calculated in figures A2.5
and A2.6

experiments done under pseudo-first order conditions in showing that the deletion mutant’s
reactivity with NO is comparable to that of the wild type. It is not clear why our results
differ so significantly from those of Lama et al.1
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A2.5. Results of SVD Analyses in Sections 4.4.5. and 4.4.6.

Figure A2.8. Results of SVD analysis of
photolysis experiments containing 19.3
M red-trHbNWT and 20.4 M 1. (a) The
three U components above noise, and (b)
the associated V components. Note only
one V component appears to be a real
signal

Figure A2.9. Results of SVD analysis of
photolysis experiments containing 30.6
M oxy-trHbNWT and 73.8 M 1. (a) The
three U components above noise, and (b)
the associated V components. Note only
one V component appears to be a real
signal
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